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The proper expression of a gene to a protein is a complicated process with many steps.  
One of the major steps is translation, the process of decoding a messenger RNA signal 
and the building of a protein from its component parts.  The control of translation is one 
of the major steps for the overall control of gene expression and its dysregulation is 
associated with a wide variety of human diseases including neurological, metabolic and 
reproductive disorders.  Dazl family proteins are germ cell restricted RNA binding 
proteins that contain a motif characteristic of this family, the DAZ domain.  Whilst 
humans encode all three family members DAZ, DAZL and BOULE, flies only possess 
the boule gene.  The members of this family have an essential conserved role in 
gametogenesis in a wide variety of organisms from worm to man with loss of function 
resulting in phenotypes ranging from male or female infertility or both.  However, little 
is known about the molecular role of these proteins in germ cell development.  
 
A previous study within the laboratory showed that several vertebrate Dazl family 
members can stimulate translation of a reporter gene in Xenopus laevis oocytes, 
suggesting a conserved role in mRNA specific translational control.  This is consistent 
with studies in invertebrates.  It was proposed that Dazl proteins fulfil this function 
through an interaction with a translation initiation factor, poly(A) binding protein, 
PABP.  The aim of this thesis was to further refine this model of action.  The work 
presented here investigates several fundamental questions regarding the mechanism of 
Dazl-mediated stimulation.  First, it investigated the step of translation initiation that 
Dazl acts upon and explored the initiation factors that may be required.  Second, it 
addressed in more detail the requirements for an interaction between Dazl and the 
poly(A) binding protein, PABP.  Third, it examined the potential role of another factor, 
DAZ associated protein 1, DAZAP1, in Dazl-mediated stimulation.  The role of multi-
protein complexes containing Dazl bound to the 3’UTR that localise, repress and 
stimulate translation of specific mRNAs at defined times during gametogenesis are 
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Chapter 1: Introduction 
 
 1
1.1 Gene expression, translational control and disease  
 
Gene expression is the process in which a gene is deciphered into a functional gene 
product, usually a protein.  This process is a complex multi-step system and needs to be 
tightly controlled for proper health and development.  The first stage in gene expression 
is transcription, where the gene is copied into a pre-messenger RNA (mRNA).  The 
mRNA then undergoes post-transcriptional processing including splicing, the addition of 
a 5’ cap and a 3’ poly(A) tail.  The next stage in gene expression is the localisation of 
the now mature mRNA from the nucleus where it is transcribed to the cytoplasm where 
it is subjected to the final stage in gene expression, translation.  Translation is the 
process by which the mRNA is ‘read’ by the cellular protein factories, the ribosomes, 
and the gene’s final protein product is produced.  Some proteins then undergo post-
translational modifications to fulfil their function or to regulate their activity.  The 
mRNA template is ultimately destroyed.  Each step within this process is highly 
regulated to ensure that genes are expressed in the correct place, in the correct form and 
at the correct time in order to properly perform their functions.  One of the major levels 
of gene expression control occurs at translation (reviewed in (Day and Tuite, 1998)) 
  
Dysregulation of translation is an important source of genetic diseases and can also play 
a critical role in many infectious disease processes such as viral infection (Thompson 
and Sarnow, 2000).  Causative mutations have been isolated from the protein synthetic 
machinery and its upstream regulators (Scheper et. al., 2007), but also in the control 
elements embedded in specific mRNAs and the trans-acting factors that mediate mRNA 




One of the physiological processes that translational control plays a key role in is 
gametogenesis, and mutations in a variety of genes linked to translation lead to 
infertility, for example members of the Dazl family of proteins (Reynolds and Cooke, 
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2005; Yen, 2004).  Gametogenesis is the process of making the haploid gametes, the 
sperm and the egg, from diploid primordial germ cells.  In order to make haploid cells 
from diploid the cells must undergo both mitosis and meiosis and periods of 
differentiation and growth or maturation.  Entry though different stages of 
gametogenesis is often controlled translationally.  At certain points during this process 
DNA is undergoing complex mitotic and meiotic processes and the packaging of DNA 
makes it unavailable for transcription.  Thus changes in the pattern of protein synthesis 
can only be achieved by the activation, repression or destruction of pre-existing mRNAs 
(Hake and Richter, 1997).  
  
1.2.1 The stages of gametogenesis  
 
Gametogenesis begins with specialist cells, named germatogonia, that act as stem cells 
for the production of gametes; these are known as oogonia in females and spermatogonia 
in males.  The germatogonia undergo both mitosis and meiosis; some reproduce 
mitotically continually replenishing the supply of germatogonia, whereas others first 
divide mitotically before entering a pathway of differentiation and meiosis that will end 




In females the process is known as oogenesis and starts with the transformation of 
oogonia to primary oocytes in a process that takes place either prenatally or shortly after 
birth.  The next step is the process by which a diploid primary oocyte is transformed to a 
haploid ootid and is called ootidogenesis.  This process begins prenatally and arrests at 
prophase I of meiosis.  The arrested primary oocytes then stay in this state until the 
beginning of menstruation when oocytes reactivate.  When reactivated the primary 
oocyte completes meiosis I and divides asymmetrically to form one haploid secondary 
oocyte and one polar body with the majority of the cytoplasm being retained in the 
oocyte.  Immediately post meiosis I, the secondary oocyte initiates meiosis II. This 
meiotic division is also halted, this time at metaphase II. This arrest lasts until 
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fertilisation when meiosis II is completed (a second polar body is also extruded at this 
point) and the newly formed ootid undergoes final differentiation into a mature ovum. 
Oogenesis is reviewed in (Hilscher, 1991). 
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Figure 1.1: Gametogenesis 
Spermatogonia and oogonia develop into gametes following a similar pathway.  Spermatogonia 
(males) and oogonia (females) first undergo a period of growth and maturation to form diploid 
primary spermatocytes (male) or primary oocytes (female) before entering into meiosis I.  After 
meiosis I is complete primary spermatocytes divide into two haploid secondary spermatocytes.  
Primary oocytes divide asymmetrically into one haploid secondary oocyte and the 1st polar body.  
Secondary spermatocytes undergo meiosis II and each forms two spermatids.  Secondary 
oocytes undergo meiosis II and again divide asymmetrically to form an ootid and a second polar 
body.  The final stage of gametogenesis is differentiation where spermatids develop into mature 







In males the process of gametogenesis is known as spermatogenesis and begins when a 
diploid spermatogonium divides mitotically to produce two diploid cells called primary 
spermatocytes.  Each primary spermatocyte duplicates its DNA and subsequently 
undergoes meiosis I to produce two haploid secondary spermatocytes.  Secondary 
spermatocytes then rapidly enter meiosis II and divide to produce haploid cells known as 
spermatids. Spermatids are sometimes referred to as ‘round spermatids’ because of their 
shape when viewed on histological sections.  The final stage is known as spermiogenesis 
and is the process of differentiation of the spermatids to mature spermatozoa.  The 
spermatids elongate and grow a tail, and develop a thickened mid-piece where the 
mitochondria gather.  Spermatid DNA also undergoes packaging, becoming highly 
condensed. The DNA is packaged firstly with specific nuclear basic proteins, which are 
subsequently replaced with protamines during spermatid elongation. The resultant 
tightly packed chromatin is transcriptionally inactive  (Kierszenbaum and Tres, 1978).  
Spermatogenesis is reviewed in (Grootegoed et. al., 2000).  
 
1.2.1 The timing of gametogenesis 
 
Although male and female gametogenesis share common features including a mitotic 
proliferative stage, entry into meiosis, and a post meiotic differentiation they differ 
greatly in the timing of these events, and indeed the stage of development at which these 
events take place.  For example, female germ cells enter meiosis during fetal 
development whereas; in contrast, male germ cells enter meiosis postnatally.  Also, in 
males gametogenesis completes the entire process once started whereas in the female the 
oocyte is arrested in the diplotene stage of meiotic prophase I, where it can remain for 
months or years. Following a growth period, the oocyte resumes meiosis, only to arrest 
at a second point, metaphase II. Finally the oocyte completes meiosis upon fertilization.  




1.3 Translation  
 
The translation of mRNA into protein within the cytoplasm is a complex process 
involving a large number of proteins, protein complexes, ribosomal subunits and tRNAs 
and can be divided into three steps: Initiation; which is the most complex of these phases 
and during which the majority of control takes place.  Elongation; during which mRNAs 
are decoded by the ribosome to make the polypeptide chain encoded by the gene.  And 
finally, termination; when completed peptides and translational machinery are released.  
Each of these steps can be regulated during global or mRNA specific control of 
translation, in which either the majority of cellular mRNAs or individual/subsets of 




The majority of translation initiation is dependent on the presence of the 5’ m7Gppp cap 
structure that is present on the majority of eukaryotic mRNAs.  The second primary 
determinant of translational efficiency is the poly(A) tail present on all but one cellular 
mRNAs.  The other methods of initiation are both cap-independent, the first is similar to 
the cap-dependent pathway but does not require the cap structure.  The second is through 
the use of internal ribosome entry sites (IRESs). 
  
1.3.1.1 Cap-dependent translation initiation  
 
Cap-dependent translation initiation can be divided into two RNA independent steps and 
four mRNA dependent steps.  The RNA independent steps are the formation of the 
ternary complex and the 43S pre-initiation complex.  The mRNA dependent steps of 
initiation can be divided into four basic steps (see figure 1.2).  First the binding of a 
protein complex at the 5’ cap of the mRNA.  Second, the recruitment of the 43S pre-
initiation complex to the mRNA at or near the 5’ end.  Third, the scanning of the small 
ribosomal subunit through the 5’UTR to the initiation codon.  The fourth and final 
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mRNA dependent step is the joining of the large ribosomal subunit at the initiation 
codon, the release of initiation factors and the start of elongation.  All of these steps 
involve the binding of many accessory protein factors, called eukaryotic initiation 
factors (eIFs).  
 
RNA independent steps of initiation 
 
Step 1: Ternary complex formation 
The first step in translation initiation is the assembly of what is known as the ternary 
complex.  This complex consists of the initiator methionyl-transfer RNA (Met-tRNAi), 
eIF2 and GTP.  The purpose of this complex is to bring the Met-tRNAi to the P-site of 
the ribosome and thus position the first amino acid of the polypeptide chain in place.  
eIF2 consists of three subunits, α, β and γ that all have separate functions (see below).  
GTP binding to eIF2 is necessary to keep the complex assembled and is hydrolysed to 
GDP during step 6 (see below).  This hydrolysis reaction is catalysed by the GTPase 
activity of eIF2 and also requires the GTPase activating protein eIF5.  eIF2 is then 
released from the ribosome in a complex with GDP and is recycled into eIF2-GTP for 
the next round of initiation by the action of a guanine nucleotide exchange factor named 
eIF2B.   
 
eIF2α is responsible for the interaction with eIF2B protein and is a key target in 
translational regulation (Krishnamoorthy et. al., 2001).  When this domain is 
phosphorylated eIF2-GDP can no longer act as a substrate for eIF2B and acts instead as 
a competitive inhibitor, thus reducing the amount of free eIF2B, which is limiting within 
cells and consequentially the amount of available eIF2-GTP for translation.  The 
structure of eIF2γ has been solved by X-ray crystallography and contains characteristics 
of a GTP binding domain (Schmitt et. al., 2002).  However eIF2γ needs another 
initiation factor, eIF5, to have functional GTPase activity.  eIF5 is a GTPase activating 
protein specific for eIF2 and supplies an “arginine finger”  to the catalytic site of eIF2γ 
(Das et. al., 2001). The eIF2β subunit is responsible for a mutually exclusive interaction 
with either eIF5 or eIF2B (Asano et. al., 1999). eIF2β also has been shown to have RNA 
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binding activity and it has been suggested that this enables eIF2 in also function in 
initiator AUG recognition (see below) (Laurino et. al., 1999). 
 
Step 2: 43S pre-initiation complex formation 
The next step is the assembly of the 43S pre-initiation complex that contains the ternary 
complex, the 40S small ribosomal subunit plus the initiation factors eIF1, eIF1A, eIF3 
and eIF5.  Initiation factor eIF1A binds eIF3 and eIF5 and is said to be essential for 
binding the ternary complex to the 43S complex (Olsen et. al., 2003). eIF3, which 
contains at least 10 subunits, binds to the 40S subunit directly in an interaction that is 
enhanced by eIF2 and the presence of eIF3 enhances 40S binding of eIF1 and eIF1A.  
Furthermore, eIF1 and eIF1A cooperate with one another in binding the ribosomal 
subunit (Majumdar et. al., 2003).   
 
In yeast it has been shown that eIF1, eIF2, eIF3 and the ternary complex can pre-
assemble independent of the ribosome and is referred to as the multifactor complex 
(MFC) (Asano et. al., 2000). In this complex eIF3 contacts eIF1, eIF2, and eIF5 directly 
and also the 40S ribosomal subunit, giving it a central role in 43S complex assembly 
(Valasek et. al., 2004).   
 
RNA dependent steps of initiation 
 
Step 1: Cap binding complex assembly 
The initial mRNA dependant step of translation is the assembly of a multi-protein 
complex at the cap known as the eIF4F complex (figure 1.2, step 1).  In animal cells the 
eIF4F complex contains the proto-oncogene eIF4E that directly interacts with the cap, a 
scaffolding initiation factor called eIF4G and an RNA-dependant helicase named eIF4A.  
Another initiation factor, eIF4B, is closely associated with the complex (Mathews et. al., 
2007).  
 
The eIF4E protein binds the methylated guanosine cap with high affinity and binds non-
methylated precursors with a much lower affinity (Morino et. al., 1996).  It is this 
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interaction that is thought to be responsible for the assembly of the eIF4F complex on 
the mRNA (though some complex assembly can occur in the absence of the cap, see 
section 1.3.1.2 below) and is thus responsible for the directionality of ribosome entry 
onto the mRNA.  The 3D structure of eIF4E bound to the cap has been solved by X-ray 
crystallography for mouse (Marcotrigiano et. al., 1997) and by NMR for yeast (Matsuo 
et. al., 1997).  From this data the structure of eIF4E is said to be resemble a cupped hand 
with the ‘cup’ of the hand forming a slot for the binding of the cap structure and a 
contiguous region for mRNA binding.  
 
eIF4G is the central core of eIF4F and is thought to be the ‘scaffolding’ protein that both 
dramatically increases affinity of the complex for cap binding (Haghighat and 
Sonenberg, 1997), by increasing the affinity of eIF4E for the cap by an unknown 
mechanism , and holds the rest of the complex together.  It can be divided into three 
areas with the N-terminal third (amino acids (aa) 1-634) containing binding sites to 
eIF4E (Mader et. al., 1995) and also to the poly(A) binding protein (PABP) (Imataka et. 
al., 1998).  The central third (aa 635-1039) binds to eIF4A and eIF3 (Imataka and 
Sonenberg, 1997) and also has RNA binding activity (Pestova et. al., 1996b).  The C-
terminal portion (aa 1040-1560) contains a second eIF4A binding site (Imataka and 
Sonenberg, 1997) and is bound by the Mnk1 kinases (Pyronnet et. al., 1999), which 
phosphorylate eIF4E.  
 
eIF4A possesses RNA-dependent ATPase activity and is the founder member of the 
DEAD box family of RNA-helicases (Oguro et. al., 2003). Its activity is stimulated by 
eIF4B and eIF4A appears more active when part of the eIF4F complex (Mathews et. al., 
2007).  When this protein is bound to the eIF4F complex via its interaction with eIF4G it 
is thought that this helicase activity unwinds secondary RNA structure in the 5’UTR in 
an ATP dependent manner, thus enabling the 43S complex to bind the mRNA.  eIF4A 
also has mRNA binding activity and is thought to be involved in further mRNA 
unwinding after 43S joining during scanning (Abramson et. al., 1987). Another factor 
named eIF4H can also stimulate eIF4A activity and both eIF4B and eIF4H have been 
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proposed to allow eIF4A to unwind longer, more stable RNA structures and to increase 
the rate and range of this unwinding (Rogers et. al., 1999).  
  
Step 2: Joining of the 43S complex to the mRNA 
The assembly of the cap-binding complex and the unwinding of secondary RNA 
structures in the 5’UTR facilitates the joining of the 43S complex to the mRNA (figure 
1.2, step 2).  The 43S complex is recruited to the mRNA in part by the association 
between eIF4G and eIF3 (Imataka and Sonenberg, 1997).  Additional interactions 
between initiation factors may also help stabilise this interaction, for example the C-
terminal domain of eIF5 can bind simultaneously to eIF4G and eIF3 and it has been 
proposed that this aids their binding to each other (Asano et. al., 2001). eIF4B has been 
proposed to aid 43S recruitment via its RNA recognition motif (RRM), which has been 
suggested to bind simultaneously to ribosomal 18S RNA and a mRNA thus bridging the 
ribosome to the mRNA (Methot et. al., 1996a).  eIF4B also can bind eIF3, again aiding 
the recruitment of the 43S complex to the mRNA (Methot et. al., 1996b). 
 
Step 3: Scanning and AUG recognition 
After the 43S pre-initiation complex has bound close to the 5’ cap it “moves” through 
the 5’UTR to the start codon in an ill-defined process known as scanning.  A linear 
movement of the 43S complex along the 5’UTR until an AUG codon is found is the 
most common view of scanning, but as elements of eIF4F such as eIF4G and eIF4A are 
required for scanning it is unsure if the complex moves along the mRNA away from the 
cap, or if the RNA is drawn toward the cap thus looping out the 5’UTR.  It has also been 
suggested that scanning in some systems may be locally bidirectional and able to move 
both in a 3’ and 5’ direction (Berthelot et. al., 2004). The movement of the 43S complex 
along the mRNA determines the tendency of most known RNAs to initiate translation at 
the start codon closest to the mRNA 5’ end, the ‘first-AUG’ rule (Kozak, 1995).  
However in mammals the first-AUG rule is moderated by other factors.  The site must 
be at least 8 nucleotides from the cap (Pestova and Kolupaeva, 2002) and generally more 
than 20, the sequence surrounding the AUG is also important with the strongest 
sequence corresponding to the ‘Kozak’ consensus: GCC(A/G)CCAUGG (the most 
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important residues aside from the AUG are shown in bold, with the +4 G being of even 
more important than the -3 purine) (Kozak, 1987b).  The initiation factors eIF1 and 
eIF1A are also important for scanning and AUG recognition.  A model has been 
suggested where 43S complexes exist in two different forms, a ‘closed’ scanning 
incompetent form in the absence of eIF1 and an ‘open’ scanning competent form in the 
presence of eIF1 (Pestova and Kolupaeva, 2002). eIF1 also prevents premature GTP 
hydrolysis by eIF2 before AUG recognition (Unbehaun et. al., 2004).  It has also been 
suggested that eIF1 and eIF5 inhibit eIF2-GTP hydrolysis at non-AUG codons (Valasek 
et. al., 2004).  As initiation of protein synthesis in cell-free systems is dependent on ATP 
hydrolysis, it is assumed that the scanning process itself is either directly or indirectly 
ATP driven (Kozak, 1980).  
 
Step 4: 60S joining and factor release 
Once scanning is complete and the 43S complex has been properly positioned at the start 
codon, the final step in translation initiation occurs; the joining of the large 60S 
ribosomal subunit to make the active 80S ribosome.  For this step to take place initiation 
factors must be released.  The first action in this process is the hydrolysis of the ternary 
complex bound GTP, catalysed by the GTPase activity of eIF2, which is activated by 
eIF5 as discussed earlier.  This causes the release of eIF2 and all other initiation factors 
are also assumed to release at this point.   
 
Until recently this single GTP hydrolysis was thought to be sufficient for 60S joining but 
the activity of a second GTPase initiation factor, eIF5B, is also required for 80S 
formation (Lee et. al., 2002). eIF5B is already complexed with GTP and eIF5B-GTP 
stimulates 60S joining but GTP hydrolysis only occurs after the joining event that then 
causes the release of eIF5B-GDP (Lee et. al., 2002). eIF5B interacts with eIF1A and this 
reaction is thought to enable eIF5B to localise to the 43S complex bound mRNA (Olsen 
et. al., 2003).  
 
After this second subunit joining step and initiation factor release occurs the ribosome is 
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Figure 1.2: mRNA dependent steps of cap-dependent translation initiation.   
This model is consistent with the majority of data available.  For simplicity not all initiation factors 
have been shown.  The sizes of the factors are not to scale, not all interactions nor the 
orientation of the factors within complexes is depicted. 
Definitions: eIF= eukaryotic initiation factor, 1= eIF1, 1A= eIF1A, 2= eIF2, 3= eIF3, 4A= eIF4A, 
4B= eIF4B, 4E= eIF4E, 4G= eIF4G, 5= eIF5, 5B= eIF5B, Met= Methionine tRNA, m7GpppG= 5’ 
mRNA cap structure, 40S= Small ribosomal subunit, 43S= Pre-initiation complex, 60S= Large 
ribosomal subunit. 
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(1) The eIF4F cap-binding complex binds to the mRNA via an interaction between eIF4E and the 
m7GpppG cap.  There is also a possibility that the observed RNA binding activity of eIF4G may 
play a role in this process.  The binding of the eIF4F complex facilities the ATP dependant 
unwinding of any secondary structure under the action of the RNA helicase activity of eIF4A.  
This activity of eIF4A is enhanced by eIF4B. 
(2) Unwinding allows the 43S pre-initiation complex to join the mRNA via interactions between 
eIF4G in the cap binding complex and eIF3 in the 43S complex.  
The 43S pre-initiation complex consists of 40S ribosomal subunit, the ternary complex (Met-
tRNA, eIF2 and GTP) and various initiation factors (eIFs 1, 1A, 3 and 5).  This complex 
assembles before joining the mRNA but the exact order of and nature of the formation of this 
complex is currently unclear. 
(3) The 43S complex then moves through the 5’UTR to the start codon via ill-defined, but ATP-
dependent, processes known as scanning.   
(4) Scanning ends when the anticodon of the Met-tRNA is engaged to a start codon.  GTP is 
hydrolysed by eIF5 and all initiation factors dissociate.  eIF5B catalyses the joining of the 60S 
ribosomal subunit.  
 
1.3.1.2 Alternative mechanisms of translation initiation 
 
IRESs - viral and cellular 
Some cellular and viral mRNAs utilise an alternative method of initiation using an 
element known as an internal ribosome entry site, or IRES.  This method of initiation 
was first identified in picornaviruses and viral IRESs normally consist of multiple stem-
loops or pseudoknot structures that can promote cap-independent initiation at a site that 
is internal to the mRNA, away from the cap structure (Schneider and Mohr, 2003). As in 
‘normal’ initiation many accessory protein factors are required, however, in general the 
cap-binding protein eIF-4E is not required (Vagner et. al., 2001).  Whilst some IRESs 
require the majority of the canonical initiation factors, other IRESs require only a subset 
and in the most extreme cases none of the eIFs are required (Spahn et. al., 2004) and the 
ribosome is recruited to the IRES directly in an event reminiscent of prokaryotic 
translation. In addition to eIFs many IRESs require other accessory proteins known as 
IRES trans-acting factors, or ITAFs, for their function, with a variety of different 
proteins being utilised by individual IRES elements.  The tertiary structure of IRESs is 
in general thought to be very important for their function and in some cases it is 
suggested the ITAFs may act to stabilise these structures (Vagner et. al., 2001).  
 
Viruses from many different families, including picornaviruses, flaviviruses and others, 
have been shown to use IRES mediated translation as a means to escape the shut-off of 
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host protein synthesis that typically occurs following viral infection (Schneider and 
Mohr, 2003). One mechanism of this shut off of translation is achieved by cleavage of 
eIF4G.  Many different viruses employ this technique and one of the best characterised 
eIF4G proteases is the 2A protease of rhinovirus (Haghighat et. al., 1996).  The cleavage 
of eIF4G causes a reduction in cap-dependent translation but the cleaved eIF4G is still 
sufficient to support IRES mediated translation, so viral mRNAs are still expressed  
(Schneider and Mohr, 2003). Cellular IRESs are frequently less structurally complex 
than their viral counterparts and function during processes such as starvation when cap-
dependent translation is down regulated (Vagner et. al., 2001). 
 
Non IRES cap-independent initiation 
This mode of translation normally describes the ability of cellular mRNAs lacking the 
physiological cap or an IRES to initiate translation but can also occur on artificial 
mRNAs made with non-m7GpppG caps.  This form of initiation is generally inefficient 
but some viruses appear to initiate translation in this manner, for example the AMV 
virus (Gehrke et. al., 1983). The mechanistic details of this process remain unclear but 
elements of the cap-binding complex appear to be required and it is proposed that they 
are still recruited to the 5’end of the mRNA, perhaps due to the RNA binding activity of 
several of the factors (Fletcher et. al., 1990). The 43S complex is then recruited as 
normal via interactions with eIF3.  Scanning, AUG recognition and 60S joining then 
proceeds as in ‘standard’ translation initiation.   
 
Re-initiation  
In most cases eukaryotic ribosomes only initiate translation once per mRNA, but in 
some cases re-initiation at a downstream AUG is possible when the 5’ proximal AUG 
triplet is followed shortly by a terminator codon.  In such cases ribosomes can reinitiate 
translation at the next AUG downstream (Kozak, 1984). The distance between the 
upstream cistron and the second AUG is important in eukaryotes with increasing gap 
increasing re-initiation with a 79 nucleotide gap after a ‘minicodon’ not affecting 
translational efficiency in one system tested (Kozak, 1987c). Re-initiation plays a vital 
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role in the translational control of a subset of cellular mRNAs, including GCN4, 
described in more detail in section 1.2.2.1. 
 
Leaky scanning 
Another mechanism by which initiation may occur at an internal rather than the 5’ 
proximal AUG is known as ‘leaky scanning’, which can occur when the first AUG lies 
in an unfavourable context for initiation and is therefore passed over in favour of a later 
more distal AUG with a better context.  This model has been developed by manipulating 
the context of the AUG in synthetic constructs (Kozak, 1986). Leaky scanning can be 
important for the correct translation of some biologically important genes, for example 
the ß-Site ß-amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1), which is 
linked to processing the proteins involved in Alzheimer's disease (Zhou and Song, 
2006). Its mRNA contains a number of uAUGs that are skipped by leaky scanning and 
this combined with a re-initiation event results in weak expression of BACE1 under 
normal conditions.  It is thought that alterations of the leaky scanning and re-initiation in 
BACE1 gene expression could play an important role in Alzheimer's disease 
pathogenesis (Zhou and Song, 2006). 
 
Shunting 
As mentioned above, in most RNAs the small ribosomal subunit is thought to undergo a 
process called scanning whereby the ribosome moves through the 5’UTR to the AUG in 
an ill-defined process.  However for a very limited number of mRNAs this mechanism is 
thought to be different with the ribosomal subunits bypassing, or shunting, segments of 
the 5’UTR as they move to the initiation codon.  This effect has be observed in 
adenovirus (Yueh and Schneider, 2000) and cauliflower mosaic virus (Pooggin et. al., 
2001) and requires “take-off” and “landing”-pads although the mechanistic details of 
this process are yet to be determined. 
 
Hopping 
Another novel initiation mechanism is that of ribosome hopping.  During translation of 
bacteriophage T4 topoisomerase subunit gene 60 mRNA the complete ribosome 
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disengages from the ORF at glycine codon 46 and re-engages at an identical codon after 
a 50 nucleotide gap, thus producing a single polypeptide from two separate ORFs 




Elongation is the step of translation in which the actual polypeptide synthesis takes 
place.  This process begins with the positioning of the Met-tRNAi into the P-site of the 
ribosome during translational initiation.  The next amino acid in the polypeptide chain, 
determined by the mRNA sequence is then delivered by its cognate tRNA into the empty 
aminoacyl ‘A’ site adjacent to the P-site.  The aminoacyl-tRNA is complexed with GTP 
and eukaryotic elongation factor 1A (eEF1A).  The base pairing between the mRNA 
codon and the tRNA’s anticodon causes conformational changes in the ribosome and the 
hydrolysis of GTP and the release of the tRNA from eEF1A-GDP.  Following 
hydrolysis of the GTP, eEF1A-GDP is released from the ribosome.  This form cannot 
bind amino acyl-tRNA and is 'recycled' to the active GTP-bound form by eEF1B, a 
guanine nucleotide-exchange factor (GEF) for eEF1A.  The release of the tRNA allows 
the aminoacyl-tRNA to form a peptide bond with the adjacent peptidyl-tRNA in a 
reaction catalysed by the ribosome’s peptidyl transferase activity.  During this reaction 
the growing polypeptide chain is passed from the first tRNA to the second, leaving the 
tRNA in the P-site deacylated.  The next step is the translocation of the complex so that 
the deacylated tRNA moves to the exit ‘E’ site from the P-site, and the polypeptide 
bound tRNA in the A-site is moved to take the now vacant position in the P-site.  The 
next codon of the mRNA is shifted to the now empty A-site ready to accept the next 
aminoacyl-tRNA.  This translocation requires GTP hydrolysis and is mediated by 
eukaryotic elongation factor 2 (eEF2).  Elongation continues until a termination codon 
(UAA, UAG or UGA) is recognised by the ribosome complex.  Elongation is reviewed 






Termination of translation occurs when one of the three stop codons, UAA, UAG or 
UGA, reaches the A-site in the ribosome.  When a stop codon enters the A-site of the 
ribosome, ribosome release factors are recruited to the mRNA/ribosome complex and 
mediate the hydrolysis of the peptide chain from the bound tRNA causing the 
dissociation of the newly synthesised peptide from the ribosome.  In eukaryotes a single 
factor, eukaryotic release factor 1 (eRF1) recognises all three stop codons.  The 
eukaryotic release factor 3 (eRF3), a GTPase, binds to eRF1 and stimulates its activity 
and together these factors induce hydrolysis of the ester bond of the P-site peptidyl-
tRNA, thus releasing the finished polypeptide from the ribosome (Alkalaeva et. al., 
2006). 
 
After peptide release the ribosome must be released from the mRNA in order to become 
available for further rounds of translation, a process that is known as ‘ribosomal 
recycling’ from post-termination complexes (post-TCs).  In prokaryotes recycling of 
post-TCs requires an initiation factor, IF3, the EF-G elongation factor and a factor 
known as the ribosomal release factor (RRF).  RRF and EF-G act to dissociate post-TCs 
into free 50S subunits and 30S subunits bound to both the mRNA and the deacylated P-
site tRNA.  IF3 then induces the release of tRNA from 30S subunits, which is followed 
by the spontaneous dissociation of the mRNA, thus leaving all the components of the 
post-TC free for re-use (Peske et. al., 2005; Zavialov et. al., 2005).  There has been no 
equivalent RRF identified in eukaryotes and the mechanism of ribosomal recycling is 
currently unknown.  
 
1.3.4 The closed loop model of translational initiation 
 
Whilst initiation occurs at the 5’ end of the mRNA, the poly (A) tail at the 3’ end is also 
a primary determinant of translational efficiency like the 5’m7GpppG cap.  The effects 
of the poly(A) tail are thought to be largely mediated by poly(A) binding protein (Kuhn 
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and Wahle, 2004; Sachs et. al., 1987), which binds in an ordered manner to poly(A) tails 
(Baer and Kornberg, 1983).  It has been shown that PABP binds to the poly(A) tail 
(Kuhn and Wahle, 2004) and also interacts with proteins that bind to the 5’ cap region 
(Gallie, 1998), and it has been suggested that these interactions can cause the 
circularization of the mRNA (Wells et. al., 1998) into a an end-to-end complex that will 
be discussed in more detail in section 1.5.2.1. 
 
1.4 The control of translation 
  
Translational regulation is important both in terms of genome diversity (Copeland, 
2003) and for controlling temporal and/or spatial gene expression (Mignone et. al., 
2002).  In the latter, effects can be either positive or negative and can act on an 
individual mRNAs or be more global in nature.  Translational regulation of individual 
mRNAs is dependent on sequences within these mRNAs.  In some cases they can be 
linked to changes in mRNA stability or localisation (Day and Tuite, 1998). Many 
different types of translational regulatory elements have been identified, with most 
located in the untranslated regions at the 3’ and 5’ ends (Wilkie et. al., 2003).   Most of 
these mechanisms work at the level of translational initiation and almost every step in 
initiation can be regulated (Gray and Wickens, 1998). However regulation of each of the 
other steps of translation have also been described, suggesting the evolution of multiple 
mechanisms of regulation where single mRNAs can be subject to multiple regulatory 
events due to the presence of different elements that function in response to different 
stimuli.  Alternative initiation mechanisms also play an important role in regulating 
translation and several mRNAs have been shown to be controlled in this way (Gray and 
Wickens, 1998). 
 
1.4.1 Global control of translation 
 
There also exist systems that can regulate whole cell translation with overall levels 
changing in response to stimuli, for example stress (Dever, 2002). Subsets of mRNAs 
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important to reacting to changes in physiological conditions normally escape this global 
control due to elements with these mRNAs.  Thus a complex network of global and 
mRNA specific controls allow the cell to respond to different conditions.  Many of these 
global regulatory events operate via phosphorylation pathways (Raught and Gingras, 
2007).  
 
1.4.1.1 Global control of translation by eIF2 
 
The pathway for translation initiation presented above started with eIF2-GTP and the 
production of this vital complex is one of the key limiting steps in translation.  At the 
end of each round of translation eIF2-GDP must exchange GDP for GTP in order to be 
available for the next round.  Nucleotide exchange of eIF2 involves eIF2B, the guanine-
nucleotide exchange factor (GEF) for eIF2.  eIF2B interacts with the α-domain of eIF2, 
(Krishnamoorthy et. al., 2001).  When eIF2 is phosphorylated on serine 51 the eIF2α 
domain translation is inhibited as eIF2-GDP can no longer act as a substrate for eIF2B 
and acts instead as a competitive inhibitor (Krishnamoorthy et. al., 2001).  Normally 
eIF2 is in excess to eIF2B, so if a small amount is phosphorylated eIF2 sequesters all the 
eIF2B and then there is a general loss of translational activity (Krishnamoorthy et. al., 
2001). This mechanism of translational control is usually the response to cellular stress.  
These stresses activate cellular kinases that then go on to phosphorylate eIF2α.  For 
example yeast GC2 kinase can be activated in response to uncharged tRNAs 
accumulating due to amino acid starvation, infection by viruses can lead to activation of 
PKR and ER-stress leads to phosphorylation via PERK (Wek et. al., 2006).  
 
1.4.1.2 Global control of translation by 4E-BP 
 
Regulatory sequestration proteins represent another type of global control mechanism; 
the eIF4E-binding protein (eIF4B-BP) is a regulatory protein that competes with eIF4G 
for binding to eIF4E and thus prevents formation of the eIF4F complex.   
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In humans there are three eIF4E binding proteins, eIF4E-BP1, eIF4E-BP2 (Pause et. al., 
1994a) and eIF4E-BP3 (Poulin et. al., 1998).  These binding proteins function by 
interacting with eIF4E leaving it unable to bind with eIF4G (Haghighat et. al., 1995).  
This results in the eIF4F complex not being able to form and cap-dependent translation 
is thus reduced.  The region of eIF4E that binds eIF4-BP is separate to the cap binding 
site (Matsuo et. al., 1997) that means that eIF4E/eIF4EBP complexes can still bind the 
cap, but not translate due to an inability to bind eIF4G, leading to RNAs held in 
translationally inactive complexes (Proud and Denton, 1997).  
 
Under stress conditions such as heat, shock or starvation eIF4E-BP1 becomes 
hypophosphorylated and binds to eIF4E whereas hyperphosphorylatred eIF4E-BP1 
cannot bind eIF4E (Pause et. al., 1994a). Interestingly not all stresses cause equal effects 
but may vary in their response to stimuli for example during heat shock (Scheper et. al., 
1997) or certain stages of adenovirus infection (Feigenblum and Schneider, 1996). 
 
1.4.1.3 Global control by eIF4E phosphorylation 
 
eIF4F complex binding is dependent on the affinity for the cap by the eIF4E protein, an 
affinity that has long been thought to be dependent on the phosphorylation state of that 
protein with increased phosphorylation on Ser-209 increasing affinity for the cap 
(Minich et. al., 1994).  However, mutation of Ser-209 to alanine does not affect the 
ability of eIF4E to mediate translation in an in vitro system (McKendrick et. al., 2001) 
suggesting that eIF4E phosphorylation may not be as important.  The importance of 
eIF4E phosphorylation as stimulatory to translation has been further challenged recently 
where it was proposed that phosphorylation instead reduces the affinity of eIF4E cap 
binding activity (Scheper and Proud, 2002).  
  
1.4.1.4 eIF4G decoys 
 
As mentioned above eIF4G is an important factor in translation initiation and its 
availability is important for translation to occur with levels of this protein being 
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regulated at both the level of synthesis and turnover (Morley et. al., 1997). The ability of 
eIF4G to interact with initiation factors may be regulated by a protein called p97, DAP-5 
or NAT1.  This protein has 30% homology to the C-terminal two thirds of eIF4G 
(Morley et. al., 1997), and appears to act as a decoy for eIF4G. It can interact with eIF3 
and/or eIF4A in vitro (Imataka and Sonenberg, 1997) but lacks the ability to interact 
with eIF4E and is thought to suppress translation.  High levels of expression of DAP-5 
represses cell growth, but this effect was not mapped to the portion of the protein that 
binds eIF3 and eIF4A therefore is not clear whether this protein repress growth by 
titrating initiation factors away from ribosomes or by some other mechanism (Levy-
Strumpf et. al., 1997).  
 
1.4.2 Specific control of translation 
 
Specific regulation is conferred by cis-acting elements that are located most frequently 
within the 5’ and 3’ untranslated regions and often serve as binding sites for positive or 
negative trans-acting factors (Gebauer and Hentze, 2004; Gray and Wickens, 1998; 
Wilkie et. al., 2003). These trans-acting factors can be RNA-binding proteins or 
miRNAs and multi-factor complexes are often required, especially for regulation 
mediated by the 3’ end (Gray and Wickens, 1998).  In the few examples that have been 
intensively studied to date, the regulation of these mRNAs appears to occur 
predominantly at the level of initiation (Gebauer and Hentze, 2004; Gray and Wickens, 
1998).  Examples of these different specific control sites are shown in figure 1.3. 
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Figure 1.3: Translational regulatory elements located in the 5’ and 3’ UTRs. 
A: 5’UTR Elements.  i) the 5’ cap, ii) stem-loop structures, iii) regulatory protein binding sites, iv) 
upstream open reading frames, v) upstream AUGs, vi) IRESs and Vii) AUG context 
B: 3’UTR Elements.  i) regulatory protein binding sites, ii) microRNA complementary sites, iii) 
stability elements iv) localisation elements, v) cytoplasmic polyadenylation elements and vii) the 
poly(A) tail.  
(Figure adapted from (Wilkie et. al., 2003).  
 
1.4.2.1 5’ translation control elements 
 
Features within the 5’ untranslated region that affect translation initiation include the 5’ 
cap, leader length, secondary structure, regulatory protein binding sites, IRESs, upstream 
ORFs or AUGs, and initiation codon context (reviewed in (Gray and Wickens, 1998)). 
 
5’ cap 
The 5’ cap is a primary determinant of translational efficiency and must be methylated 
to stimulate translation via eIF-4E recruitment, though an unmethylated cap still 
increases mRNA stability by resisting decapping and protecting the mRNA from 5’ to 3’ 






Stable secondary structure within the 5’UTR is associated with decreased translation 
efficiency.  Relatively weak secondary structures (-30 kcal/mol) are capable of 
inhibiting translation when located close to the cap structure whilst more stable 
structures (-61 kcal/mol) are required to prevent efficient initiation from downstream 
sites (Kozak, 1989a). Stem-loops located close to the cap physically prevent the binding 
of the 43S complex whereas those in a cap-distal position prevent scanning of the 43S 
complex (reviewed in (Day and Tuite, 1998)). Ornithene decarboxylase (ODC) is an 
example of a gene that is regulated in this way.  ODC mRNA translation is impeded by 
140 nucleotide GC-rich region that is predicted to form a very stable stem loop structure 
in the 5’UTR close to the cap structure (Gray and Hentze, 1994b).  If the sequence is 
mutated in such a way that the loop is destabilised, then the translational efficiency of 
the mRNA is increased (Gray and Hentze, 1994b).  It has also been established that if 
the inhibitory region was inverted translation of ODC mRNA was still poor, indicating 
that the structure itself is inhibitory rather than serving as a binding site for a repressor 
protein (Gray and Hentze, 1994b).   
 
Not all secondary structures are inhibitory: Secondary structures positioned downstream 
from the initiation codon can enhance its recognition.  If a stem loop structure is present 
14 nucleotides downstream from the initiation codon this forces pausing of the 43S 
complex at the AUG with the initiation centre directly above the initiator codon thus 
aiding recognition (Kozak, 1990).  
 
RNA binding proteins 
Stem-loop structures are frequently the binding sites for regulatory proteins, which can 
repress translation in a manner similar to secondary structures, but in these cases the 
repression is often highly regulated by controlling the binding of the repressor protein.  
 
A well characterised example of a stem-loop that acts as a binding site for a regulatory 
protein is the iron responsive element (IRE) that is found in the 5’UTR of a number of 
mRNAs including ferritin and erythroid 5-aminolevulinate synthase (eALAS).  The IRE 
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is the binding site for iron regulatory proteins 1 and 2 (IRP-1 and IRP-2) and its mode of 
action is dependent on its position in the 5’UTR.  If the IRE is more cap-proximal then 
43S complex joining is blocked (Gray and Hentze, 1994a). If the IRE is moved to a 
more cap-distal position then 43S joining can occur but there is still some action of 
bound IRPs with a delay in scanning being detected (Paraskeva et. al., 1999).  However 
it appears that the stalled 43S complexes can overcome the effect of the IRE by 
displacing IRP in an unknown mechanism, though the action of helicases disrupting the 
RNA structure of the IRE is suggested (Paraskeva et. al., 1999). 
 
Not all regulatory protein-binding sites within the 5’UTR are structured (as above) and 
not all lead to repression as exemplified by the ITAFs that interact with IRES elements. 
An example of a different type of protein binding site is that of the adenine-rich auto-
regulatory sequence (ARS) in the 5’UTR of the PABP protein mRNA.  This binding site 
is cap-distal, does not have a stable secondary structure and binds a multi protein 
complex of PABP and two other proteins, IMP1, an orthologue of chickenzip-
codebinding polypeptide, and UNR, a protein that can bind PABP (Patel et. al., 2005).  
This complex bound to the ARS represses translation of the PABP mRNA by interfering 
with ribosome scanning and thus auto regulates the expression of PABP (Bag, 2001).  
 
Upstream ORF 
Some transcripts have open reading frames upstream of the main open reading frames 
(ORFs) that are known as upstream ORFs (uORFs).  uORFs in general cause a decrease 
in translation from the main open reading frame by sequestering ribosomes from the 
main open reading frame but are often involved in intricate patterns of control.  
Translation of the main ORF in transcripts containing a uORF is dependent on re-
initiation or leaky scanning (see above).  
 
Although most uORFs are inhibitory, on some genes they can be responsible for the 
activation of translation, as in the case of the yeast gene GCN4.  GCN4 is a transcription 
factor that activates the genes in yeast that are responsible for amino acid biosynthesis.  
The GCN4 mRNA contains four short uORFs (uORF 1, 2, 3 and 4) upstream of the 
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initiation codon of the main ORF.  In nutrient rich conditions, these uORFs restrict the 
flow of scanning ribosomes to the GCN4 AUG and thus the protein is produced at low 
levels.  The translation of uORF4 is especially inhibitory as a GC-rich region adjacent to 
its stop codon causes full disassembly of the ribosome.  Following translation of the first 
uORF, the 60S ribosomal subunit is thought to dissociate, but the 40S subunit remains 
bound and has the potential to reinitiate translation further down the mRNA, but this 
requires additional ternary complexes.  When ternary complexes are plentiful, the 
ribosome can re-initiate efficiently and the probability of translation of uORF4 
increases, and thus translation of GCN4 decreases.  However, under starvation 
conditions, when eIF2 is phosphorylated and ternary complex formation is thus inhibited 
(see section 1.2.1.1) the efficiency of re-initiation is reduced and the translation of 
uORF4 decreases, allowing more 40S subunits to reach the GCN4 AUG and thus initiate 
translation of the GCN4 protein and activation of the amino acid biosynthetic pathways 
occurs (GCN4 translational control is reviewed in (Hinnebusch, 1997)).  
 
In some cases the peptide encoded by the uORF can be involved in the regulation of the 
main ORF as in the case of S-adenosylmethionine decarboxylase (AdoMet) mRNA in 
response to polyamine levels.  The uORF is predicted to produce a short peptide and if 
the sequence of the uORF is altered so the peptide sequence is changed then translation 
of the main ORF is increased, indicating that the uORF peptide regulates the translation 
of the main ORF (Hill and Morris, 1993). 
 
Upstream AUGs 
Some mRNAs have upstream AUGs (uAUGs) (or other initiation codons, see viii 
below) 5’ of the main ORF that unlike uORFs do not have in frame termination codons.  
As the standard initiation pathway will end when they reach the uORF any initiation of 
the downstream AUG will be the result of leaky scanning (see section above).  The 
presence of a uAUG is usually strongly inhibitory, with the inhibition being stronger the 
better the context of the AUG is (Kozak, 1987b). Because uAUGs are not necessarily in 
frame with the main ORF and because there are no termination codons, uAUGs do not 
give the same options for re-initiation as uORFs so are generally more inhibitory.  These 
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are frequently found in mRNAs that encode cytokines, growth factors and transcription 
factors and are proposed to maintain low levels of expression (Kozak, 1991).  
  
In addition to controlling translation from the main open reading frame, multiple start 
codons can also be utilised to produce more than one protein from a single mRNA.  An 
example of this type of translational control is the liver-enriched transcriptional activator 
protein (LAP) and the liver-enriched transcriptional inhibitor protein (LIP) (Descombes 
and Schibler, 1991). LAP is an activator of transcription and LIP, which is produced by 
leaky scanning on the same mRNA, lacks the transcriptional activator domain and 
therefore antagonises the action of LAP.  Changes in the ratio of the two proteins 




As mentioned earlier, an IRES enables an mRNA to initiate translation in a cap-
independent manner.  In addition to viruses some cellular mRNAs also have IRESs.   
Because of the IRES the mRNA is subject to different regulation when compared to 
other mRNAs and can allow translation of a specific mRNA even when general cap-
dependent translation is impaired (Schneider and Mohr, 2003).   
 
For example the human FGF-2 gene, which encodes a growth factor, contains an IRES 
that can initiate translation even when general translation is inhibited due to sequestering 
of eIF4E (Vagner et. al., 1995).  This allows FGF-2 to be translated under conditions 
such as cell growth arrest or stress when normal translation is inhibited.  Production of 
this growth factor could result in the reactivation of translation, stimulation of cell 
proliferation or differentiation and has been suggested to play a key roll in wound 
healing (Vagner et. al., 1995). 
 
Length of UTR 
The length of the 5’UTR can affect translational efficiency with short UTRs 
(approximately less than 20 nucleotides) leading to ‘leaky scanning’, meaning that 40S 
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ribosomal subunits do not efficiently recognise the first AUG due to its proximity to the 
cap-structure and continue to scan to downstream AUGs (Kozak, 1991). Conversely 
increasing the length of the 5’UTR can increase translational efficiency if the sequences 
are unstructured by increasing the number of 40S ribosomal subunits that can bind to an 
mRNA at a time (Dever, 2002), however most 5’UTRs are between 20-100 nucleotides 
(Kozak, 1987a). The upper limit is thought to be in part because an increase in length 
beyond this is more likely to encompass secondary structures, uAUGs or uORFs 
(Kozak, 1987a). 
 
Start site context 
Start site context influences the efficiency of translation by affecting the ability of the 
small ribosomal subunit to recognise the initiation codon (Kozak, 1987b). Consequently, 
context not only plays a role in recognising the initiator codon (AUG or non-AUG) at 
the start of the open reading frame but also at upstream uORFs and AUGs and this 
contributes to amount of inhibition mediated by these elements.  Non-AUG codons, such 
as GUG or CUG can sometimes serves as initiation codons but even the most efficient of 
these (GUG) has only 3-5% the activity of AUG  (Kozak, 1989b).  
 
1.4.2.2 3’ translation control elements  
 
Elements that affect translation within the 3’ untranslated region include the poly(A) tail, 
microRNA complimentary sequences, regulatory protein binding sites, RNA localisation 
elements and stability elements.  
 
Poly(A) tail and changes in poly(A) tail length 
Like the 5’cap, the poly(A) tail is also a primary determinant of translation efficiency.  
Messenger RNAs emerge from the nucleus with a poly(A) tail of approximately 250 
nucleotides and after translocation to the cytoplasm, the poly(A) tail becomes 
progressively shorter over time finally signalling the mRNA for degradation (Sheiness 
et. al., 1975). However, poly(A) tail length can also be subject to tight regulation and 
mRNAs can undergo both regulated deadenylation and polyadenylation within the 
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cytoplasm (Richter, 1999). The length of the poly(A) tail is thought to be linked to 
translation such that polyadenylation leads to translational activation and deadenylation 
with translational silencing (Wickens et. al., 1997).  The main effector protein for the 
poly(A) tail is the poly(A) binding protein, PABP, which will be discussed in detail 
below in section 1.5.  This control system by poly(A) tail length has been best 
characterised during oogenesis and oocyte maturation and early development in mice, 
flies and Xenopus. 
 
The signals in the 3’UTR that promote cytoplasmic polyadenylation and deadenylation 
have perhaps been most intensively studied in Xenopus oocytes, but both the elements 
and the trans-acting factors appear to be conserved between species.  The signals for 
cytoplasmic polyadenylation are bipartite; the first part consists a highly conserved 
AAUAAA sequence that is also required for nuclear polyadenylation (Mendez and 
Richter, 2001).  The second element is a U-rich element that is known as a cytoplasmic 
polyadenylation element (CPE) and includes diverse sequences but a consensus is 
UUUUUAU (Mendez and Richter, 2001).  In addition to directing active 
polyadenylation the CPE, can promote deadenylation (Kim and Richter, 2006) and can 
also recruit a translation-repressive complex (de Moor and Richter, 1999).  The activities 
of CPEs are dependent on a RNA-binding protein called CPE-binding protein (CPEB).  
Repressed mRNAs have multiple CPEs that bind CPEB that have been suggested to 
recruit a repressor protein named Maskin that binds to eIF4E and prevents its binding 
eIF4E, thus preventing translation initiation (Stebbins-Boaz et. al., 1999). The switch to 
polyadenylation is achieved by the phosphorylation of CPEB on serine 174, by the 
serine/threonine kinase Aurora A (Sarkissian et. al., 2004), which leads to activation of a 
CPEB-associated poly(A) polymerase complex that contains the cleavage and specificity 
factor (CPSF) that binds to the germline development deficient (GLD2) poly(A) 
polymerase (Barnard et. al., 2004).  This polymerase then elongates the poly(A) tail that 
then binds PABP, which interacts with eIF4G and helps displace Maskin from the 
repressive Maskin-cap complex, resulting in translational activation.   
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This system of regulating polyadenylation and translation is especially important in 
oocyte development, spermatogenesis, early embryogenesis, and some areas of neurons 
where the majority of gene expression is regulated at the mRNA level (Richter, 1999).  
Unlike most cell types there is no decay of unadenylated mRNAs in Xenopus oocytes 
through oocyte development and early embryogenesis until the mid-blastula transition 
(Mendez and Richter, 2001).  Messages can be adenylated and deadenylated as needed 
to modulate translation.  It is known that adenylation state is the primary determination 
of gene expression on most (but not all, see below) mRNAs in oocytes.  One of the main 
activation points of mRNAs with CPEs is oocyte maturation when oocytes re-enter 
meiosis following fertilisation.  Not all mRNAs in oocytes contain CPEs and 
housekeeping genes lacking CPEs are adenylated and active until oocyte maturation.  
Following oocyte maturation these mRNAs undergo default deadenylation by a 
maturation-activated deadenylase that is released from the nucleus upon germinal 
vesicle breakdown (Wickens, 1990).  Therefore overall at oocyte maturation, some 
poly(A) tails get longer, activating their mRNAs, and some poly(A) tails get shorter, 
deactivating their mRNAs. 
 
MicroRNAs as translational repressors  
MicroRNAs (miRs) are small (approximately 22 nucleotides) regulatory RNAs that 
inhibit the translation of the mRNAs to which they bind (Pillai et. al., 2007). These 
micro-RNAs are anti-sense but do not form perfect duplexes with their target sites, 
which are often found in the 3’UTR of mRNAs (Pillai et. al., 2007). miRs are thought to 
bind to their target mRNAs as part of a large RNA/protein particles known as 
‘microRNA containing ribonucleoprotein particles’ or miRNPs (Pillai et. al., 2007).  
MicroRNAs inhibit protein synthesis as miRNPs containing Argonaute family proteins 
but the mechanisms of regulation remain highly controversial.  A number of studies 
have reported that these miRNP complexes block the initiation phase by a mechanism 
that requires a functional cap (Humphreys et. al., 2005). Whilst other studies have 
implicated the elongation phase (Olsen and Ambros, 1999), the observation that miRNPs 
migrate in heavy pseudo-polysomal like complexes (Thermann and Hentze, 2007) may 
underline some of the disparity of opinion. 
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A novel class of small non-coding mRNAs have been identified in the mouse male 
germline that have been termed piwi-interacting RNAs (piRNAs) (Aravin et. al., 2006) 
(Girard et. al., 2006).  piRNAs are longer than miRs and are typically around 30 
nucleotides in length (Aravin et. al., 2006) (Girard et. al., 2006).  piRNAs are associated 
with MIWI, a spermatogenesis-specific PIWI subfamily member of the Argonaute 
protein family, and depend on MIWI for their biogenesis and/or stability (Grivna et. al., 
2006).  A subpopulation of these piRNAs associate with polysomes, suggesting a 
potential role in translational regulation (Grivna et. al., 2006). 
 
Protein complexes 
Binding sites for regulatory proteins are also present within the 3’UTR.  Unlike their 5’ 
counterparts these sequences are normally unstructured and are thought to recruit protein 
complexes rather than single factors, which are often sufficient to achieve regulation 
within the 5’UTR.  This suggests that regulation within the 3’UTR may be 
mechanistically more complex, perhaps due in part because of its relative distance from 
the site of initiation.  Proteins bound to the 3’UTR can be translational repressors, 
translational activators, stability factors or a combination. 
 
An example of a repressor complex is the control of Drosophila hunchback mRNA by a 
complex containing the Nanos protein.  hunchback encodes a transcription factor that is 
required to be expressed differentially across early Drosophila embryos to establish the 
anterior/posterior axis.  To ensure proper axis establishment Hunchback protein must 
only be expressed in the posterior of the embryo however, maternal hunchback mRNA 
is present uniformly throughout the embryo and its translation would result in too high a 
concentration of Hunchback protein in the anterior of the embryo.  Because of this 
translation of non-posterior localised hunchback mRNA has to be inhibited.  hunchback 
mRNA is repressed via the Nanos protein binding sites known as nanos response 
elements (NREs) in the 3’UTR.  Interestingly, Nanos does not bind to the NRE directly, 
instead an adaptor protein, Pumilio, does so and then recruits Nanos to the NRE and thus 
represses translation (Wickens et. al., 2002). Maternal nanos mRNA is localised to the 
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embryonic posterior, thus establishing a gradient of Nanos protein from posterior to 
anterior, to ensure Hunchback is only expressed in the anterior.  The second cofactor is 
Brain Tumour, which is recruited jointly via interactions with Pumilio and Nanos 
(Edwards et. al., 2003). 
 
Another well-characterised translational repression system is that of 15- lipoxygenase 
(LOX) in erythroid precursor cells, where control of gene expression often occurs at the 
level of translation as the nucleus is lost during the course of erythroid differentiation.  
The function of LOX, which attacks intact phospholipids, is to participate in the 
breakdown of the internal membranes, such as those of mitochondria, during 
reticulocyte maturation.  The mRNA encoding LOX is synthesized in the early stages of 
erythropoiesis, but is only activated for translation in peripheral reticulocytes when it is 
required.  Until then its expression controlled by multiple CU-rich elements, known as 
DICE, in the 3’UTR that are bound by and repressed by a complex of two proteins, 
hnRNP K and hRNP E1 (Ostareck et. al., 1997).  This 3’UTR bound complex represses 
translation by preventing the 60S subunit from joining the mRNA (Ostareck et. al., 
2001). 
 
During the final stage of spermatogenesis, where nuclear restructuring of the nucleus is 
taking place in the differentiating spermatid, the expression of a number of important 
proteins are controlled at the level of translation.  Translational control is important 
during this stage as transcription terminates during mid-spermiogenesis (Kierszenbaum 
and Tres, 1978).  During the restructuring of the nucleus the histone proteins that 
package the DNA are replaced with smaller packaging proteins, first with the transition 
proteins and later with protamines.  The 3’UTRs of the mRNAs that encode the 
protamine 1 and 2 proteins contain cis acting RNA elements that regulate their temporal 
expression in the spermatogenic pathway by repressing the mRNAs until a change in 
phosphorylation releases the inhibitor (Hecht, 1998; Kwon and Hecht, 1993). These 
elements are amongst those bound by the Testis Brain-RNA-binding protein (TB-RBP), 
which can bind to conserved sequence elements in a large number of translationally 




3’UTRs often contain both translation repression and mRNA localisation elements that 
are often in close proximity.  For some RNAs translational control is coupled to mRNA 
localisation to achieve proper temporal and spatial expression.  An example of this 
system is the Drosophila oskar mRNA, which is silenced during transport to its site of 
action in the oocyte (Gunkel et. al., 1998).  The localisation and translation of oskar 
mRNA is thought to be mediated by a RNA binding protein named Staufen, which has 
distinct domains that mediate localisation and translation separately (Micklem et. al., 
2000).  It has been demonstrated by investigation of a Drosophila kinesin heavy chain 
mutant that the Staufen-oskar mRNA complex is localised by the Kinesin motor protein, 
as in the mutant the complex is not transported as normal (Brendza et. al., 2000). During 
localisation this mRNA is repressed by a protein named Bruno that binds to sequences in 
the 3’UTR that are required for this translational repression, named Bruno responsive 
elements (BREs) (Castagnetti et. al., 2000). Loss of Bruno-mediated repression is not 
sufficient for full Oskar activation and the functions of several proteins that are located 
in the posterior of the oocyte contribute to its full activation (Wilson et. al., 1996). 
 
Stability elements 
Rapid turnover of an mRNA will affect the amount available for translation and thus 
gene expression.  There are a number of sequence elements that contribute to the control 
of mRNA stability by either stimulating or inhibiting degradation.  AU-rich elements 
(AREs) are sequence elements found in the 3’UTR of a number of mRNAs that are rich 
in adenosine and uridine bases and are known to target mRNAs for rapid degradation.  
AREs are bound by ARE-binding proteins (ARE-BPs) of which there are many 
examples, with AUF1, HuR and Triestetrapolin being the most extensively studied 
(Gonzalez et. al., 2007). Some of these proteins promote mRNA stabilisation whilst 
others prompt mRNA turnover by recruiting components of the degradation machinery 
(Gonzalez et. al., 2007). The mechanism of ARE-dependent degradation is an initial 
deadenylation event followed by decapping and degradation by exonucleases.  The 
principal degradation pathway in mammalian cells is by a large multi-protein complex 
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called the exosome that contains 3'-5’ exonucleases rather than 5’ to 3’ via Xrn1 
homologues (Barreau et. al., 2005). 
 
In addition to a reduction in protein synthesis as a result of mRNA turnover, AREs can 
also repress the translation of the mRNAs that contain them (Barreau et. al., 2005).  The 
inhibitory effects of ARE-BPs on translation are thought to be mediated by the 
deadenylation of the mRNA leading to a loss of PABP and thus a destabilisation of the 
end to end complex (Barreau et. al., 2005).   
 
1.4.2.3 Regulation of translation by both the 5’ and 3’UTR 
 
Some translational control systems operate via both the 5’ and 3’UTR.  The Drosophila 
male-specific-lethal 2 (msl-2) gene products are vital for the hyper-transcription of the 
single male X chromosome and the dosage compensation needed to balance gene 
expression (Bashaw and Baker, 1997). In females dosage compensation does not occur 
due to a lack of MSL-2 that is caused by the inhibition of the msl-2 mRNA by the 
female-specific RNA-binding protein Sex-lethal (SXL).  The SXL protein partially 
inhibits gene expression by affecting splicing but also affects translation directly with 
the protein binding sites in the 5’ and 3’UTR.  SXL binding the 3’UTR inhibits the 
recruitment of the 43S subunit to the mRNA (Beckmann et. al., 2005) in an association 
with another RNA binding factor, UNR (upstream of N-ras) (Duncan et. al., 2006).  43S 
complexes escaping this block and binding to the 5’UTR are further challenged by SXL 
bound to the 5’UTR where it interferes with the scanning process thus further inhibiting 








1.5 The poly(A) binding protein family  
 
As mentioned in section 1.3.4 the poly(A) tail is a primary determinant of translation 
efficiency with its length thought to be linked to translation such that polyadenylation 
leads to translational activation and deadenylation leads to translational silencing.  The 
main effector protein for the poly(A) tail is the poly(A) binding protein, (PABP) a 
protein defined by its ability to bind to poly(A) tails.   
 
In Xenopus laevis oocytes, the poly(A)-tail can be functionally replaced by tethering 
either PABPC1 or ePABP to unadenylated reporter mRNAs (Gray et. al., 2000) showing 
that the poly(A) tail primarily provides a scaffold for recruiting these proteins. In 
oocytes, PABPs are also thought to protect mRNAs from deadenylation (Voeltz and 
Steitz, 1998), and over expression of Xenopus PABPC1 during maturation delays the 
deadenylation that would normally be silenced (Wormington et. al., 1996). 
 
1.5.1 The PABP family 
 
There are six cytoplasmic PABPs, four of which (PABPC1, tPABP, PABP4, ePABP) 
share a similar structure, a further cytoplasmic PABP (PABP5) has a distinct structure, 
and the final cytoplasmic PABP (ePABP2) shares a very different structure with the one 
nuclear PABP (PABPN1).  The general structure of the PABP family members are 






ePABP RRM1 RRM2 RRM3 RRM4 P-rich PABPC
PABP5 RRM1 RRM2 RRM3 RRM4
PABPN1
ePABP2 RRM
RRM1 RRM2 RRM3 RRM4 P-rich PABPC
RRM1 RRM2 RRM3 RRM4 P-rich PABPC
RRM1 RRM2 RRM3 RRM4 P-rich PABPC
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Figure 1.4: General structure of PABP family members 
PABP1 contains four non-identical RNA recognition motifs (RRMs) linked by an unstructured 
proline-rich region (P-rich) to a globular C-terminal domain (PABPC).  tPABP, PABP4 and 
ePABP maintain a similar structure to PABP1.  By contrast, PABP5 does not contain either the 
proline-rich linker or the PABPC domain.  PABPN1 and ePABP2 contain only one RRM and 
have a long acidic N-terminus and a shorter arginine-rich C-terminus. 
(Figure adapted from (Gorgoni and Gray, 2004)). 
 
Nuclear PABP and ePABP2 
Nuclear PABP has a structure (predicted by amino acid sequence) that is very different 
to that of most of the cytoplasmic PABPs.  It only has one RNA recognition motif 
(RRM) and an arginine-rich carboxy-terminal domain (Kuhn and Wahle, 2004).  
Nuclear PABP functions in the polyadenylation of mRNAs in the nucleus.  It binds to 
nascent poly(A) tracts of 11-14 adenosines (Meyer et. al., 2002) and along with CPSF, it 
forms a complex with poly(A) polymerase (PAP) and stimulates PAP to switch from 
distributive to processive, continuous synthesis (Bienroth et. al., 1993).  PABPN1 
monomers continue to bind the poly(A) tail until it reaches its full length of 
approximately 250 nucleotides (Keller et. al., 2000).  This binding is accompanied by 
the formation of a 21nm spherical particle that is thought to consist of the growing 
poly(A) tail and bound sequential molecules of PABPN1 (Keller et. al., 2000).  These 
particles have been suggested to act as a ‘molecular ruler’ that dictates the final length of 
the poly(A) tail; the particles encompass a stable complex until the tail reaches 
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approximately 250 nucleotides at which point the whole adenylation complex 
destabilises and PAP can no longer add any more nucleotides (Keller et. al., 2000).   
 
A second PABP that shares the structure of PABPN1 was identified in Xenopus, and was 
named ePABP2.  Unlike PABPN1 that is expressed ubiquitously in the nucleus, this 
protein is predominantly expressed during early embryogenesis and the oocyte (Good et. 
al., 2004) and is cytoplasmic.  It was suggested that ePABP2 may play a similar role to 
PABPN1 but in cytoplasmic, rather than nuclear, polyadenylation. 
 
PABPC1 
The primary cytoplasmic PABP is called PABPC1, though when the term “PABP” is 
used it normally refers to this protein (it is also referred to as PAB, PAB1 and PABP1).  
The poly(A) binding protein (PABP1) is a 68kDa protein characterised by its ability to 
bind to the poly(A) tails of mRNAs.  PABP binds specifically to poly(A), requiring a 
minimum of 12 residues to bind but covering about 25 nucleotides when bound to a long 
section of poly(A) (Gorgoni and Gray, 2004). It contains four N-terminal RNA 
recognition motifs (RRMs) separated by short linker sequences.  PABP1 also contains a 
C-terminal region that does not bind RNA and is thought to largely mediate protein-
protein interactions (Kozlov et. al., 2001).  This C-terminal domain (PABC) is 
composed of 5 α-helices and is linked to the RRMs by a proline- and glutamine- rich 
linker region (Gorgoni and Gray, 2004).  The PABC domain together with the linker 
region is sometimes referred to as the PABP C-terminal region (PABPCt). 
 
PABPC1 is often regarded as being ubiquitously expressed but experimental data 
suggests that though it is widely expressed there may be differences in expression levels 
between different tissues.  Northern blots suggest that human PABPC1 is expressed 
highly in heart, lung, liver (Yang et. al., 1995), testis and ovary (Feral et. al., 2001).  
Compared to other tissues it is less highly expressed in brain, skeletal muscle (Yang et. 
al., 1995), and colon (Feral et. al., 2001).  A northern blot of mouse PABP1 showed low 
levels of expression in muscle, liver and brain (Kleene et. al., 1994).   
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Traditionally antibodies to PABP have not discriminated between the family members 
and have likely been cross reactive to multiple PABPs, making expression analysis at 
the protein level unreliable with regards to which PABP is expressed where.  However a 
current project seeks to address this issue but is still in the initial stages (Ross Anderson 
and Hannah Burgess, unpublished).     
     
tPABP 
A testis specific PABP (tPABP, also known as PABP3) has also been identified, 
originally in mouse (Kleene et. al., 1994) but subsequently in human (Feral et. al., 
2001). The gene coding for this protein is thought to have derived from a 
retrotransposition of the PABPC1 gene (Kleene et. al., 1998).  The gene is intronless and 
codes for a protein with high homology (92.5%) to PABPC1 (Feral et. al., 2001).   
 
Unlike PABP1 that is widely expressed, northern blot analysis has shown tPABP to be 
restricted to testis in humans (Feral et. al., 2001), though the experiment only queried 
eight tissues.  RT-PCR followed by southern blotting has suggested a similar result in 
mice (Kleene et. al., 1998).  tPABP was also shown to be localised to round spermatids 
in human adult testis sections (Kleene et. al., 1998).  Northern blots of fractionated testis 
cells suggested that tPABP RNAs are present in spermatocytes and round spermatids but 
are absent in elongating spermatids in mouse testis (Kleene et. al., 1994). 
 
This gene’s distinct expression profile from PABPC1 may indicate that the protein has 
either functional differences or a different biological role.  The subcellular localisation 
seen in the testis would imply a direct function in spermatogenesis.  
 
PABP4 
PABP4, (also known as inducible PABP and PABPC4) was originally described as an 
mRNA upregulated in activated T-cells and as a protein expressed on the surface of 
activated platelets (Yang et. al., 1995).  PABPC4 also shares homology with PABPC1 
but is more divergent sequence than tPABP; the human proteins share 89% identity in 
the RRMs (Sladic et. al., 2004) and 45% in the PABPC domain (Okochi et. al., 2005).  
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The expression pattern of PABPC4 awaits to be determined at the protein level but it 




ePABP was initially identified in Xenopus (Voeltz et. al., 2001) and also appears to be 
present in mammals (Seli et. al., 2005; Wilkie et. al., 2005).  ePABP has been shown to 
be highly expressed in Xenopus laevis oogenesis and embryogenesis (Cosson et. al., 
2002) and in ovary and testis in mouse with levels well exceeding that of PABPC1(Seli 
et. al., 2005; Wilkie et. al., 2005).  As the dominant PABP in oogenesis this PABP may 
play a significant role in this process.  ePABP appears to have the same general structure 
as PABPC1 but is the most divergent of the similar cytoplasmic PABPs (PABPC1, 
tPABP, PABPC4 and ePABP) and shows most divergence in RRM3 and the proline rich 
linker region (Voeltz et. al., 2001).  
 
PABP5 
PABP5 is encoded by a gene located on the X chromosome identified in humans and 
mice and like tPABP appears to be mammalian specific.  It differs from the first three 
PABPs mentioned here in that is lacks the PABPCt domain.  A low level of expression 
has been noted in various human tissues at the RNA level and a higher level of 
expression seen in the ovary (Blanco et. al., 2001).  It has not been investigated further 
and its function is currently unknown.   
 
1.5.2 PABP functions 
 
Not all the PABPs have an identified function; PABPC1 has been shown to function in 
mRNA translation and stability in the cytoplasm.  Of the other cytoplasmic PABPs only 
ePABP has also been shown to function in translation (Wilkie et. al., 2005), tPABP, 
iPABP, PABP5 and ePABP2 have all yet to be examined, though ePABP, ePABP2, 
tPABP, iPABP have all been shown to bind to poly(A).  
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1.5.2.1 The function of PABP in translation 
 
The poly(A) tail is a major determinant of translational efficacy and PABP is the 
effector molecule for the poly(A) tail (Kuhn and Wahle, 2004) but the exact mechanism 
of PABP stimulation of translation is unclear. 
 
In yeast based cell-free experimental systems a complex of PABP and poly(A) binds to 
eIF4G, which interacts in turn with eIF4E bound to the cap (Tarun and Sachs, 1995).  
Atomic force microscopy showed that such a complex formed from purified proteins 
could be visualised as a ring structure with 3’ and 5’ binding portions interacting and the 
RNA forming a loop between them (Wells et. al., 1998) and also that these components 
could stimulate the translation of a reporter RNA in vitro (Tarun and Sachs, 1995).  A 
model for translational stimulation via PABP, in which PABP circularises mRNAs it 
binds to and promotes stable 48S complex formation thus enhancing translation, was 
formulated on the basis of these results.  This model of action was enhanced by the 
discovery that the PABP-eIF4G interaction enhances the binding affinity of PABPC1 for 
poly(A) (Le et. al., 1997) as measured by electro mobility shift assay.  The PABP-eIF4G 
interaction also increases eIF4E affinity for the cap as shown by using a rabbit 
reticulocyte lysate in vitro system to examine the potential of cap analogue to displace 
eIF4E from a reporter in the presence and absence of PABP (Borman et. al., 2000).  
 
In vitro coimmunoprecipitation assays have shown that PABP also interacts with a 
protein called the PAB-interacting protein (PAIP1) (Craig et. al., 1998).  Subsequently, 
Paip1 interacts with eIF4A as shown by further coimmunoprecipitations and was shown  
to stimulate translation of a reporter mRNA in cultured mammalian cells (Craig et. al., 
1998). The interaction with eIF4A was proposed to stimulate translation possibly by 
stimulating the RNA unwinding activity of eIF4A in the 5’UTR of an mRNA and thus 
enabling more efficient ribosome joining (Craig et. al., 1998).  eIF4A is known to be 
important for translation of all mRNAs, as dominant-negative mutants of eIF4A repress 
translation in a rabbit reticulocyte translation system (Pause et. al., 1994b).  PABP also 
interacts with eIF4B as demonstrated by Far Western blotting of proteins purified from 
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wheat germ extracts (Le et. al., 1997) and in vitro coimmunoprecipitations (Bushell et. 
al., 2001).  The interaction of PABP with eIF4G had a positive effect on the ATPase and 
RNA helicase activity of a complex of eIF4A, eIF4B and eIF4G as shown by an ATPase 
and helicase assay respectively using purified proteins (Bi and Goss, 2000).  On the 
basis of these results it was suggested that PABP may enhance the rate of RNA 
unwinding in translational initiation thus enhancing translation (Bi and Goss, 2000).  
 
Though the in vitro evidence for PABP’s role as a translational activator gives some 
information, its role in living cells is less clear.  It has been suggested that yeast PAB is 
important for translation in vivo: Yeast pab1 mutations show synthetic lethal interactions 
with eIF4E mutations indicating that they interact in vivo (Tarun et. al., 1997).  Other 
evidence for PABP’s role in vivo again came from yeast with depletion of PAB in S. 
cerevisiae by promoter inactivation that resulted in the inhibition of translation initiation 
(Sachs and Davis, 1989).  
 
Tethered function assays in Xenopus oocytes also provide direct support for a role of 
PABP as a stimulator of translation.  PABP tethered to the 3’UTR of a reporter mRNA 
stimulates translation of that reporter in cis and can do so without the presence of a 
poly(A) tail (Gray et. al., 2000).  Tethered function assays also reveal that multiple and 
separate parts of the Xenopus PABP protein can stimulate translation with RRMs 1-4, 1-
2 and 3-4 all being able to stimulate translation as well as the full length protein (Gray 
et. al., 2000).  This experiment implies that the interaction of PABP with eIF4G is not 
the only mechanism by which PABP stimulates translation as RRMs 3-4 are unable to 
bind eIF4G but still stimulate the reporter.  This is consistent with reports that PABP can 
stimulate translation through multiple mechanisms (Kahvejian et. al., 2005). 
 
 PABP has not just been implicated in stimulating 40S joining; effects of PABP binding 
on 60S ribosomal subunit joining have also been reported (Sachs and Davis, 1989). A 
yeast genetics approach showed that the absence of eIF5B or a defect in eIF5, proteins 
involved in 60S joining, specifically reduced the translation of a polyadenylated RNA, 
suggesting that poly(A), and therefore PABP may promote a role in 60S joining 
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(Searfoss et. al., 2001).  It was further suggested that PABP may act in this manner by 
inhibiting two putative RNA helicases (genes SKI2 and SLH1) that otherwise inhibit 
eIF5 and eIF5B (Searfoss et. al., 2001).  A role for PABP in 60S joining is supported by 
experiments in a mammalian cell-free system where it was demonstrated by sucrose 
gradient analysis that depletion of PABPC1 leads to reduced 80S complex formation in 
addition to reduced 43S complex formation (Munroe and Jacobson, 1990), though 
mechanisms of this action remain unclear.  A second in vitro system using PABP 
depleted mammalian cell extracts showed both 48S and 80S complex formation was 
inhibited by the depletion of PABP and identified stronger inhibition (approximately 
twofold) of 80S complex formation and argued that PABP plays a direct role in 60S 
subunit joining (Kahvejian et. al., 2005). 
 
PABP also interacts with a eukaryotic release factor, eRF3, as shown by yeast-two 
hybrid assays and in vitro GST coimmunoprecipitations (Hoshino et. al., 1999).  It was 
suggested that PABP may link translational termination to translational initiation, thus 
promoting ribosomal recycling (Uchida et. al., 2002) but no exact mechanism has been 
proposed. 
 
1.6 The Dazl family  
 
Dazl is a member of a gene family of RNA binding proteins called the DAZ family.  
DAZ was first described as a candidate factor underlying spermatogenesis defects in 
infertile men (Reijo et. al., 1995; Reynolds and Cooke, 2005).  It is located on a region 
of the Y chromosome deleted in roughly 10-15% of men who fail to produce sperm 
(azoospermia) in the ejaculate; and is referred to as the azoospermia factor region, or 
AZF (Vogt et. al., 1996).  Subsequent studies have shown that this region contains 
several candidate genes that could be the cause of the genetic defect (Foresta et. al., 
2001).  Two RNA binding proteins were identified from this region; the first was named 
RBMY (RNA-binding motif) (Ma et. al., 1993) and is believed to play a role in splicing, 
based on finding that it co-localises with splicing factors as assessed by co-
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immunohistochemistry on human testis sections (Elliott et. al., 1998).  The second 
protein was identified in a study examining microdeletions of the AZF region in patients 
suffering from spermatogenic failure (Reijo et. al., 1995).  This gene was named Deleted 
in Azoospermia (DAZ).  Both DAZ and RBMY are present in multiple copies within 
this region (Chai et. al., 1997; Yen et. al., 1997).  
 
1.6.1 Evolutionary distribution 
 
Analysis of the DAZ sequence has identified a family of related proteins that has three 
members, DAZ, Dazl and Boule, known collectively as the Dazl family of proteins.  
These proteins are found in many different species across evolution ranging from 
invertebrates to humans but not all species have the same complement of family 
members (Haag, 2001; Xu et. al., 2001).  DAZ is restricted to humans and Old World 
monkeys (Shan et. al., 1996).  An autosomal homologue of DAZ is found on 
chromosome 3 in humans called Dazl (DAZ-Like).  This gene is also found in other 
vertebrates, including the popular laboratory models mice, Xenopus laevis and zebrafish 
(Cooke et. al., 1996; Houston et. al., 1998; Maegawa et. al., 1999).  An ancestral 
autosomal homologue, called Boule, has also been identified, originally in Drosophila 
(and is the only DAZ family member found in Drosophila) (Eberhart et. al., 1996).  
Boule has also been shown to exist in mouse, human and worm, it is also predicted to 
exist in zebrafish and Xenopus laevis (Karashima et. al., 2000; Xu et. al., 2001). It has 
been proposed that Boule is the original representative of the family and that DAZL 
arose from Boule in an ancestor of vertebrates (Haag, 2001). The DAZ gene is thought 
to have originated from a duplication-transposition of the DAZL gene to the Y-
chromosome of an ancestor of today’s Old World monkeys (Foresta et. al., 2001).   
Repeated amplification of the DAZ gene has lead to most men having four DAZ genes, 
though about 2% of the male population have only two DAZ genes due to a 1.6-Mb 
deletion (Repping et. al., 2003).  The multiple copies of the DAZ genes are not all 
identical and they vary in both the number of RNA Recognition Motifs (RRMs) and 
DAZ repeats (Saxena et. al., 2000; Yen et. al., 1996).  Western blotting of human testis 
 42
extracts with a DAZ-specific antibody has only detected one band, suggesting that not 
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Figure 1.5: Phylogenetic tree based on the protein structure of Dazl family genes.   
Hs = Homo sapiens.  Mm = Mus muscularis.  Xl = Xenopus laevis.  Xt = Xenopus tropicalis.  Dr 
= Danio rerio.  Ce = Caenorhabditis elegans.  Dm = Drosophila melanogaster.  Tree routed to 
human hnRNPA1. 
 
1.6.2 Dazl family protein structure 
 
The structure of Dazl family proteins has not been solved but they contain two 
recognisable motifs, an RNA recognition motif and a DAZ motif.  RRM motifs are 
found in many RNA-binding proteins including those involved in mRNA splicing, 
translation, localisation and stability.  Solution of the structure by NMR of a number of 
RRMs bound to RNA have illustrated how the face of the protein that does not interact 
with RNA can, in a number of investigated cases, be utilised for protein-protein 
interactions to mediate effects on RNA utilisation.  For example RRMs 1-2 of PABP 
have been shown, when bound to RNA, to form a globular structure composed of anti-
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parallel β-sheets backed by two α-helices (Deo et. al., 1999). This structure allows one 
face of the domain to bind RNA, leaving the other face free for protein-protein 
interactions (Deo et. al., 1999).  Whilst Dazl and Boule only contain a single RRM, 
some copies of human DAZ contain two RRMs (Moore et. al., 2004). However, as 
mentioned above, not all the human DAZ genes appear translated (Reijo et. al., 2000; 
Slee et. al., 1999), leaving the relevance of DAZ proteins with multiple RRMs unclear. 
A number of studies have demonstrated that Dazl proteins are capable of binding RNA 
and have sought to identify the RNA binding specificity of Dazl proteins (see RNA 
targets).  The DAZ motif, which appears unique to this family, consists of repeats of a 
24 amino acid sequence rich in glutamine, proline and tyrosine and is believed to 
mediate protein-protein interactions and polysome association (Tsui et. al., 2000b).  The 
number of DAZ repeats varies between different family members, DAZ proteins can 
contain between 8-24 copies of the repeat (Foresta et. al., 2001) although DAZL and 
Boule only possess a single repeat. Homology between Boule and DAZL/DAZ is 
essentially limited to the RRM (78% similar) and the DAZ repeat (50% similar).  DAZL 
and DAZ are similar through most of their lengths apart from the difference in the 
number of DAZ repeats; DAZL also has an extended C-terminal region after its DAZ 
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Figure 1.6: Protein structure of Dazl family.  
The structures are based on the amino acid sequence of the human proteins.  DAZ contains one 
RNA recognition motif (RRM) and 8 DAZ repeats (DAZ).  DAZL is overall 50% identical and 57% 
similar to DAZ, but is much more conserved up to the end of its first DAZ repeat (82% identical, 
87% similar) thereafter the two proteins begin to differ with DAZL lacking the multiple DAZ 
repeats that DAZ contains but having a extended C-terminal region that is not present in the 
DAZ protein.  BOULE has the same general structure as DAZL with one DAZ repeat and the 
extended C-terminal region.  However the sequence of BOULE is much more divergent from 
DAZL with an overall 30% identity and 44% similarity.  Again the area containing the RRM and 
DAZ repeat is the most conserved with a 37% identity and 54% similarity. 
 
1.6.3 Expression pattern of Dazl family members 
 
The expression patterns of the different Dazl family members are not all the same.  
Often their expression patterns overlap but are not identical suggesting the possibility 
that the different proteins may have separate functions in gametogenesis and may 
interact with different protein partners or mRNA targets in doing so.  This section will 
discuss what is known about the expression pattern of Dazl family genes in different 
species. 
 
Invertebrates; Drosophila and C. elegans 
As mentioned above invertebrates only possess one Dazl family gene, which is 
homologous to human BOULE, which confusingly in C. elegans is called daz-1.  daz-1 
has been shown to be expressed in the gonad of C. elegans by whole mount in situ 
worms hybridisation (Karashima et. al., 2000). daz-1started expression in the distal 
mitotic region of the gonad, began to accumulate in the meiotic transition zone, and 
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reached the maximum level in the proximal pachytene region (Karashima et. al., 2000). 
In Drosophila Boule protein is expressed in testis as shown by Western blot and 
immunofluorescent staining, with expression being observed in pre-meiotic and meiotic 
spermatocytes and post-meiotic spermatids,  (Cheng et. al., 1998).  An isoform of Boule 
has also been found expressed in the nervous system of Drosophila using 
immunohistochemistry (Joiner and Wu, 2004), which represents a possible role for a 
Dazl family member outside of the germline.  
 
Xenopus and zebrafish 
Xenopus laevis Dazl (Xdazl) RNA expression was first identified by northern blot in 
adult testis and ovary (Houston et. al., 1998). In situ hybridisations found Xdazl RNA to 
be localised to the vegetal cortex of oocytes, exclusively in the germ plasm of early 
embryos and to be expressed in the spermatogonia and spermatocytes of Xenopus testis 
(Houston et. al., 1998).  The presence of Xdazl protein expression in the ovary and testis 
was later confirmed by Western blotting (Mita and Yamashita, 2000). Xdazl expression 
was further characterized and was shown to be present in all stages of male and female 
germ cells except mature spermatozoa (Mita and Yamashita, 2000). In embryogenesis 
Xdazl protein is not localised to any specific region in early-stage embryos (in contrast 
to the strict localization of its mRNA in the germ plasm) and disappears after 
gastrulation before reappearing in the primordial germ cells situated at the genital ridge 
(Mita and Yamashita, 2000).  
 
Zebrafish Dazl (zDazl) mRNA has been shown to be expressed in the gonads of both 
sexes by northern blot, in ovary it was localised in the region of oocytes that becomes 
the germ cells using in situ hybridisations (Maegawa et. al., 1999). Further experiments 
of the same type revealed that the zDazl gene is expressed in spermatogonia and 
spermatocytes but not in secondary spermatocytes, spermatids or mature sperm 






Mouse Dazl (mDazl) transcript was detected predominantly in the testis, but also at 
lower levels in ovaries (Reijo et. al., 1996).  In testes of wildtype mice, Dazl 
transcription is detectable 1 day after birth, then increases steadily as spermatogonial 
stem cells appear before it plateaus as the first wave of spermatogenic cells enters 
meiosis and then is sustained thereafter (Reijo et. al., 1996).  Immunostaining with an 
anti-mouse Dazl antibody on sectioned testis showed that mDazl protein is expressed in 
the germ cells with spermatogonia and early and late spermatocytes identified as 
positive for Dazl (Ruggiu et. al., 1997).  Dazl protein was also identified in germ cells in 
the ovary by the same method (Ruggiu et. al., 1997).  
 
In contrast to the work of Riejo in 1996, a further study detected Dazl transcripts before 
birth (Seligman and Page, 1998).  Northern blotting of developing gonads in mouse 
detected Dazl transcripts at 12.5 days post coitum (dpc) in male and female gonads, 
during which period the only germ cells present are primordial germ cells (Seligman and 
Page, 1998).  Dazl transcript was also detected by RT-PCR in testis and ovary RNA 
samples isolated from 14.5 dpc mouse embryos (Brekhman et. al., 2000). 
 
Both the Boule transcript and the Boule protein were found to be confined to the testis,  
however its cellular distribution is different to that of other family members, with Boule 
not being expressed in the mitotic germ cells but instead being restricted to the meiotic 
cells (Xu et. al., 2001). 
 
Human 
In humans, Dazl transcript was detected by RT-PCR in testis and ovary RNA samples 
isolated from human foetuses at approximately 23 weeks gestation (Brekhman et. al., 
2000).  RNA in-situ hybridisation of human embryonic ovary from the same time point 
found Dazl transcripts in oogonia, oocytes and granulosa of primordial follicles in ovary 
and in germ cells in human testis, also from foetuses at approximately 23 weeks 
gestation (Brekhman et. al., 2000).  Immunohistochemistry was used to show that 
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DAZL is expressed in embryos in germ cells of girls and in mature oocytes (Dorfman et. 
al., 1999). 
 
Dazl family proteins are expressed only in germ cells, in fact DAZ protein was 
investigated using an antibody for immunostaining and was found to be expressed in the 
spermatogonial stem cells, spermatocytes and prenatal primordial germ cells in humans 
but is absent from late spermatocytes or postmeiotic cells (Moore et. al., 2004).  DAZL 
is expressed in spermatogonia, primary and secondary spermatocytes, spermatids and 
postmeiotic cells, and also in foetal germ cells (Reijo et. al., 2000; Ruggiu and Cooke, 
2000; Ruggiu et. al., 1997). DAZL transcript and protein has also been detected in 
mature human spermatozoa (Lin et. al., 2002). BOULE protein is expressed in 
spermatocytes, persists through meiosis and decreases in early spermatids in humans, no 
expression is seen in spermatogonial stem cells, as determined by immunostaining of 
sectioned tissue (Luetjens et. al., 2004; Xu et. al., 2001).  
 
1.6.4 Knock out phenotypes and effects in humans 
 
It has been suggested by knock-out and knock-down phenotypes that the DAZ family 
have a common function in germ cell formation in a variety of species, although clear 
differences in the phenotypes exist.  This section will examine the phenotypic effects of 
Dazl family disruption in model organisms and also the effects seen in humans.  
 
Invertebrates: Drosophila and C. elegans 
In Drosophila, disruption of boule results in a block at the first meiotic division during 
spermatogenesis (Eberhart et. al., 1996). Interestingly, no effect on oogenesis has been 
reported in Drosophila, despite the fact that no other family members are present.  
 
In C. elegans only the female line appears affected, loss of function mutants in daz-1 
leads to an eventual arrest at pachytene during oogenesis (Karashima et. al., 2000), and 
knock-down in C. briggsae prevents the sperm/oocyte switch in hermaphrodites (Otori 




Xdazl has been shown to be essential for primordial germ cell proliferation and 
migration as specific depletion of maternal Xdazl mRNA by injecting an antisense DNA 
oligonucleotide results in tadpoles lacking, or severely deficient in, primordial germ 
cells (PGCs) (Houston and King, 2000). Immunostaining of primordial germ cell 
markers in embryos revealed that in Xdazl depleted embryos, PGCs are lost at the late 
tailbud stage, at or near the time when they begin their dorsal migration to the site of the 
gonads (Houston and King, 2000).  
 
Mouse 
In mice knocking-out Dazl leads to loss of germ cells and the complete absence of 
gamete production in both sexes.  In females, this germ cell loss has been characterised 
by looking at ovary sections; in the Dazl null mice the ovaries appear relatively normal 
at 15 dpc but by 19 dpc there is a marked deficiency of oocytes, and many of those 
remaining are degenerating and being absorbed (Ruggiu et. al., 1997).  It was also noted 
that in the absence of Dazl expression no follicles form in the mouse ovary (McNeilly et. 
al., 2000).  A later study investigated the ovary at 17.5 dpc and showed that germ cell 
loss had occurred at this point (Saunders et. al., 2003). 
 
In male Dazl null mice 19 dpc embryo, testis histology reveals that the ratio of somatic 
Sertoli cells to germ cells raises from the 4:1 ratio seen in wild type individuals to 8:1 
(Ruggiu et. al., 1997). This male germ cell loss occurs at a late prenatal stage and the 
postnatal testes have very low levels of germ cells and even these arrest early during the 
spermatogenic differentiation, before meiosis (Schrans-Stassen et. al., 2001). Another 
study on the same mice strain discovered that some surviving germ cells could reach the 
leptotene stage of meiotic prophase I before arresting (Saunders et. al., 2003).  It was 
concluded that in the absence of Dazl germ cells can embark on functional 
differentiation but cannot progress through the meiotic prophase (Saunders et. al., 2003).  
A later study investigated the influence of genetic background on the nature of the 
meiotic arrest seen in Dazl knockout mice (Lin and Page, 2005).  Here the knockout was 
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bred onto a C57BL/6 background.  The effect of this was loss of germ cells at embryonic 
stage e14.5, earlier than in previous studies, indicating that genetic background has a 
clear effect on Dazl knockout phenotype in mice. 
 
It should be noted that, although the phenotypes observed in male and female mice occur 
at different times and stages during development, the timings of cell death in the ovary is 
at the point at which meiosis is starting and that this phenotype parallels the situation in 
the male.  The difference in the time of onset of the phenotype reflects the difference in 
the timing of entry into meiosis in the male and female germ cells (see section 1.2.1).  
 
Human 
As mentioned earlier in humans azoospermia is associated with loss of the region of the 
Y chromosome that contains DAZ, the AZF (Tiepolo and Zuffardi, 1976).  The AZF is 
commonly divided into three (Vogt et. al., 1996), and the region containing DAZ, the 
AZFc region, has been found to be much more likely to be deleted in azoospermic men 
than the other regions with 71% missing AZFc compared with 13% missing AZFa and 
31% missing AZFb (Ferlin et. al., 1999). Though it must be considered that the sample 
size investigated was limited to 180 men and that although DAZ is a strong candidate for 
the AZFc azoospermia factor it has not been formally proven.  In a separate study loss of 
DAZ gene was shown to be related to problems with spermatogenesis ranging from 
azoospermia to oligospermia (Reijo et. al., 1995).   
 
Since the initial observations that loss of DAZ causes problems with spermatogenesis the 
situation has become more complicated with the knowledge that the area of the Y 
chromosome that contains the AZF is prone to mutation, recombination and deletions 
(Repping et. al., 2006).  Therefore some of the variations in the phenotypes seen in 
deletions of the AZF regions could be explained by genetic variations in the locus 
deleted, with different haplotypes having different implications for an AZF deletion with 
different specific DAZ genes being present before or after the deletion.  Deletion of the 
gene cluster containing DAZ1 and DAZ2 is responsible for severe oligospermia 
(Fernandes et. al., 2002) whereas deletion of DAZ2 alone does not appear to have any 
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affect on fertility (Fernandes et. al., 2004). Deletion of both DAZ3 and DAZ4 is common 
and has deleterious effect on fertility (Fernandes et. al., 2004).  Different ethnic groups 
are also typified by different deletions or modifications in the AZF region.  For example, 
partial duplication at AZFc on the Y chromosome is a risk factor for impaired 
spermatogenesis in Han Chinese in Taiwan (Fernandes et. al., 2004) and certain Chinese 
men possess a Y chromosomal haplotype that increases the chance of a complete AZFc 
deletion (Zhang et. al., 2007).   
 
The evidence for links between the other Dazl family members and infertility in humans 
is less compelling.  A lack of BOULE protein was detected in the testis biopsies with 
meiotic arrest by immunochemistry  (Luetjens et. al., 2004), but mutations in the 
BOULE gene were not found and the absence of the protein could have been due to the 
meiotic arrest rather than the cause. A genetic study investigating women with 
premature ovarian failure and infertile men has linked mutations in DAZL to these 
conditions (Tung et. al., 2006), though no functional work was undertaken. 
 
In all cases humans studies have been limited to observations of gene or protein loss and 
associated problems with fertility.  Due to the difficulty of using humans as an 
experimental system no molecular evidence of causality has been presented, but taken 
together these results strongly support a critical and evolutionarily conserved role for 
these proteins in gametogenesis. 
 
Dazl family redundancy  
There is a partial but not complete redundancy within the Dazl family of proteins.  
Human DAZ (Slee et. al., 1999) or DAZL (Vogel et. al., 2002) can partially rescue the 
phenotype of a Dazl knock-out mice and Xenopus dazl (Xdazl) and human BOULE have 
both been shown to partially rescue the Drosophila BOULE phenotype (Houston et. al., 
1998) (Xu et. al., 2003).  However this redundancy is limited, for example a Dazl 
knockout mouse still has Boule but the gametogenesis failure phenotype is still apparent.  
However the degree of overlap in expression within the testis is yet to be determined.  
Thus this could be caused by a dosage effect or differential expression.  An alternative 
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explanation is that the different family members have partially distinct functions or 
targets. 
 
1.7 Dazl family function 
 
Genetic studies have shown that the Dazl family proteins are important in gametogenesis 
but their exact molecular functions remain unclear.  As a RRM has been identified in all 
the Dazl family proteins it has been suggested that at least one function of Dazl must be 
as an RNA binding protein.  Their predominantly cytoplasmic localisation also suggests 
that their role is probably a cytoplasmic one.  This was confirmed in elegant experiments 
in Drosophila where the nuclear localisation of Boule was disrupted without affecting 
entry into meiosis (Cheng et. al., 1998) 
 
The ability of Dazl proteins to bind RNA (Houston et. al., 1998) and their presence 
within germ cells in a variety of species (see section 1.4.3) suggested a potential role in 
gene regulation in these cells.  It has been suggested that Boule acts in the cytoplasm to 
regulate the stability or translation of messenger RNA encoding an essential meiotic 
factor (Cheng et. al., 1998). In invertebrates the first genetic link to a role in translational 
regulation came from experiments in Drosophila where Boule was shown to be required 
for the translation of twine mRNA (Maines and Wasserman, 1999). However, these 
studies did not address whether this was a direct effect mediated by binding of Boule to 
this mRNA.  More recently, C. elegans daz-1 was shown to bind FBF mRNAs and loss 
of function mutations lead to a modest reduction in the accumulation of these proteins 
(Otori et. al., 2006). In vertebrates, Tsui et al initially demonstrated that mouse Dazl 
could be found on actively translating polysomes (Tsui et. al., 2000b) from testis 
suggesting a likely role in mRNA translation or stability, a finding that was later 





1.7.1 Dazl family members as translational regulators 
 
A direct role for a variety of vertebrate DAZL proteins in translation was shown by 
tethering these proteins to reporter mRNAs in Xenopus oocytes (Collier et. al., 2005). It 
was demonstrated that DAZL family proteins can interact with PABP proteins providing 
a potential model for their roles as translational activators (Collier et. al., 2005). A 
conserved interaction between DAZL proteins including Xdazl, mDazl, hDAZL, hDAZ 
and hBOULE and two poly(A)-binding proteins (PABP1 and ePABP) was detected by 
yeast-two hybrid analysis (Collier et. al., 2005). Both of these PABP proteins are present 
in the Xenopus oocytes in which the DAZ proteins above were shown to stimulate 
translation in tethered assays making them attractive candidate factors.  Directed yeast 
two-hybrid analysis demonstrated that Xdazl did not interact with a panel of other 
canonical translation initiation factors including subunits of eIF1, eIF1A, eIF2, eIF2B, 
eIF3, eIF4A, eIF4E, eIF4G, eIF4H, eIF5, eIF5A and eIF5B.  Co-immunoprecipitation 
experiments using isolated stage VI oocytes or testis extracts showed RNA-independent 
interactions between endogenous Xdazl and PABP1 and ePABP, demonstrating a true 
protein-protein interaction.  This interaction was shown to be mediated by the C-
terminus of Xenopus PABP.  This region of Xenopus PABPs does not show a strong 
capacity to stimulate translation in isolation, in contrast to other parts of the protein.  
Thus simultaneous interactions of PABP with DAZL and key factors required for its role 
in promoting initiation would not be precluded.  The interaction with PABP was 
mediated by amino acids 99-166 of mouse Dazl.  Deletion of this PABP binding domain 
was shown to completely abrogate the stimulatory effect of Dazl in the tethered function 
assay although these mutants were still bound to mRNA via the tether protein.  
 
It was suggested that the DAZL family of proteins act as translational enhancers of 
specific mRNAs during gametogenesis (Collier et. al., 2005).  A mechanism for 
translational stimulation by Dazl was proposed following these results and a working 
model suggested.  The model is as follows; Dazl binds to the 3’UTR of its target 
mRNAs, it then recruits molecules of PABP thorough direct protein-to-protein 
interactions (Collier et. al., 2005).  These molecules of PABP then stimulate translation 
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initiation through multiple interactions with translation initiation factors as demonstrated 



















Figure 1.7: Models for the role of PABPs in DAZL-mediated stimulation of target mRNAs.  
A: Molecules of PABP interact with other translation factors, circularising the mRNA and 
promoting translation. 
B: Dazl family members directly recruit additional molecules of PABP to mRNAs with short 
poly(A) tails, increasing end-to -end complex formation, leading to enhanced ribosomal subunit 
recruitment (not shown).  Multiple DAZL proteins may recruit multiple PABPs.  This does not 
require changes in polyadenylation.  Model adapted from Collier et al (Collier et. al., 2005). 
 
Figure 1.7 represents the model for translational stimulation by Dazl.  Dazl binds to a 
sequence within the 3’UTR of the mRNA and thus brings extra molecules of PABP to 
the mRNA.  These extra PABP molecules then interact with eIF4B, eIF4G and Paip1, 
and perhaps other factors, thus stimulating translation of the mRNA.  The key concept of 
this working model is the ability of Dazl to bind to PABP and which results in 
translational stimulation.  
 
The model proposed for Dazl action leads to the prediction that Dazl proteins should 
stimulate the translation of mRNAs with short poly(A) tails more than those with long 
poly(A) tails, because long poly(A) tails will already have multiple PABP molecules 
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bound  (Collier et. al., 2005).   To test this prediction Collier et al utilised two reporters 
identical except for the fact that one had a poly(A) tail and the other did not.  Mouse 
Dazl stimulated both of these reporters and the mRNA with the poly(A) tail gave the 
highest levels of translation.  However it was the mRNA without the poly(A) tail that 
was stimulated to the greatest degree by mDazl.   
 
During gametogenesis many stored mRNAs have relatively short poly(A) tails and are 
translationally inactive (Thompson et. al., 2007). This phenomenon has been extensively 
studied in the oocytes of Xenopus and these changes in polyadenylation have been 
shown to be critical for oocyte maturation in both Xenopus and mouse (Gebauer et. al., 
1994; Sheets et. al., 1994). Polyadenylation of these mRNAs in discrete waves during 
gametogenesis has been shown to lead to translational activation of many mRNAs, due 
to the recruitment of PABP (Belloc et. al., 2008).  However, not all activated mRNAs 
undergo polyadenylation and recruiting PABP via protein-protein interaction may 
provide an explanation for the activation of some of these mRNAs (Collier et. al., 2005).  
Cytoplasmic polyadenylation has also been shown to have more extensive roles in 
gametogenesis, with CPEB knock-out mice showing defects at the pachytene stage of 
meiosis in males and females (Tay and Richter, 2001). Conditional knock-outs showed 
cytoplasmic polyadenylation is also important at the dictyate stage of oocyte growth and 
for oocyte-follicle signalling (Racki and Richter, 2006).   
 
1.7.2 mRNA targets 
 
The confirmation of the function of Dazl as a translational regulator was made more 
difficult by the lack of identified targets of Dazl, either in vitro or in vivo.  This section 
will examine some potential targets of Dazl family proteins.  
 
A potential target of Drosophila boule was identified in a genetic study based on the 
observation that the twine mutant had a similar phenotype to boule mutants.  twine 
encodes a meiosis specific Cdc25C phosphatase that activates cyclin B1 that is required 
for the G2/M transition of meiosis.  In boule mutants the level of Twine protein, but not 
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the twine mRNA, is significantly reduced (Maines and Wasserman, 1999). Furthermore, 
expression of Twine from a spermatocyte specific transgene led to the partial rescue of 
the boule mutant (Maines and Wasserman, 1999).  However a direct interaction between 
Boule protein and twine mRNA remains to be demonstrated.   
 
Drosophila twine mRNA was shown to be able to recruit zDazl using reporter mRNAs 
containing the twine 3’UTR.  In this cell-free assay zDazl was found to mildly stimulate 
this reporter dependent on a ‘GUUC’ sequence in this UTR (Maegawa et. al., 2002; 
Maegawa et. al., 1999). An interaction between CDC25A (the mammalian homologue 
of Twine) and BOULE has been suggested to be conserved in humans.  A study showed 
that there was a correlation between a lack of BOULE and a lack of CDC25A by 
immunochemistry in human testis samples (Luetjens et. al., 2004). However no causality 
was established so this interaction still remains to be convincing in any system.  
 
In C. elegans DAZ-1 protein was shown by co-immunoprecipitation and electromobility 
shift assays to bind specifically to the mRNAs encoding the FBF proteins, which are 
translational regulators for the sperm/oocyte switch (Otori et. al., 2006).  The authors 
went on to present data that they claimed showed that the level of the FBF proteins was 
lowered in the daz-1 mutant thus implying a direct translational effect, but the data was 
unconvincing. 
 
Other potential targets of mouse Dazl have been identified from screens using 
immobilised recombinant GST-Dazl fusions that were incubated with mouse testis 
extracts to bind mRNAs that were then identified by differential display (Jiao et. al., 
2002).  This method identified a number of mRNAs including Tpx-1, which is a 
testicular cell adhesion protein essential to the progression of spermatogenesis, GRSF-1, 
an mRNA binding protein involved in translational activation and TRF2, a TATA box 
binding protein involved in transcriptional regulation (Jiao et. al., 2002). A similar 
screen was undertaken in human testis looking for mRNAs that could be bound by 
DAZL and one of its protein partners, PUM-2 (see below).  Immobilised fusion proteins 
were washed with human testis mRNA extract before bound mRNAs were eluted, 
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amplified by RT-PCR and sequenced (Fox et. al., 2005).  61 possible targets were 
identified but only one was investigated in more detail, SDAD1, which is homologous to 
the sda1 (severe depolymerisation of actin) gene in yeast.  The value of this sort of 
screen remains to be seen as none of the interactions have been verified in vivo, though 
they produce plenty of possible avenues of investigation. 
 
A recent screen using a combination of microarray and immunoprecipitation analysis 
has identified a number of mRNA targets of mouse Dazl (Maratou et. al., 2004). Two of 
these targets have been explored in detail: The first of these targets is the mouse vasa 
homologue (Mvh) (Reynolds et. al., 2005), a gene that is known to be essential for male 
gametogenesis. In particular, the Mvh knockout phenotype is a block at leptotene to 
zygotene of meiotic prophase I (Tanaka et. al., 2000), a phenotype that corresponds to 
that of the Dazl knockout mouse (Saunders et. al., 2003).  The second characterised 
target is the synaptonemal complex protein 3 (Sycp3).  This protein is essential for 
gametogenesis with a mouse knockout model showing a block in meiotic prophase that 
was similar to the Dazl knockout mouse.  It was shown using Xenopus oocyte reporter 
assays that Dazl stimulates translation via both the Mvh and Sycp3 3’UTRs (Reynolds et. 
al., 2007; Reynolds et. al., 2005). It was also shown via immunofluorescence of testis 
sections that germ cells of Dazl null mice contain reduced levels of both proteins, 
indicating that Dazl mediated regulation of these mRNAs contributes to changes in their 
protein expression (Reynolds et. al., 2007; Reynolds et. al., 2005). 
 
1.7.3 Dazl interacting proteins 
 
The potential functions of Dazl family proteins in translation and some of the mRNA 
targets have been discussed.  The importance of the interaction with PABP, was 
discussed in section 1.5.1, however Dazl family members are also known to interact 




The evidence for Dazl protein-protein interactions is summarised in figure 1.6 and table 
1.1.  Figure 1.8 shows the protein interactions that have been mapped to a specific area 
of a Dazl family member and table 1.1 details both mapped and unmapped interactions 

































Figure 1.8: Known protein partners for the Dazl family proteins.   
Proteins known to interact with Dazl family members are shown for Dazl, DAZ and BOULE.  
Note that this figure is not limited to one species, but instead maps all interactions across 
species.  The area of the protein required to bind known protein partners for each of the Dazl 
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Ce_DAZ-1 Ce_CPE-3 No CoIPo, IH (Hasegawa et. al., 
2006) 
Table 1.1: Dazl family member interacting proteins 
Species specific protein interactions with Dazl family protein members and the methods by 
which these interactions were discovered are detailed.  
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Definitions: Y2H = Yeast two hybrid.  CoIPe = Co-immunoprecipitation with endogenous 
proteins.  CoIPo = Co-immunoprecipitation with over expressed proteins.  GST = GST pulldown 
assays.  IH = immunohistochemistry.  Hs_DAZ = Human DAZ.  Hs_DAZL = Human Dazl.  
Hs_BOL = human BOULE.  Mm_dazl = Mouse Dazl.  Xl_dazl = Xenopus laevis dazl.  Ce_DAZ-1 
= C. elegans DAZ-1.   
 
 
DAZAP1 and DAZAP2 
Using DAZ as bait in a two-hybrid screen two novel interacting proteins were identified 
(Tsui et. al., 2000a).  These proteins were named DAZ-associated protein 1 and 2 
(DAZAP1 and DAZAP2).  DAZAP1 is an RNA binding protein that shuttles from the 
nucleus to the cytoplasm during spermatogenesis (Dai et. al., 2001), and has also been 
isolated as Prrp in Xenopus oocytes (Zhao et. al., 2001), as a protein implicated in the 
localisation of mRNAs.  This Dazl family interacting protein is the focus of chapter 5 of 
this thesis and will be described in more detail then.   
 
Very little is known about DAZAP2, it lacks any recognisable functional domains and 
has been shown to be expressed ubiquitously at the RNA level by northern blot (Tsui et. 
al., 2000a). This expression pattern makes it an unlikely partner of the germ cell specific 
Dazl family but so little is known about it that it is impossible to comment further on any 
possible functions.   
 
Pumilio 
Human DAZ was first identified to interact with human PUMILIO-2 (PUM-2) in a 
yeast-two hybrid screen (Moore et. al., 2003).  This interaction was shown to require 
amino acids 124-173 of DAZ (see figure 1.6).  PUM-2 was shown to be expressed in 
human embryonic stem cells and germ cells and it has also been shown that it co-
localised with DAZ and DAZL in germ cells (Moore et. al., 2003).  The ability to 
interact with PUM-2 was also established for human BOULE, as demonstrated by yeast-
two hybrid and in vitro co-immunoprecipitation (Urano et. al., 2005).  
 
Overexpressed Xenopus Pumilio was also shown to interact with overexpressed tagged 
Xenopus Dazl from Xenopus oocytes by co-immunoprecipitation (Padmanabhan and 
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Richter, 2006).  Pumilio was also shown to co-immunoprecipitation with Xenopus 
ePABP in the same system.  It was suggested that Pumilio, Dazl and ePABP could all 
interact together and modulate the expression of a newly identified potential target 
mRNA named RINGO/Spy (Padmanabhan and Richter, 2006).  However all the 
interactions were observed separately and it was not established if such a multi-protein 
complex is formed on the mRNA at any point. 
 
Pumilio proteins have well characterised functions in germ cell line maintenance and 
differentiation and have been previously shown to control translation as part of a multi-
protein complex (Wickens et. al., 2002).  They have typically been associated with 
translational repression of specific mRNAs.  The function of the interaction between 
PUM-2 and Dazl has yet to be investigated.  It is possible that it could act as a 
translational repressor of Dazl or it could be involved in aiding the binding of Dazl to an 
mRNA as it does for Nanos in Drosophila (Wickens et. al., 2002).  
 
DZIP 
Another novel protein that interacts with DAZL is (Moore et. al., 2004) DAZ-interacting 
protein or DZIP.  This protein was identified in a yeast 2-hybrid screen (Moore, 2003) as 
one that interacted with human DAZ, and confirmed by in vitro co-immunoprecipitation 
(Moore et. al., 2004), though the Western blot data was unconvincing. The DZIP gene is 
expressed predominantly in human embryonic stem cells and foetal and adult germ cells 
(Moore et. al., 2004).  Some immunohistochemical evidence has been produced 
suggesting that DZIP co-localises with both DAZ and DAZL in mouse testis but no 
functional characterisation has been undertaken.  The lack of further information on 
DZIP is such that it will not be investigated further in this thesis, though there is 
potential for a possible function in translation with Dazl that may form the basis of 
future work. 
 
Dynein light chain  
The C-terminal portion of human Dazl has been shown to interact with the dynein light 
chain, a component of the dynein-dynactin motor complex, initially on the basis of in 
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vitro co-immunoprecipitations with over expressed proteins that were later verified by 
co-immunoprecipitations of endogenous proteins from testis extracts (Lee et. al., 2006).   
 
It was suggested that this could indicate that Dazl has a RNA localisation function and 
this hypothesis was investigated by immunohistochemical investigation of Dazl in 
cultured cells in the presence and absence of inhibitors of microtubules.  It was 
discovered that Dazl was localised to specific areas of a cell, in a manner that was 
dependent on intact microtubules, suggesting that Dazl could indeed function in RNA 
localisation in concert with dynein  (Lee et. al., 2006).  Such a function in RNA 
transport could be important for Dazl’s overall function of ensuring that its target 




In C. elegans DAZ-1 (BOULE homologue) was shown to be co-expressed with and 
interact with CPB-3 (shown by immunohistochemistry and co-immunoprecipitation 
respectively), a homologue of CPEB (Hasegawa et. al., 2006).  It was suggested that this 
may have relevance to DAZ-1’s proposed function in gametogenesis in C. elegans but 
no function was determined experimentally (Hasegawa et. al., 2006). 
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1.8 Thesis aims 
 
The observation that multiple Dazl family members from a variety of species can 
stimulate the translation of specific mRNAs suggests that this conserved function is 
likely to be critical to their roles in oogenesis and spermatogenesis.  Consequently, it is 
of interest to understand how they stimulate translation.  As the functions of mRNA 
specific translational activators are poorly understood, few if any paradigms exist for the 
function of Dazl proteins.  The observation that Dazl stimulates translation via 
recruitment of PABP still leaves many important questions unanswered.  PABP proteins 
are thought to enhance translation by multiple mechanisms (Gray et. al., 2000) 
(Kahvejian et. al., 2005), in keeping with the finding that multiple domains of this 
protein (Gray et. al., 2000) can stimulate translation and interact with a wide variety of 
basal translation factors (Gorgoni and Gray, 2004). It is unclear whether DAZL bound 
PABP maintains all its interactions with other translation factors and which of the steps 
of initiation DAZL stimulates.  Moreover, this observation does not rule out the 
possibility that other Dazl-interacting factors may aid or co-operate with PABP to 
promote Dazl-mediated stimulation. 
 
The results of this thesis address three separate but related aims pertaining to the 
molecular mechanism of Dazl-mediated translation: 
 
i) To examine the stage and factors required for Dazl-mediated translational stimulation. 
ii) To delineate the residues within DAZL that are important for its interaction with 
PABP.   
iii) To investigate the role of DAZAP1 in DAZL-mediated regulation.  
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Chapter 2: Materials and Methods 
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2.1 Solutions and reagents 
 
All chemicals and reagents used during this project were supplied by either Sigma or 
Roche unless detailed otherwise.  All solutions used were as described in Molecular 
Cloning – A Laboratory Manual (Sambrook et. al., 1989). General solutions were 
prepared by technical staff.   
 
2.2 General Microbiological techniques 
 
2.2.1 Bacterial strains used 
 
All plasmids were propagated in the E. coli strain XL1-Blue (Stratagene), genotype = 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB lacIqZΔM15 Tn10 
(Tetr)]. 
 
2.2.2 Growth of Bacterial strains 
 
Bacterial strains were maintained on Luria Bertani (LB) agar plates or in LB medium 
containing appropriate antibiotics (Kanamycin at 50mg/ml or Ampicillin at 100mg/ml).  
 
2.2.3 Bacterial transformations 
 
Chemically competent XL1-Blue cells were thawed on ice before the addition of 
approximately 100ng of plasmid to 50μl cells.  Cells were then incubated on ice for 
30min before being heat shocked at 42°C for 45sec, and returned to ice for a further 
2min.  200μl of LB medium was added before incubating the cells for 60min at 37°C, 
after which 100μl of the cells were plated on LB plates containing the appropriate 




2.2.4 Yeast strains used 
 
Yeast two-hybrid analysis was performed with S. cerevisiae strains L40ura- 
(MATa,ura3-52, leu2-3,112, his3, trpΔ1, ade2, Δgal4, lys::(lexAop)-HIS3, 
ura3::(lexAop)-LacZ) (Zhang et. al., 1999) and Mav99 (MATa ura3-52, leu2-3, 112, 
trpl-901, his3A200, ade2-101, gal4A, gal80A canlR, cyh2R GAL1::HIS3@LYS2 
GALJ::lacZ, SPAL10::URA3) (Vidal et. al., 1996) as described previously (Zhang et. 
al., 1999). 
 
2.2.5 Growth of yeast strains 
 
All yeast strains were initially grown in YPD medium or on YPD agar plates at 30°C.  
Yeast transformed with plasmids containing selectable markers (tryptophan (trp) and/or 
leucine (leu)) were grown on selective minimal media (SD + 1 x dropout mix, + 1 x 
histidine, + 1 x tryptophan, + 1 x uracil) without trp or leu as appropriate at 30°C.  
Yeast amino acids stocks: 10 x Dropout = 200mg arginine, 300mg isolucine, 300mg 
lysine, 200mg methionine, 500mg phenylalanine, 2000mg threonine, 300mg tyrosine, 
1500mg valine in 1l water.  100 x histidine stock = 100mg histidine in 50ml water.  100 
x tryptophan stock = 100mg tryptophan in 50ml water.  100 x uracil stock = 100mg 
uracil in 50ml water. 
 
2.2.6 Yeast transformations 
 
Single colonies of the appropriate yeast strain were used to inoculate 5ml of YPD broth 
and incubated overnight with shaking at 30°C.  1ml of the overnight culture was used to 
inoculate 50ml of YPD broth that was grown shaking at 30°C until OD600 was between 
0.6-1.0.  1ml of yeast culture was spun down at 7000rpm (10,000rcf) for 1min for each 
transformation.  The supernatant was removed and the yeast pellet was washed first with 
1ml of water and next with 1ml 0.1M LiOAc/1 x TE (10mM Tris, pH 7.5, 1mM EDTA).  
After washing the pellet was resuspended in 50μl 0.1M LiOAc/1 x TE and 6μl of 
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salmon sperm carrier DNA (Clontech) with 1μg of each plasmid to be transformed.  
300μl of 40% PEG/0.1M LiOAc/1 x TE was then added to each sample, which were 
then vortexed and incubated at 30°C for 30min.  Yeast were then heat shocked in a 42°C 
water bath for 15min.  The yeast was pelleted by spinning at 7000rpm (10,000rcf) for 
2min and resuspended in 400μl water.  150μl was then plated onto appropriately 
selective media. 
 
2.3 General Recombinant DNA techniques 
 
2.3.1 Plasmid propagation and extraction 
 
Plasmid DNA was prepared using Qiagen prep systems as described in the 
manufacturer’s instructions.  Mini, Midi and Maxi preps were all employed as 
appropriate for the volume of plasmid desired.  Purity was confirmed by 1% agarose gel 
electrophoresis followed by ethidium bromide staining and the DNA concentration was 
measured by UV absorption at 260nm. 
 
2.3.2 Purification of Nucleic Acid 
 
Phenol/Chloroform extraction 
DNA was purified by the addition of equal volumes of 25:24:1 
phenol:chloroform:isoamyl alcohol (50% buffered phenol, 48% chloroform, 0.5% 3-
methyl-1-butanol pH>7.8) followed by vortexing and centrifugation (13,000rpm 




DNA was precipitated by the addition of 2.5 volumes 100% molecular biology grade 
ethanol and 0.1 volumes 3M NaOAc. 
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2.3.3 Restriction enzyme digests 
 
Restriction digests were conducted using New England Biolabs (USA) or Roche 
(Germany) restriction enzymes according to manufacturer’s specifications using 
appropriate buffers as supplied.  Restriction enzymes never exceeded 10% of the volume 
to avoid star activity produced by excess glycerol.   
 
2.3.4 Dephosphorylation of digested plasmids 
 
Linearised plasmid DNA for ligations was dephosphorylated using Calf intestinal 
alkaline phosphatase (Roche) according to manufacturer’s instructions.  Generally 20μg 
of cut vector plasmid was dephosphorylated in 100μl total volume with 1 x alkaline 
phosphatase buffer (Roche) and 20 Units (2μl) phosphatase.   
 
2.3.5 Gel purification of DNA fragments 
 
Plasmid DNA for purification was run on 1-2% agarose gels containing 0.5μl/ml 
ethidium bromide.  The bands were visualised with UV light and cut out of the gel using 
a clean razor blade.  DNA was purified from the gel fragments using the Qiagen Gel 
Purification Kit according to the manufacturer’s instructions.  
 
2.3.6 Ligation of DNA fragments 
 
Ligations of gel purified, dephosphorylated, linearised plasmid and gel purified DNA 
inserts were performed overnight at 16°C using T4 DNA ligase (Stratagene) according 
to the manufacturer’s instructions.  The molar ratio of plasmid to insert was 1:3 unless a 





2.3.7 PCR reaction 
 
The standard PCR reaction used (50 μl) contained; 10 ng/μl of template DNA, 5 mM 
MgCl2 (Roche), 1x PCR reaction buffer (Bioline), 1mM dNTPs, 2.5 units cloned Bio-X-
Act Long High-Fidelity polymerase (Bioline), 50pM oligonucleotide primers.  Reactions 
were incubated in a PTC-225 PCR machine (MJ Research) for 30 cycles with a standard 
annealing temperature of 60°C.  PCR products were separated by gel electrophoresis and 
the bands of the desired product were cut out and gel purified.  Standard program: 1) 
5mins @ 94°C, 2) 30secs @ 94°, 3) 1min @ 60°C, 4) 1.5min @ 68°C, 5) repeat steps 2-
4 30 times, 6) 10min @ 68°C.  
 
2.3.8 Site directed mutagenesis PCR 
 
The method used to generate the mutants was a PCR based site directed mutagenesis 
approach called overlap extension PCR.  This allows the insertion of point mutations 
into DNA sequences without the need to generate single stranded DNA as in other 
techniques (Ling and Robinson, 1997). Tthis technique involves designing two 
mutagenic primers containing the mutation, partially or completely complementary to 
each other. Each primer is used in a separate reaction with an outer flanking primer 
designed to one end of the region of interest.  The two halves of the amplicon are 
generated in this manner in two separate reactions and mixed in the next step, where 
they anneal in the 25-30 bp region of complementarity and prime off each other, to 
produce the full length product.  Finally the mutagenised amplicon is amplified as 
normal, subcloned and sequenced to ensure that it contains the desired mutations and 











Figure 2.1: Site directed mutagenesis method.    
1: original double stranded wild type sequence.  2+3: Two separate PCR reactions are used to 
generate overlapping fragments containing the mutation (as indicated by X).  Primers are 
represented by red arrows; primers with mutated residues contain an X.  4: The products of the 
original two reactions are annealed together and the single stranded areas are filled in by a PCR 
reaction priming off the free ends.  5: The then mutagenised product is then amplified by in a 
standard manner. 
 
The conditions for the PCR reactions are as follows: First reactions (20μl): 10 ng/μl of 
template DNA, 100pM oligonucleotide primers, 5mM MgCl2 (Roche), 1x PCR reaction 
buffer (Bioline), 1 unit Bio-X-Act Long High-Fidelity polymerase (Bioline), 0.2mM 
dNTPs (Clontech).  Reactions were incubated in a PTC-225 PCR machine (MJ 
Research) for 12 cycles with a standard annealing temperature of 56°C.  PCR products 
were separated by gel electrophoresis and the bands of the desired product were cut out, 
gel purified and eluted in 20μl of dH2O.  Two reactions (PCR I and PCR II) were 
conducted for each mutant (see chap 4).  Program: 1) 5mins @ 94°C, 2) 30secs @ 94°, 
3) 1min @ 56°C, 4) 1min @ 68°C, 5) repeat steps 2-4 12 times, 6) 10min @ 68°C.  
 
Second reactions (50μl): 1.5μl PCR I, 1.5μl PCR II, 5 mM MgCl2 (Roche), 1X PCR 
reaction buffer (Bioline), 2.5 unit Bio-X-Act Long High-Fidelity polymerase (Bioline), 
0.2mM dNTPs (Clontech).  Reactions were incubated in a PTC-225 PCR machine (MJ 
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Research) for an initial 7 cycles with a standard annealing temperature of 56°C.  After 
these initial cycles the reaction was stopped and 100pM oligonucleotide primers were 
added and the reactions were returned to the PCR machine for a further 28 cycles.  
Program: 1) 5mins @ 94°C, 2) 30secs @ 94°, 3) 1min @ 56°C, 4) repeat steps 2-4 7 
times, 5) 10min @ 68°C, 6) stop and add primers 7) repeat 2-4 7 times, 8) 1min @ 68°C. 
 
2.3.9 Agarose gel electrophoresis  
 
0.8-1.5% agarose gels were made by dissolving appropriate amounts of agarose in 1 x 
TAE (90mM Tris-HCl pH 8.3, 90mM acetic acid, 2mM EDTA) by heating in a 
microwave for 1-2min.  Gels were poured with ethidium bromide added to a 
concentration of 0.5μl/ml.  1/6 volume of DNA loading buffer (0.25% bromophenol 
blue, 0.25% xylene cyanol FF, 30% glycerol) was added to DNA samples before 
loading.  Gels were run at 50-150 volts in 1 x TAE buffer for 30-90min, depending on 
size of the fragment to be visualized and agarose concentration of the gel.  2-log ladder 
(New England Biolabs) was used to estimate DNA band sizes.  
 
2.3.10 DNA sequencing  
 
All plasmid constructs were verified using the in-house sequencing service offered at the 
Human Genetics Unit.  Briefly, DNA sequencing was performed using Big Dye 
Terminator Sequencing Kit (Applied Biosystems (UK)) using an in house protocol 
modified from the manufacture’s instructions with a reduced enzyme concentration.  
 
2.3.11 Quantification of Nucleic acids 
 
DNA or RNA was quantified by measuring its absorbance spectra at 260nm using either 
a Nanodrop ND-1000 (Nanodrop Technologies Inc.) or an Ultraspec 3000pro 
(Amersham Biosciences) spectrophotometer.  Quality of nucleic acids was assessed via 
comparing the ratios of absorbance at 260nm vs. 280nm. 
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2.4 General RNA techniques 
 
2.4.1 In vitro transcription 
 
Plasmids to be transcribed were linearised by digestion with restriction enzyme as 
follows; MS2-mDazl and MS2-U1A were cut with HindIII, pLG-MS2, pCSFV-luc-MS2 
and pPV-luc-MS2 were Linearised with BglII.  Linearised plasmids were purified by 
two phenol/chloroform extractions followed by ethanol precipitation prior to 
transcription. 
 
RNA templates were prepared by T7-RNA polymerase catalysed in vitro transcription of 
linearised plasmids.  
 
The transcription reactions were set up as follows; 0.1μg/μl of template DNA, 1X 
Transcription Buffer (Stratagene), 30mM DTT, 1mM ATP, 1mM UTP, 1mM CTP 
(Pharmacia), 7mM m7GpppG Cap (New England Biolabs) or ApppG Cap (New 
England Biolabs), 0.2 units RNasin (Roche) and 4 units T7 RNA polymerase 
(Stratagene).  
 
The transcription reaction was incubated for 5min at 37°C in the presence of m7GpppG 
or ApppG to produce capped RNA.  After an initial round of capping 1mM GTP 
(Pharmacia) was added to allow template elongation.  This results in an efficiency of 
capping greater than 95% (R. Stipecke, personal communication).  The reactions were 
incubated at 37°C for 90min.  The reaction mixtures were digested with RNase-free RQ 
DNase I (Promega) for 25 in at 37°C to remove the template DNA.  Synthesised RNAs 
were purified twice with acidic phenol/chloroform/isoamylalcohol (25:24:1) (Ambion) 
and passed over Chroma spin-100 DEPC-H2O columns (Clontech) to remove short, 
incomplete partially transcribed RNA products and excess 7mGpppG cap and 
nucleotides.  The RNA was then ethanol precipitated and resuspended in 10μl of RNase-
free distilled H2O.  
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RNA integrity was confirmed by agarose gel electrophoresis.  RNA concentration was 
determined by UV spectrophotometry.  
 
2.5 General Protein techniques 
 
2.5.1 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
 
SDS-PAGE separating gels were made with 10-13.5% polyacrylamide (40:1 
acrylamide:bis-acrylamide), 375mM Tris-HCl pH 8.8 and 0.1% SDS.  Stacking gels 
were made with 4% polyacrylamide, 115mM Tris-HCl pH 6.8 and 01% SDS.  The gels 
were polymerised with 1% ammonium persulphate (APS) and 0.1% TEMED.  
 
Samples were mixed 1:1 with 2x SDS-PAGE loading buffer (20% glycerol, 10% 2-
mercaptoethanol, 4% SDS, 0.25% bromophenol blue and 160mM Tris-HCl pH 6.8) and 
heated for 5min at 95°C before immediate storage on ice.  Samples were loaded onto the 
gel alongside a pre-stained Benchmark molecular weight marker (Invitrogen).  Gels 
were run at 150 volts in SDS-PAGE running buffer (50mM Tris, 0.4M glycine and 0.1% 
SDS.  pH 8.8) until the dye front was run off the gel (1-2 hours). 
 
2.5.2 Fixing and drying of 35-S methionine radiolabelled gels 
 
Separating gels were fixed in 10:10 fixative (10% methanol and 10% acetic acid) for 20-
30min, then EN3HANCE (NEN Life Science Products) for 30min.  The gels were 
washed twice in water and dried for 1-2 hours on a Model 583 Gel dryer (Bio-Rad).  






2.5.3 Transfer to membrane 
 
After SDS-PAGE stacking gel was discarded and proteins were transferred onto 
Hybond-P nitrocellulose membrane (Amersham) using a semi-dry transfer apparatus 
(Millipore).  Gels were transferred onto membranes surrounded by two sheets of 2mm 
blotting paper soaked in transfer buffer (0.25M Tris, 1.92M glycine, 20% Methanol, pH 
8.3) either side of the gel/membrane.  Proteins were transfer using a fixed current of 
200mA for 1 hour.   
 
2.5.4 Western blotting 
 
Membranes with immobilised proteins were blocked in either TBST (Tris-buffered 
saline (TBS; 20M Tris, 137mM NaCl, pH 7.6, 0.1% Tween 20) supplemented with 5% 
(w/v) skimmed milk powder or in commercial blocking solution (Bohringer) dependent 
on the primary antibody used.  Primary antibodies were diluted in appropriate blocking 
solution and incubated with membranes either at 4°C overnight or 1 hour at room 
temperature on a rotating platform.  The membranes were washed three times with 
TBST for five minutes each wash at room temperature, again on a rotating platform 
before the addition of the secondary antibody diluted in TBST.  The membrane was 
incubated with the secondary antibody for 1 hour at room temperature.  Membranes 
were washed a further 4 times with TBST before treatment with enhanced 
chemiluminescence (ECL) solutions (Amersham).  Membranes were blotted to remove 
excess fluid and wrapped in cling film before being exposed onto X-ray film (Kodak). 
 
Antibody Primary dilution Secondary antibody 
Anti-Xenopus Dazl  1:1000 Anti-mouse HRP 1:10000 
Anti-DAZAP1-Rabbit1-
D109 
1:1000 Anti-rabbit HRP 1:10000 
Anti-DAZAP1-Rabbit2-
D109 
1:1000 Anti-rabbit HRP 1:10000 
Anti-DAZAP1-Affinity 
purified 
1:1000 Anti-rabbit HRP 1:10000 
Table 2.1: Antibodies used 
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The anti-Dazl antibody was a gift from Masakane Yamashita.  The anti-DAZAP 
antibodies were generated in the course of the thesis (see below).  Goat secondary anti-
mouse HRP (Dako) and goat anti-rabbit HRP (Sigma) were bought commercially.  
 
2.5.5 Generation of an antibody to DAZAP1 
 
The generation and testing of the anti-DAZAP antibodies is described in more detail in 
chapter 5.  Briefly polyclonal antibodies to Xenopus DAZAP1 were raised commercially 
by Covalab (France).  Two rabbits were injected with two peptides corresponding to 
DAZAP1, GWTGQPPQTWQGYS and SGQQDFPFSQFGNAC over a three month 
period.  Regular bleeds were collected from both rabbits as detailed in chapter 5.   
  
2.5.6 In vitro Transcription and translation (TNT)  
 
Transcription/translation (TNT) reactions were conducted utilising a T7 Quick TNT 
system (Promega) according to manufacturer’s instructions.  Briefly, 2µg of miniprep 
DNA was incubated in TNT lysate in the presence of [35S]-methionine for 60min at 





Where indicated, stage VI Xenopus laevis oocytes were incubated for 6 hours with [35S]-
methionine (GE Healthcare) to label newly synthesized proteins.  Labelled or unlabelled 
oocytes were lysed in immunoprecipitation lysis buffer (10µl/oocyte) (20mM HEPES 
[pH 7.6], 10mM KCl, 1.5mM MgCl2, 100mM NaCl, 0.5% Triton X-100, 0.5mM 
dithiothreitol, Complete Protease Inhibitor Cocktail Tablets (Roche)).  The oocyte lysate 
was cleared by centrifugation.  The volume was increased to 1ml with 
immunoprecipitation lysis buffer and mixed for 1 hour or overnight at 4°C with an anti-
PABP antibody or anti-ePABP antibody; 30µl of protein G-Sepharose beads (Amersham 
 75
Pharmacia Biotech) was added to the lysate and mixed for 60 to 90min at 4°C.  The 
beads were washed three times with immunoprecipitation lysis buffer.  Where indicated, 
200U of RNase I (Ambion) was added to the last wash and incubated at 37°C for 15min. 
Bound material was eluted in 30µl of SDS gel loading dye prior to SDS-PAGE and 
Western analysis. 
 
2.6 Xenopus oocyte techniques 
 
2.6.1 Obtaining Xenopus Oocytes 
 
Female Xenopus laevis were euthanised by immersing in 400ml water containing a 
lethal dose of 4g 4-aminobenzoic acid for 15min.  Once animals failed to “right” a 
further lethal dose of 0.4ml Phenobarbital was delivered to the heart.  Death was 
confirmed by exsanguination by removing the head and heart.  The ovaries were 
removed and washed in 1 x MMR buffer (5 mM HEPES, 2 mM KCl, 100 mM NaCl, 0.2 
M MgCl2, 0.1 M CaCl2 and 0.1% Pen/Strep). 
 
2.6.2 Microinjection of Xenopus oocytes 
 
Stage VI Xenopus laevis oocytes were microinjected as described previously (Gillian-
Daniel et. al., 1998). Briefly, lobes of a dissected Xenopus laevis ovary were torn open 
using tweezers under a Leica MZ6 dissecting microscope.  Individual oocytes were 
separated from the ovary membrane by mechanical scraping with a metal loop.  Stage VI 
oocytes were manually sorted from others based on their size and appearance.  All 
oocyte manipulations were conducted in MMR buffer. 
 
Purified RNA was injected into the animal cap side of the midline of each oocyte using a 
Harvard apparatus (USA) microinjector and a Narishige (Japan) micromanipulator.  
RNAs were injected in sets of 25.  Oocytes were incubated overnight at 16°C in 1 x 
MMR, before processing.  
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2.6.3 In vivo protein radio-labelling of oocytes 
 
When radioactive labelling of newly synthesised proteins was required oocytes were 
labelled by incubation in 1ml of MMR containing 10μl/ml of [35S]-methionine (In vitro 
labelling grade 35S-methionine, specific activity 50 mCi/μl, GE Healthcare) overnight.     
 
Injected and labelled oocytes were collected and pooled in groups of five.  Any 
obviously necrotic oocytes were discarded.  Oocytes were washed in fresh MMR buffer 
to remove any non-internalised [35S]-methionine.  Oocytes were resuspended in 10μl per 
oocyte of TE with added protease inhibitors and homogenised mechanically with pestles 
(Anachem).  Lysates were centrifuged for 10min at 13,000 rpm (16,060rcf) in a bench 
top centrifuge to remove yolk proteins.  The supernatant was collected and centrifuged 
for a further 5min at 13,000 rpm (16,060rcf).  10μl of the supernatant was added to 10μl 
of SDS-PAGE 2X loading buffer and heated at 95°C for 5min before being transferred 
immediately to ice.  The samples were then analysed on a 10% SDS-PAGE acrylamide 
gel. 
 
2.6.5 Luciferase and β-galactosidase reporter assays 
 
Any obviously necrotic oocytes were discarded prior to assaying.  The sets of 25 oocytes 
were divided into groups of five oocytes before assaying to reduce the effect of variation 
between individual oocytes.  Lysis buffer (Tropix) was added to the oocytes in the ratio 
of 40μl per oocyte and the oocytes were mechanically homogenised with pestles.  
Luciferase activity was assayed in 5μl of oocyte lysate.  The lysate was mixed with 
100μl of luciferase assay reagent (LAR) (Promega), and the luciferase activity was 
measured with a Monolight 3010 Luminometer (Pharmingen).  β-galactosidase (β-gal) 
activity was assayed by adding 2.5μl of oocyte lysate to 100μl of a 1/100 dilution of 
Galacton-Plus (Tropix) in Galacto Reaction Buffer Dilutent (Tropix).  The samples were 
then incubated for 60min in the dark at room temperature before β-gal activity was 
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measured by Luminometer using Accelerator II reaction substrate (Tropix).  The relative 
amounts of β-galactosidase activity were used to account for any variations in the 
amount of RNA injected and relative luciferase light activity was calculated.  This was 
achieved by normalising each luciferase value to the level of β-galactosidase in each 
sample group of oocytes, therefore oocytes with low expression of both reporters were 
normalised relative to the oocytes showing the highest expression.  
 
2.6.6 Progesterone induced maturation 
 
Oocyte maturation was induced by incubating oocytes overnight in 1 x MMR containing 
10μg/ml progesterone.  Maturation was identified by the appearance of a white spot on 
the vegetal hemisphere, indicating the occurrence of germinal vesicle breakdown.  
 
2.7 Specific techniques 
 
2.7.1 Electromobility shift assays 
 
2.7.1.1 Generation of radiolabelled RNA 
 
Radiolabelled RNA was generated as described in section 2.3.1 for unlabelled RNAs but 
the transcription reaction was as follows; 0.1μg/μl of template DNA, 1x Transcription 
Buffer (Stratagene), 30mM DTT, 1mM ATP, 1mM GTP, 1mM CTP, 0.1mM UTP 
(Pharmacia), 7 mM m7GpppG Cap (New England Biolabs), 0.2 units RNasin (Roche), 8 
units T7 RNA polymerase (Stratagene).  50μCi of 32P UTP (Amersham) was also 
included in each reaction. 
 
2.7.1.2 RNA-protein complex assembly 
 
Protein preparations were pre-treated on ice with protein de-oligomerisation buffer 
(1mM acetic acid and 1mM DTT).  Binding of protein to RNA was performed on ice in 
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binding buffer (0.2M Tris-HCl pH 8.5, 160mM KCl, 20mM magnesium acetate and 
160mg/ml bovine serum albumin (BSA)) for 1 hr. Unlabelled competitor RNAs were 
added prior to 32P labelled probes.  Heparin (final concentration 5mg/ml) was added 1 hr 
after the addition of 32P labelled probes.  RNA-protein complex formation was analysed 
by non-denaturing gel electrophoresis.  
 
2.7.1.3 Non-denaturing gel electrophoresis 
 
Non denaturing separating gels were made with 4% polyacrylamide (30:0.5 
acrylamide:bis-acrylamide) and 1 x TBE (90 mM Tris-HCl pH 8.3, 90mM boric acid, 
2mM EDTA).  The gels were polymerised with 0.1% ammonium persulphate (APS) and 
0.04% TEMED.  Loading buffer was made from glycerol with a small amount of 
Bromophenol-Blue sodium salt added.  1 x TBE was used as running buffer.  
 
50ml gels were cast for each assay.  Gels were run at 250V for 4-5 hrs at 4°C.  Gels 
were fixed in 40% methanol, 10% glacial acetic acid, 50% dH2O before being exposed 
to X-ray film (Kodak). 
 
2.7.2 RNA Stability assays by QPCR 
 
2.7.2.1 Extraction of RNA from oocytes 
 
Groups of between 10-20 oocytes were mechanically homogenised in 10μl Tri-reagent 
(Sigma) per oocyte.  The lysates were snap frozen in liquid nitrogen, thawed and an 
additional 300μl of tri-reagent was added.  The lysates were centrifuged for 10min at 
13,000 rpm (16,060rcf) at 4°C.  The supernatant was collected and incubated at room 
temperature for 5 min.  100μl of chloroform was added to each sample and vortexed for 
15sec before centrifugation for 15min at 13,000 rpm (16,060rcf) at 4°C.  The colourless 
top phase was collected and RNA precipitated by the addition of 250μl of iso-propanol 
at room temperature for 5min preceding a third centrifugation for 10min at 13,000 rpm 
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(16,060rcf) at 4°C.  Finally the pellets were washed twice in 75% ethanol and 
resuspended in 20μl of dH2O. 
 
2.7.2.2 Reverse transcription 
 
cDNA was synthesized from total RNA with an OMA reverse transcription kit (Qiagen) 




Quantitative RT-PCR analysis was performed in a 7900HT Fast Real-Time PCR System 
(Applied Biosystems) by SYBR  green incorporation with primers 5'-
GGCGCGGTCGGTAAAGTT-3' and 5'-AGCGTTTTCCCGGTATCCA-3' for luciferase 
and 5'-TCACGAGCATCATCCTCTGC-3' and 5'-CAGCGGATGGTTCGGATAATGC-
3' for β-galactosidase.  The reactions were performed in 1 X SYBR Master Mix (Applied 
Biosystems). 
 
Data analysis was performed with the SDS2.1 program (Applied Biosystems), and 
standard curves generated from luciferase and β-galactosidase DNA standards were used 
to determine concentrations in the test samples.  All samples were analyzed in triplicate.  
 
2.7.3 Yeast-2-Hybrid assays 
 
Two-hybrid protein-protein interactions were detected by β-galactosidase assays as 
following: Colonies from yeast transformed with “bait” and “pray” plasmids were re-
streaked onto appropriate selective media (SD –trp –leu) and grown overnight at 30°C.  
Yeast colonies were streaked onto selective media (SD –trp –leu) plates topped with 
2mm whatman filter papers and grown overnight at 30°C.  Filter papers were removed 
from the plates and immersed in liquid nitrogen for 20 sec before being thawed at room 
temperature.  The freeze thawed filters were placed in a petri dish atop two more 
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whatman filters soaked in Z-buffer (60mM Na2HPO4, 10mM KCl, 1mM MgSO4, 50mM 
β-mercatoethanol, pH 7) supplemented with 150μg/ml X-gal.  The dish was sealed with 
parafilm before being incubated at 30°C until a blue colour was observed (usually 1-4 
hours).    
  
2.7.4 Translational analysis by sucrose gradient 
 
2.7.4.1 Pouring gradients 
 
10-50% sucrose gradients were prepared as follows: 10% and 50% sucrose (w/v) 
containing 250mM KCl, 2mM MgCl2, 20mM HEPES pH7.4, 0.5% NP-40, 2.5mM DTT, 
0.5μg/ml Heparin were prepared.  Gradients were poured by mixing equal amounts of 
10% and 50% sucrose solutions using a dual chamber manual gradient pourer.  
Gradients were weighed for balance and left to stand overnight at 4°C.   
 
2.7.4.2 Preparation of oocyte extracts 
 
Oocytes were collected and injected (if desired) as before.  Where appropriate oocytes 
were pre-treated with cycloheximide by incubating them in MMR supplemented with 
20μg/ml cycloheximide at 16°C for 10min before homogenisation.  Oocytes were 
homogenised in homogenisation buffer (250mM KCl, 2mM MgCl2, 20mM HEPES 
pH7.4, 0.5% NP-40, 2.5mM DTT) supplemented with either 150μg/ml cycloheximide or 
20mM EDTA as appropriate.  100μl of buffer was used per 10 oocytes.  After 
homogenisation extracts were incubated on ice for 10min the centrifuged for 10min, 







2.7.4.3 Centrifugation of samples and collection of fractions 
 
Equal volumes of oocytes extracts were loaded onto the gradients by gentle layering on 
top of the sucrose.  Gradients were centrifuged at 30,000rpm (r-average 110,583rcf) at 
4°C for 150min in a Sorval TH-641 rotor.  Once spun, the gradients were divided into 
fractions using a Pharmacia Superfrac fraction collector and the absorbance of cytosolic 
protein and RNA at A254 was recorded by an inline UV monitor (Pharmacia).   
 
2.7.4.4 TCA precipitations 
 
The protein in the gradient fractions was precipitated by the addition of equal amounts 
of 20% trichloroacetic acid (TCA), before centrifugation for 15min, at 13,000rpm at 
4°C.  Pellets were washed twice with cold acetone and dried by placing in a hot block at 
95°C for 5mins.  Pellets were resuspended in SDS-PAGE loading buffer and analysed 






2.8.1 Tethered fusion protein constructs 
 
pMSPN-U1A and pMSPN.xPABP have been previously described (Gray et. al., 2000).  
 
pMSPN.mDazl has been previously described (Collier et. al., 2005)  
 
pMSPN.DAZAP1 was supplied by Professor Philip Cohen (MRC protein 
phosphorylation Unit, Dundee).  Human DAZAP1 was cloned into the BamHI and SpeI 
of pMSPN. 
 
pMSPN.DAZAP1.T-A was supplied by Professor Philip Cohen (MRC protein 
phosphorylation Unit, Dundee).  Human DAZAP1 containing mutations T269A T315A 
was cloned into the BamHI and SpeI of pMSPN. 
 
pMSPN.DAZAP1.T-D was supplied by Professor Philip Cohen (MRC protein 
phosphorylation Unit, Dundee).  Human DAZAP1 containing mutations T269D T315A 
was cloned into the BamHI and SpeI of pMSPN. 
 
pMSPN.Xl.DAZAP1 was created by generating a fragment containing the ORF of 
Xenopus DAZAP1 by PCR using oligodeoxyribonucleotides “5'XlPrrpNhe 
” (=5’ GTCAGTGCTAGCATGAACAACCAAGGGGGGGAC 3’) and “3'XlPrrpSpe 
” (=5’ GTCAGTACTAGTTCAAATCCACTCGGACAATTTCAC 3’) using 
pET.Xl.DAZAP1 as a template.  The PCR product was cut with NheI and SpeI and 







2.8.2 Tethered function assay reporter constructs  
 
pLG-MS2 has been previously described (Gray et. al., 2000).  
 
pJK-350 has been previously described (Evans et. al., 1994). 
 
pLG-luc-A45, pLG-luc-MS21 and pLG-luc-MS29 have all been previously described 
(Collier et. al., 2005). 
 
pPV-Luc-MS2 and pCSFV-Luc-MS2 have been previously described (Gorgoni et. al., 
2005). 
 
pPV-Luc-ΔMS2 and pEMCV-Luc-ΔMS2 have been previously described (Bergamini 
et. al., 2000). 
 
pCSFV-CAT has been previously described (Ostareck et. al., 2001). 
 
pEMCV-Luc-MS2 was constructed by Mr J. Glover.  A fragment containing the 
EMCV IRES and a fraction of the luciferase ORF cut from pEMCV-Luc-ΔMS2 with 
SmaI and ClaI was ligated into pLG-MS2 vector cut with HindIII (then blunt ended) and 
ClaI. 
 
pCSFV-Luc-ΔMS2 was constructed by Mr W. Richardson.  A fragment containing the 
CSFV IRES was created by PCR using oligodeoxyribonucleotides (5’ 
GAGTCAAAGCTTCGATCCGTCGACAAGGTTAGCTC) and (3’ 
GAGTCAAAGCTTCCCGGTTCCTCCACTCCCACTGG) using pCSFV-CAT as a 






2.8.3 Yeast-two hybrid constructs 
 
pACT-hDazl, pACT-hDAZ and pACT-mDazl have all been previously described 
(Ruggiu and Cooke, 2000). 
 
pGAD.hBOULE and pGAD-Xdazl have been previously described (Collier et. al., 
2005). 
 
BTM.LexA and pACT.IRP have been previously described (SenGupta et. al., 1996). 
 
pACT.xPaip has been previously described (Gray et. al., 2000). 
 
pACT.hPaip has been previously described (Gorgoni et. al., 2005). 
 
BTM.Xl-ePABPCt has been previously described (Wilkie et. al., 2005). 
 
pGEM.tPABP and pGEM-hPABP were supplied by Dr B. Collier and contained the 
relevant ORFs cloned into pGEM.T-easy (Promega) following manufacturer’s 
instructions.  
 
BTM.hPABP5 was made by Mr. Ross Anderson by cutting a fragment containing the 
ORF of human PABP5 from pET.PABP5 and ligating it into cut BTM vector.  
 
Vp16.PABP16 was a gift from Dr. Scott Ballantyne.  This plasmid was isolated in a 
yeast-two hybrid screen and is a fusion of the VP-16 activation domain and contains part 
of RRM4 and the C-terminal region of Xenopus PABP1. 
 
pGBK.BaitIII was a gift from Dr D. Cazalla and contains the N-terminal third of the 








pGEM.tCt A fragment containing the human testis PABP C-terminal region (amino 
acids 396-631) was created by PCR using oligodeoxyribonucleotides  “jws5'h3ct2 
” (=5’GTCAGTGAATTCCGAGCACCTCCTTCAGGTTAC 3’) and “jws3'h3ct2 
” (=5’ GTCAGTGGATCCTTAAACAGTTGGAACACCGGTTAC 3’) using pGEM-
tPABP as a template.  The PCR product was subcloned into pGEM.T-easy (Promega) 
following manufacturer’s instructions.  
 
BTM.tCt A fragment containing the human testis PABP C-terminal region (amino acids 
396-631) was cut from pGEM.tCt with EcoRI and BamHI ligated into BTM vector cut 
with EcoRI and BamHI.  
 
pGEM.hCt A fragment containing the human PABP1 C-terminal region (amino acids 
394-633) was created by PCR using oligodeoxyribonucleotides “jws5'hct” (=5’ 
GTCAGTGAATTCATCAACCCCTACCAGCCAGCAC 3’) and “jws3'hct” (=5’ 
GTCAGTGAATCCTTAAACAGTTGGAACAACGGTGGC 3’) using pGEM-hPABP 
as a template.  The PCR product was subcloned into pGEM.T-easy (Promega) following 
manufacturer’s instructions. 
 
pGAD.hCt A fragment containing the human PABP1 C-terminal region (amino acids 
394-633) was cut from pGEM.hCt with EcoRI and BamHI and ligated into pGADT7 
(Clontech) vector cut with EcoRI and BamHI. 
 
BTM.hCt A fragment containing the human PABP1 C-terminal region (amino acids 
394-633) was cut from pGEM.hCt with EcoRI and BamHI and ligated into BTM vector 
cut with EcoRI and BamHI. 
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pGAD.hDAZL A fragment containing the ORF of human DAZL was created by PCR 
using oligodeoxyribonucleotides “JWS5HDE” (=5’ 
GTCAGTGAATTCATGTCTACTGCAAATCCTGAAAC 3’) and “JWS3HDB” (=5’ 
GTCAGTGGATCCTCAAACAGATTTAAGCATTGCCC 3’) using pACT.hDAZL as a 
template.  The PCR product was cut with EcoRI and Bam HI and ligated into pGADT7 
(Clontech) vector cut with EcoRI and BamHI. 
 
pGAD.hDAZ A fragment containing the ORF of human DAZ was created by PCR 
using oligodeoxyribonucleotides “JWS5HDZE” (=5’ 
GTCAGTGAATTCATGTCTGCTGCAAATCCTGAG 3’) and “JWS3HDZB” (=5’ 
GTCAGTGGATCCTCAGTCTCTTCTCTGGATTAAAC 3’) using pACT.hDAZL as a 
template.  The PCR product was cut with EcoRI and Bam HI and ligated into pGADT7 
(Clontech) vector cut with EcoRI and BamHI. 
 
pGAD.hBOULE.106-173 A fragment containing amino acids 106-173 of human 
BOULE was created by PCR using oligodeoxyribonucleotides “hB106FEco” (=5’ 
GTCAGTGAATTCGAAAAACTTAATTATAAGG 3’) and “hB173RBam” (=5’ 
GTCAGTGGATCCTGAAGGCCAAGGCGGTGG 3’) using pGAD.hBOULE as the 
template.  The PCR product was cut with EcoRI and Bam HI and ligated into T7 
(Clontech) vector cut with EcoRI and BamHI. 
 
pGBK.mDazl.99-166 A fragment containing amino acids 99-166 of mouse Dazl was 
cut from pAS.mD99-166 with NdeI and BamHI.  The resulting fragment was ligated 
into pGBKT7 (Clontech) that had been cut with NdeI and BamHI.   
 
pGBK.mDazl.129-166 A fragment containing amino acids 129-166 of mouse Dazl was 
created by PCR using oligodeoxyribonucleotides “5mD129” (=5’ 
GTCAGTGAATTCTTGATTTTTAATCCTCTTCCTCC 3’) and “JWS399B” (=5’ 
GTCAGTGGATCCCTGAACATACTGAGTGATAGG 3’) using pGAD.mDAZL as the 
template.  The PCR product was cut with EcoRI and Bam HI and ligated into pGBKT7 
(Clontech) that had been cut with EcoRI and BamHI. 
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pGBK.mDazl.139-166 A fragment containing amino acids 139-166 of mouse Dazl was 
created by PCR using oligodeoxyribonucleotides “5mD139” (=5’ 
GTCAGTGAATTCTTCCAGAGTGTTTGGAGTAGTAG 3’) and “JWS399B” (=5’ 
GTCAGTGGATCCCTGAACATACTGAGTGATAGG 3’) using pGAD.mDAZL as the 
template.  The PCR product was cut with EcoRI and Bam HI and ligated into pGBKT7 
(Clontech) that had been cut with EcoRI and BamHI. 
 
pGBK.mDazl.149-166 A fragment containing amino acids 149-166 of mouse Dazl was 
created by PCR using oligodeoxyribonucleotides “5mD149” (=5’ 
GTCAGTGAATTCGAGACTTACATGCAGCCTCC 3’) and “JWS399B” (=5’ 
GTCAGTGGATCCCTGAACATACTGAGTGATAGG 3’) using pGAD.mDAZL as the 
template.  The PCR product was cut with EcoRI and Bam HI and ligated into pGBKT7 
(Clontech) that had been cut with EcoRI and BamHI. 
 
pGEM.mDazl.M3.E/B was made using the mutagenic PCR method detailed in section 
2.3.8.  The initial PCR reaction was conducted using oligodeoxyribonucleotides 
“JWS5M6” (=5’ GCTGAGACTGTCATGCAGCCTCC 3’) and “JWS3M6” (=5’ 
GGAGGCTGCATGACAGTCTCAGC 3’) using pGAD.mDAZL as the template.  The 
second PCR reaction used oligodeoxyribonucleotides “JWS5MDE” (=5’ 
GTCAGTGAATTCATGTCTGCCACAACTTCTGAG 3’) and “JWS3MDB” (=5’ 
GTCAGTGGATCCTTAGTAGAGATGATCAGATTTAAGC 3’).  The resultant 
fragment was subcloned into pGEM.T.easy as per manufacturer’s instructions. 
 
pGEM.mDazl.M2,3.E/B was made using the mutagenic PCR method detailed in 
section 2.3.8.  The initial PCR reaction was conducted using oligodeoxyribonucleotides 
“JWS5M5” (=5’ GAGTAGTCCAGCTGCTGAGAC 3’) and “JWS3M5” (=5’ 
GTCTCAGCAGCTGGACTACTC 3’) using pGAD.mDAZL as the template.  The 
second PCR reaction used oligodeoxyribonucleotides “JWS5MDE” (=5’ 
GTCAGTGAATTCATGTCTGCCACAACTTCTGAG 3’) and “JWS3MDB” (=5’ 
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GTCAGTGGATCCTTAGTAGAGATGATCAGATTTAAGC 3’).  The resultant 
fragment was subcloned into pGEM.T.easy as per manufacturer’s instructions. 
 
pGEM.mDazl.M1,2,3.E/B was made using the mutagenic PCR method detailed in 
section 2.3.8.  The initial PCR reaction was conducted using oligodeoxyribonucleotides 
“JWS5M4” (=5’ GTTCCAGAGTGTTGTGAGTAGTCC 3’) and “JWS3M4” (=5’ 
GGACTACTCACAACACTCTGGAAC 3’) using pGAD.mDAZL as the template.  The 
second PCR reaction used oligodeoxyribonucleotides “JWS5MDE” (=5’ 
GTCAGTGAATTCATGTCTGCCACAACTTCTGAG 3’) and “JWS3MDB” (=5’ 
GTCAGTGGATCCTTAGTAGAGATGATCAGATTTAAGC 3’).  The resultant 
fragment was subcloned into pGEM.T.easy as per manufacturer’s instructions. 
 
pGAD.mDazl.M3 pGEM.mDazl.M3.E/B was cut with EcoRI and BamHI.  The 
resulting fragment was ligated into pGADT7 (Clontech) that had been cut with EcoRI 
and BamHI. 
 
pGAD.mDazl.M2,3 pGEM.mDazl.M2,3.E/B was cut with EcoRI and BamHI.  The 
resulting fragment was ligated into pGADT7 (Clontech) that had been cut with EcoRI 
and BamHI. 
 
pGAD.mDazl.M1,2,3 pGEM.mDazl.M1,2,3.E/B was cut with EcoRI and BamHI.  The 
resulting fragment was ligated into pGADT7 (Clontech) that had been cut with EcoRI 
and BamHI. 
 
MSPN.mDazl.M3 A fragment containing the mDazl.M3 ORF was created by PCR 
using oligodeoxyribonucleotides “M1674” (=5’ CATGCACAATTGATGTCTGC 
CACAACTTCTGAGGCTCC 3’) and (=5’ 
CATGCAACTAGTTTAGCAGAGATGATCAGATTT 3’) using pGEM.mDazl.M3.E/B 
as the template.  The PCR product was cut with MfeI and SpeI and ligated into pMSPN 
vector cut with MfeI and SpeI. 
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MSPN.mDazl.M2,3 A fragment containing the mDazl.M2,3 ORF was created by PCR 
using oligodeoxyribonucleotides “M1674” (=5’ CATGCACAATTGATGTCTGC 
CACAACTTCTGAGGCTCC 3’) and (=5’ 
CATGCAACTAGTTTAGCAGAGATGATCAGATTT 3’) using 
pGEM.mDazl.M2,3.E/B as the template.  The PCR product was cut with MfeI and SpeI 
and ligated into pMSPN vector cut with MfeI and SpeI. 
 
MSPN.mDazl.M1,2,3 A fragment containing the mDazl.M1,2,3 ORF was created by 
PCR using oligodeoxyribonucleotides “M1674” (=5’ CATGCACAATTGATGTCTGC 
CACAACTTCTGAGGCTCC 3’) and (=5’ 
CATGCAACTAGTTTAGCAGAGATGATCAGATTT 3’) using 
pGEM.mDazl.M1,2,3.E/B as the template.  The PCR product was cut with MfeI and 
SpeI and ligated into pMSPN vector cut with MfeI and SpeI. 
 
2.8.4 Other plasmids 
 
pMSCU-CAT has been previously described (Ostareck et. al., 2001). 
 
pET.PABP5 was constructed by Mr Ross Anderson.  A fragment containing the ORF of 
human PABP5 was created by PCR using oligodeoxyribonucleotides (5’ 
GGATCCTTATGGGGAGCGGGGAGCC) and (3’ 
GCGTGGACTCAGCACCTGCGCCTGGCCT) using IMAGE clone BC0631B as a 
template.  The PCR product was digested with BamHI and SalI and ligated into 
pET.28c+ that had been cut with BamHI and SalI. 
 
pET.Xl.DAZAP1 was the kind gift of Paul W Huber (University of Notre Dame, IN, 
USA) and contains the coding sequence of Xenopus DAZAP1 inserted into the NdeI and 
Sal I sites of pET-23b. 
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The Dazl family proteins are a family of RNA-binding proteins essential for 
gametogenesis.  Prior work by a number of laboratories has suggested a conserved role 
in translational regulation in a variety of species.  Dazl was shown to associate with 
polysomes in mice and zebrafish (Maegawa et. al., 2002; Tsui et. al., 2000b), suggesting 
a role in mRNAs actively undergoing translation.  The Drosophila homologue of Dazl, 
Boule, was shown to be required for the translation of twine mRNA (Maines and 
Wasserman, 1999).  Subsequently, a role in translational activation was directly 
established in this laboratory when a variety of Dazl family members were shown to be 
capable of translational regulation in Xenopus oocytes (Collier et. al., 2005).  
 
A number of putative vertebrate targets for this translational activity have been recently 
identified in a variety of species (Fox et. al., 2005; Jiao et. al., 2002), with in vivo 
evidence being available for two mouse targets, the mouse vasa homologue (Mvh), and 
SYCP3 (Reynolds et. al., 2005; Reynolds and Cooke, 2005). Both proteins are essential 
for mouse gametogenesis and share aspects of the Dazl phenotype in males.   
 
This chapter explores the model proposed for Dazl-mediated stimulation of translation.  
In this model Dazl is recruited to the 3’UTRs of translationally inactive mRNAs and in 
turn recruits PABP that then interacts with 5’UTR bound factors, circularising the 
mRNA and enhancing translation.  This is in keeping with the sucrose gradient analysis 
in the presence of cycloheximide that shows Dazl stimulates translation at the stage of 
initiation (Collier et. al., 2005).  As PABP has various effects on initiation and interacts 
with multiple factors (see section 1.5.2.1), it is not clear which factor and consequently 
which step in translation initiation a DAZL/PABP complex would stimulate. 
 
The aim of this chapter is to enable a better understanding of when and how Dazl 
stimulates translation and the model proposed by Collier et. al.  To this end, a definition 
of the stage in translation initiation that Dazl acts upon will be sought.  This will be 
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useful in aiding the understanding the nature of the translational stimulation provided by 
Dazl.  The data presented in this chapter will also help in understanding the effect of 
PABP recruitment by Dazl as PABP has been proposed to affect initiation at multiple 
points.  It will be interesting to note whether Dazl stimulates all the stages that have been 
previously described for PABP or whether it has a more focused role.   
 
3.2 The tethered function assay 
 
The nature of the translational stimulation mediated by Dazl will be further investigated 
using tethered function assays with mRNAs that utilise a subset of canonical translation 
factors to initiate translation.  A tethered function approach was utilised as target 
mRNAs had not been definitively identified at the time of the work.   
 
The tethered function assay has become an established assay in understanding the 
function of RNA-binding proteins.  It enables functional analysis of RNA binding 
proteins even in the absence of knowledge of their endogenous target sites for binding 
and allows functional domains to be mapped (Coller et. al., 1998). 
 
The key component of this assay is the use of a tether protein of unrelated function to 
bring the protein of interest to a reporter mRNA.  The tether is used in lieu of the 
protein’s own RNA binding activity.  This has a number of advantages; by using an 
unrelated binding site it is possible to control exactly where the protein is localised to on 
the mRNA that means the assay is very specific with no known incidence of cross 
reaction in vivo (Keryer-Bibens et. al., 2007).  It also avoids any interference from the 
endogenous protein if it is present in the system.  Because the tether brings the protein of 
interest to the reporter RNA it is not necessary to know the RNA binding sequence of 
the protein, which is of great benefit as frequently the RNA targets for RNA binding 
proteins that are identified genetically are unknown.  This was the case for Dazl when it 
was first investigated for its translational activity.   
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There are a number of different tethering systems available.  These include the RNA-
binding domain of the λ phage antiterminator protein N with its specific λ-N binding site 
(boxB) (De Gregorio et. al., 2001) and the human iron regulatory protein (IRP) that 
recognises a stem-loop known as the iron-responsive element (Gray and Hentze, 1994a). 
Perhaps the most widely utilised system is the bacteriophage MS2 coat protein that 
recognises defined stem-loops known as MS2 binding sites. 
 
The particular assay that was chosen for use in this study was the MS2 tethered function 
system, as this has been utilised for the study of a number of translational regulators in 
stage VI Xenopus oocytes including Dazl.  This assay has two components; a fusion of 
the protein of interest with the bacteriophage MS2 coat protein and a luciferase reporter 














Measure Luciferase and Gal
 
 
Figure 3.1: MS2 tethered function assay.   
A: RNA encoding MS2-fusion protein is injected into the cytoplasm of stage VI oocytes and 
incubated for 6 hours to allow fusion protein expression.   
B: Oocytes are then injected in the cytoplasm with a luciferase and an internal control β-
galactosidase reporter mRNAs.  
C: The expressed fusion protein binds to the MS2-binding sites in the 3’UTR of the luciferase 
reporter thus tethering the protein to the reporter.  The oocytes are then incubated overnight to 
allow effects on reporter translation.  Lysates are then made and Luciferase and β-galactosidase 
activities are measured. 
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In all the tethered function assays in this thesis a negative control protein, U1A, is used 
to measure the baseline translation of the reporter mRNA bound by a tether fusion 
protein.  U1A is a RRM containing protein that functions in mRNA metabolism but is 
known not to affect translation in the cytoplasm (Jovine et. al., 1996).  When a MS2 
fusion of U1A is tethered, it produces the same level of luciferase as when the MS2 
protein alone is tethered (Gray et. al., 2000).  This shows that stimulation of translation 
is not a general property of tethering RRM containing proteins (Gray et. al., 2000).   
 
The activity of the luciferase reporter is used as measure of translation.  The effect of 
tethering proteins in the absence of changes in the mRNA levels (see section 3.11 
below) is observed by assessing the changes in luciferase production.  The luciferase 
values are always normalised to β-galactosidase levels from a co-injected β-
galactosidase reporter.  This reporter is polyadenylated and lacks MS2 binding sites so is 
unbound by the fusion proteins and thus gives a value that can be used to account for 
any differences in translational activity in the oocytes. 
 
3.3 Xenopus oocytes as a model for vertebrate germ cells 
 
The tethered function assays discussed above can be used in a variety of systems 
including cell culture, in vitro and in Xenopus oocytes.  The system utilised in this thesis 
is stage VI Xenopus oocytes (unless specifically stated) that comes with a variety of 
advantages.   
 
A single Xenopus ovary contains hundreds of oocytes at different stages of development.  
Xenopus oocytes are sub-divided into six clearly defined stages, as an oocyte progresses 
from stage one to stage six; it grows progressively larger until it reaches stage VI 
(Dumont, 1972).  At this point it is regarded as a fully developed oocyte but has yet to 
complete meiosis (Ferrell, 1999).  The next stage is the maturation of the oocyte into an 
unfertilized egg via the application of the hormone progesterone to the oocyte; this 
causes the oocyte to complete meiosis.  This can be easily achieved in vitro and mature 
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oocytes are easily identified by the appearance of a white spot on the animal pole 
(Ferrell, 1999).  
 
The stage VI oocytes offer a number of advantages for translation assays.  These cells 
are large, approximately 1.3mm; which means that they are relatively easy to manipulate 
and microinject.  It is possible to conduct biochemical assays, such as luciferase or β-
galactosidase assays, in oocyte extracts derived from large numbers of oocytes that give 
simple experimental measurements.   
 
RNAs injected into oocytes are stable both with the m7GpppG cap and also with the 
non-functional ApppG cap analogue (Gillian-Daniel et. al., 1998). Another advantage is 
that unadenylated mRNAs are also uniquely stable in these cells (Audic et. al., 1997). 
This allows for a large number of experimental manipulations of reporter mRNAs.  
Translation in Xenopus oocytes is however profoundly responsive to  poly(A) tail length, 
for instance adenylation of c-mos and cyclin B1 mRNA increases their translation 10 
and 75 fold respectively (Sheets et. al., 1994). This is an important asset for 
investigating Dazl function, in that the current model posits that Dazl utilises PABP 
(Collier et. al., 2005), which is responsible for the translational effects of the poly(A) tail 
(Gray et. al., 2000). 
 
Late stage oocytes, mature eggs and early embryos are essentially transcriptionally silent 
(Mendez and Richter, 2001).  Thus all changes in the pattern of protein synthesis come 
from changes in translation or turnover of RNA.  This is used to advantage in tethered 
function assays as reporter mRNAs are injected into the oocyte cytoplasm thus any 
effects on transcription or export by multifunctional proteins will not affect the results of 
the translation assays. 
 
A final advantage of oocytes in this study is that they are vertebrate germ cells.  As the 
Dazl family proteins are primarily germ cell specific this system is a particularly 
relevant model system.  They are also very accessible vertebrate germ cells as you can 
extract thousands of oocytes from one Xenopus ovary.  This gives plenty of material to 
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work with, especially when compared to mice, where a super ovulated ovary would 
return approximately thirty oocytes.  There is evidence that Dazl family members have a 
functional conservation across species since Xenopus Dazl or human BOULE can both 
partially rescue the Drosophila boule knockout (Houston et. al., 1998; Xu et. al., 2003). 
Similarly, human DAZ and DAZL partially rescue a Dazl knockout mouse (Slee et. al., 
1999; Vogel et. al., 2002).  These results indicate that looking at mammalian Dazl 
proteins in model germ cells can give valid functional information.  
 
3.4 Dazl stimulates translation as shown by the tethered 
function assay  
 
Published work (Collier et. al., 2005) has shown that DAZL family members can 
stimulate translation when tethered in stage VI Xenopus oocytes. To confirm this finding 
mRNAs encoding the mouse Dazl fusion and the negative control MS2-U1A were 
transcribed and injected into the cytoplasm of stage VI oocytes and left for six hours to 
allow the fusion proteins to be expressed.  Subsequently Luc-MS2 and β-gal reporters 
(see figure 3.1) were injected directly into the cytoplasm and oocytes were incubated 
overnight, this allows the fusion proteins time to bind to the luciferase reporter and 
modulate luciferase production.  25 oocytes were injected for each separate experimental 
point.  After the overnight incubation any obviously necrotic oocytes were discarded and 
the remainder were grouped into batches of five.  These oocytes were then mechanically 
lysed and the lysates assayed for luciferase and β-galactosidase activity using a 
luminometer.  
 
A typical set of results is represented in figure 3.2, with graphs A and B showing the raw 
β-galactosidase and luciferase values respectively.  In this case enough oocytes survived 
for four sets of five oocytes for both MS2-U1A and MS2-mDazl.  Luciferase values 
were then normalised relative to β-gal activity in order to take account of any differences 
in translational activity between different oocytes.  As can be seen from figure 3.2A β-
galactosidase is largely consistent but some oocyte sets have higher or lower activity 
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than others necessitating a correction.  A typical correction was between 10% and 30%, 
and any set that showed a variation greater than this was discarded.  Figure 3.2C shows 
the result of the corrected luciferase values.  These values are then averaged to give an 
average luciferase activity for each fusion protein normalised to β-galactosidase activity 
as shown in figure 3.2D.  Finally, luciferase value given by the U1A control were set to 
one and expressed as the relative stimulation given by the protein of interest.  Multiple 
repetitions of an experiment are conducted and the stimulation values are averaged and 
the standard error of that value is calculated giving the final average stimulation for the 
protein of interest as shown in figure 3.2E.  This is the data format given in all 
subsequent tethered function assay figures unless explicitly stated. 
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Figure 3.2: (Part 1) mDazl stimulates translation.  
Mouse Dazl can stimulate translation in a tethered function assay.  m7GpppG -capped Luc-MS2 
reporter (M7G-Luc-MS2) was co-injected with β-Gal mRNA into stage VI oocytes expressing 
MS2-U1A or MS2-mDazl.  A: Surviving oocytes were sorted into sets of five (1-8).  Each set was 
assayed for β-galactosidase activity.  The relative β-galactosidase activity for each set of 
oocytes was plotted as shown.  B: Oocytes sets were also assayed for luciferase activity.  The 
relative luciferase activity for each set was shown.  C: Raw luciferase activity was normalised to 
β-galactosidase activity to give an adjusted luciferase value for each set.  D: The average value 
of luciferase activity normalised to β-galactosidase activity was calculated for MS2-U1A and 




























Figure 3.2: (Part 2) mDazl stimulates translation. 
E:  The average adjusted luciferase values from part D were used to show the ability of mDazl to 
stimulate translation.  Average relative luciferase units were plotted with MS2-U1A values set to 
one.  The average of six separate experiments is shown.  Standard error between experiments 
is shown as error bars.  F: The MS2-fusion proteins are expressed in oocytes.  Oocytes were 
injected with fusion-protein mRNAs and incubated in buffer containing 35S-methionine for 6 
hours and protein lysates made.  An oocyte’s worth of lysate was separated by SDS-PAGE and 
analysed by autoradiography.  Arrows indicate the fusion protein bands. 
 
To ensure that the fusion proteins were expressed as expected, stage VI oocytes were 
injected with RNAs encoding MS2-mDazl and MS2-U1A and new protein production 
was monitored by metabolically labelling the oocytes with 35S-methionine.  Protein 
extracts from oocytes were made and analysed using SDS-PAGE.  Bands corresponding 
to MS2-U1A protein and MS2-mDazl protein can be observed in the relevant lanes 
(figure 3.3F).  The MS2-U1A band has a higher intensity than the MS2-mDazl band but 
this is consistent with the number of methionines in the two proteins with U1A 
containing seventeen and Dazl containing only six. 
 
Consistent with published results, Dazl stimulates luciferase expression (figure 3.2E).  It 
has been shown previously that this stimulation of luciferase by mDazl is a specific cis 
effect that requires the presence of the MS2 binding sites in the 3’UTR of the Luc-MS2 
reporter (Collier et. al., 2005) and is not mediated by changes in mRNA stability.  
 100
Confirmation of these observations is presented in figure 3.9.  Typically the level of 
translational stimulation observed for mouse Dazl was eight-fold but varied between 
different injections with stimulation values of between 4 and 11 observed over the 
course of these experiments.  This variation is thought to be due to natural variations in 
the translational activity of oocytes.  It has been noticed that the quality of the oocytes 
regarding survival and the levels of stimulation seen varies greatly.  These effect have 
been observed when other proteins such as SLBP and PABP were studied using the 
same system.  Particular times of year are also known to produce poor quality oocytes.  
 
It is thought that the Xenopus have an internal circadian clock and may be sensitive to 
subtle changes in day/night cycle or temperature despite being kept in a temperature and 
light controlled environment.  Oocyte quality varies with the seasons of the year and it is 
thought that these changes could represent the frog’s life style in the wild.  For example, 
there is often a noticeable drop in quality in autumn that could be related to the breeding 
season for wild Xenopus.  External influences can also affect oocyte quality, for example 
in recent years there has been an outbreak of a fungus (Batrachochytrium dendrobatidis) 
infecting amphibian populations around the world.  This fungus is known to affect germ 
cell quality, so any contamination in animal stocks could conceivably affect 
experimental results.  Another extremely important external influence is the quality of 
the water the Xenopus live in.  In particular is ensuring the removal of any chloramine 
(that is added to water as a disinfectant) as it is toxic to amphibians.   
 
As the Xenopus populations that are supplied for laboratory use are not inbred strains 
there may be an effect of genetic background on translation experiments.  In fact it is 
known that suppliers regularly collect wild-type frogs for their colonies.  This means 
that both oocyte quality and possibly translational activity could vary greatly between 
different animals and could account for much of the variation seen in my experiments, 
especially as other factors such as water quality and housing conditions are actively kept 
as consistent as possible. 
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3.5 The variable reporter tethered function assay 
 
Although it has been previously established that Dazl can stimulate translation, little is 
known about the mechanism or nature of this stimulation.  Previous work in our lab 
utilising sucrose gradients has demonstrated that Dazl stimulates translation initiation 
and an interaction with a pleiotropic initiation factor, PABP, has been shown (Collier et. 
al., 2005).  To understand the mechanism of Dazl mediated translation stimulation 
further it is necessary to distinguish whether early or late steps in initiation are targeted 
and what initiation factors are required for regulation.  
 
Translation initiation can be divided into four basic mRNA dependant steps (see Chapter 
1.3.1 for more detail on translation initiation).  These are; first cap binding, second 43S 
complex joining, third scanning and fourth 60S subunit joining.   
 
To investigate which of these initiation steps is affected a variable reporter tethered 
function assay was used.  This approach has been previously utilised in oocytes to 
investigate a different translational activator, the stem-loop binding protein (SLBP) 
(Gorgoni et. al., 2005), and was instrumental in identifying that this protein functions in 
an early stage of the cap-dependant initiation pathway, targeting the cap-binding 
complex. 
 
The technique is a modification on the standard tethered function assay in oocytes, 
employing the same fusion proteins but a series of modified luciferase reporters, shown 
























Figure 3.3: The varied tethered function assay reporters.  
The first reporter, here referred to as m7G, is the standard reporter used in figure 3.2.  This 
reporter is capped with the m7GpppG cap that is found on endogenous mRNAs.  The second 
reporter, ApG, is capped with an artificial ApppG cap, which is non-functional regarding its 
capacity to bind eIF4E.  Three other ApG capped reporters contain an IRES is their 5’UTRs.  
The ‘PV’ reporter contains the Poliovirus IRES, the ‘EMCV’ reporter the encephalomyocarditis 
IRES and the ‘CSFV’ reporter contains the Classical Swine Fever Virus.  The ApG cap 
minimises any cap-dependent translation from these IRES-containing mRNAs. 
 
Reporters are capped with either an m7GpppG cap, which is the endogenous functional 
cap, or an artificial ApppG cap.  Both these caps act to stabilise the RNA and prevent 5’ 
exonucleases from digesting the injected reporters but they differ significantly in 
function (Gillian-Daniel et. al., 1998). In inhibition assays, injected m7GpppG cap 
analogue could reduce the activity of a reporter by 98.5% whereas the effect of ApppG 
was much lower at 6.5% indicating the difference in the ability to recruit translational 
machinery between the two (Gillian-Daniel et. al., 1998). 
 
Some of the variable reporters contain an IRES in the 5’UTR.  These are areas of 
specific RNA sequence that form secondary RNA structures consisting of RNA stems 
and loops.  These three-dimensional structures provide protein and ribosomal-RNA 
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binding sites and allow for differing mechanisms of translation initiation between the 
different IRESs.  The initiation mechanism of each IRES will be discussed in detail 
below. 
  
3.6 Dazl Stimulation is not cap dependent 
 
As discussed earlier, the mRNA dependent steps of translation can be subdivided into 
different steps the first of which is commonly accepted to be cap-binding.  This process 
can be said to be initiated when the cap binding complex, eIF4F, binds the m7GpppG 
cap through the action of the cap binding protein, eIF4E.  When synthesising in vitro 
transcribed RNAs it is possible to cap them with a non-functional cap analogue, ApppG.  
Where the m7GpppG cap structure contains of a 5´ 7-methyl guanosine nucleotide the 
ApppG cap contains a leading adenosine nucleotide.  This difference in nucleotide is not 
sufficient to alter the stabilizing role of the cap structure in oocytes but it severely 
inhibits eIF4E/cap interaction.  Thus by using a luciferase reporter capped with ApppG 
rather than m7GpppG it will be possible to assess if the cap binding is stimulated by 
Dazl.  
 
The mechanism of cap-independent initiation of non-IRES containing mRNAs is 
proposed to be as follows.  A complex containing elements of the cap-binding complex 
still forms in the area of the cap, but it is unsure what interactions mediate this process.  
The 43S complex is then recruited as normal via interactions with eIF3.  Scanning, AUG 
recognition and 60S joining then proceeds as in ‘standard’ translation initiation.  This 
proposed mechanism is based on a number of experimental observations.  First, an 
mRNA that undergoes decapping does not change preference for the selection of the 5’-
proximal AUG codon (Kozak, 1989b), thus implying that such mRNAs still initiate 
translation by scanning from the 5’end.  Second, the inefficient translation of uncapped 
reporter mRNAs can be rescued by addition of sufficient eIF4F (Fletcher et. al., 1990).  
Third, protease cleavage of eIF4G does not affect the translation of these mRNAs, 
demonstrating independence from eIF4E (Ohlmann et. al., 1995).  
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A luciferase mRNA with an m7pppG cap was shown to be translated 48-fold more 
efficiently than the same mRNA with an ApppG-capped RNA in Xenopus oocytes 
(Gillian-Daniel et. al., 1998). In my assays the difference in baseline translation (figure 
3.4B and 3.4C, MS2-UIA values for ApG and M7G) between the m7GpppG and ApppG 
capped luc-MS2 reporter is an approximate 100-200-fold loss of translation  (note the 
different scales between figure 3.4B and 3.4C). 
 
Tethered function assays were performed using the ApppG capped luciferase reporter 
with the M7G reporter acting as a positive control for Dazl-mediated stimulation.  Dazl 
stimulated the translation of the m7GpppG capped mRNA 8-fold (figure 3.4D) and 
importantly also stimulated luciferase production of the ApG reporter by 11-fold (figure 
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Figure 3.4: mDazl stimulates translation of the ApG-Luc-MS2 reporter. 
A: The ApG-Luc-MS2 reporter initiates translation by assembling a complex at the 5’end of the 
RNA that does not use eIF4E and is cap independent.  4G=eIF4G.  4A=eIF4A.  4B=eIF4B.  
1=eIF1.  1A= eIF1A.  2=eIF2.  3=eIF3.  5=eIF5.  5B=eIF5B.  Met=initiator tRNA methionine.  
40S= 40S ribosomal subunit.  60S= 60S ribosomal subunit.  AUG= indicates initiation codon and 
start of ORF.  4E= the eIF4E protein is probably still present in the complex; but is unable to bind 
the ApppG cap. 
B + C: MS2-mDazl can stimulate both a m7GpppG -capped Luc-MS2 reporter (M7G-Luc-MS2) 
or a ApppG capped Luc-MS2 reporter (ApG-Luc-MS2).  Reporters were co-injected with β-Gal 
mRNA into stage VI oocytes expressing MS2-U1A or MS2-mDazl.  Relative luciferase 
normalised to β-galactosidase activity was plotted for both reporters.  Due to the extreme 
differences in luciferase levels the two reporters have been plotted on separate graphs with 
different scales.  One representative experiment is shown. 
D:  Translational stimulation was plotted with MS2-U1A values set to one.  The averages of five 
experiments are shown.   
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The ability of Dazl to stimulate the ApppG capped reporter indicates that Dazl does not 
stimulate translation by enhancing the interaction of the cap-binding complex to the cap 
because this reporter does not initiate translation by cap-binding. 
 
3.7 Dazl can stimulate translation via the Poliovirus IRES 
 
The results from the ApppG reporter mRNA suggests that Dazl mediated translation 
stimulation may be cap independent.  However, as discussed above the mechanism of 
initiation of non-capped mRNAs is unclear.  Hence to test the requirement for cap-
binding more rigorously, IRES containing luciferase reporters were used.  The different 
IRES containing reporters (figure 3.3) utilise different mechanisms of translation and 
also have different initiation factor requirements.  By testing which of these reporters 
Dazl can enhance we may be able to learn more about the mechanism of Dazl’s 
translational activity.  Initially the poliovirus (PV) IRES reporter was used, the PV IRES 
is known to initiate translation away from the cap structure, utilising a large complex 
structural region within the 5’UTR.   
 
The PV IRES does not require the eIF4E cap binding initiation factor but is thought to 
utilise all other initiation factors.  This requirement was inferred from experiments 
where eIF4G was cleaved by a rhinovirus protease, thus separating the N-terminal eIF4E 
binding portion of eIF4G from the C-terminal domain that binds eIF3 and eIF4A.  The 
cleavage impairs eIF4F’s function on capped mRNAs but the C-terminal fragment is 
sufficient for the efficient translation of the PV IRES (Lamphear, 1995).  The lack of 
requirement for eIF4E was reinforced by the insensitivity of the IRES to the over 
expression of the eIF4E-binding protein that sequesters eIF4E (Pause, 1994).  
Subsequently a strong requirement for the eIF4A/eIF4G complex was suggested by the 
strong inhibition of this IRES by a dominant negative form of eIF4A (Pause, 1994). 
 
Thus, a mechanism for the translation of the PV IRES was formulated in which the 
IRES initiates translation away from the cap by recruiting a complex consisting of the C-
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terminal of eIF4G, eIF4A and eIF4B (see figure 3.5A).  This complex then recruits the 
43S complex, in part through interactions between eIF4G and eIF3.  The 43S complex is 
then thought to scan through the remainder of the 5’UTR and recognise the AUG and 
recruit the 60S ribosomal subunit as normal.  
 
When compared to the luciferase levels given by the M7G reporter the PV reporter gives 
much lower levels with values 33-fold lower than the M7G.  However, importantly this 
mRNA is translated more efficiently than ApppG capped mRNAs, showing that the 
IRES is active (see figure 3.5B).  When comparing the ApppG capped reporter alone to 
an ApppG capped reporter with a PV IRES the average relative luciferase changes from 
6,000 relative luciferase units to 11,000 in one representative experiment.   
 
As can be seen in figure 3.5C Dazl can stimulate translation of this reporter when 
tethered.  Typical stimulation was 11-fold compared to the 8 fold stimulation seen on the 
m7GpppG capped reporter.  As a specificity control, a reporter with the PV IRES but no 
MS2 sites (PV-Luc-∆MS2) was employed.  The stimulatory effect of Dazl required MS2 
binding, as no effect on translation was observed in the absence of MS2 binding sites in 






















































Figure 3.5: mDazl stimulates translation of the PV-Luc-MS2 reporter. 
A: The PV-Luc-MS2 reporter initiates translation away from the cap and utilises all initiation 
factors except eIF4E.  4G=eIF4G.  4A=eIF4A.  4B=eIF4B.  1=eIF1.  1A= eIF1A.  2=eIF2.  
3=eIF3.  5=eIF5.  5B=eIF5B.  Met=initiator tRNA methionine.  40S= 40S ribosomal subunit.  
60S= 60S ribosomal subunit.  AUG= indicates initiation codon and start of ORF. 
B: MS2-mDazl can stimulate a m7GpppG -capped Luc-MS2 reporter (M7G-Luc-MS2) and 
ApppG capped PV-Luc-MS2 reporter (PV-Luc-MS2).  The reporters were co-injected with β-Gal 
mRNA into stage VI oocytes expressing MS2-U1A or MS2-mDazl.  Luciferase activity was 
normalised to β-galactosidase activity and plotted. 
C:  Translational stimulation was plotted with MS2-U1A values set to one.  The average of four 
experiments is shown.   
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Dazl’s ability to stimulate the translation of this reporter further reinforces the 
hypothesis that Dazl does not stimulate cap-binding by eIF4E as in this reporter 
initiation is completely separate from the cap structure.  This effectively eliminates cap 
binding as the target of Dazl action and suggests that it must act on 43S joining, 
scanning, or 60S recruitment and not at the first mRNA dependent step in initiation. 
 
3.8 Dazl can stimulate translation via the encephalomyocarditis 
IRES 
 
As discussed the PV IRES utilises the majority of canonical translation factors with the 
exception of eIF4E and the N-terminal fragment in eIF4G.  This virus belongs to the 
type 1 subtype of picornaviruses (Pilipenko et. al., 1989) and its mode of translation has 
been described as ‘land and scan’.  This is because the small ribosomal subunit scans to 
a downstream AUG from the point at which it is initially recruited by the IRES.  It was 
therefore of interest to examine an IRES that utilises the same canonical initiation 
factors but whose mechanism of initiation deviates somewhat from that of the PV. 
 
The encephalomyocarditis virus (EMCV) IRES again initiates translation away from the 
5'-cap structure at a 400 nucleotide long structure that contains multiple stem loops.  The 
initiation factors eIF4G, eIF4A, eIF4B form a complex on the stem loop structure that 
then recruits the 43S complex, probably through interactions between eIF4G and eIF3 
(Pestova et. al., 1996a). Again EMCV proteases cleave eIF4G in infected cells.  The 
initiation AUG codon is immediately after the IRES structure and the 43S complex is 
localised directly to it upon recruitment.  This action is sometimes referred to as a ‘land 
and dock’ initiation and does not require scanning.  After this point 60S joining 
continues as normal. 
 
When the luciferase levels produced by the EMCV reporter are compared to the M7G 
reporter with the U1A protein the EMCV reporter produces seven fold less luciferase 
(figure 3.6B).  This indicates that the EMCV reporter is more active than both the ApG 
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and PV reporters but is still less active than a reporter with an m7GpppG cap and no 
IRES.  This is in keeping with the results of others who have shown that the EMCV 
IRES is more efficiently translated on oocytes than an ApppG capped luc-MS2 or PV-
luc-MS2 RNA (W Richardson, unpublished).   
 
As can be seen in figure 3.6C Dazl can stimulate this reporter when tethered though the 
observed stimulation is greatly reduced compared to M7G and PV (figure 3.5C) and is 
typically only 2.5-fold.  A reporter with the EMCV IRES but no MS2 sites (EMCV-Luc-
∆MS2) was not stimulated showing that this reduced level of stimulation was specific 
























































Figure 3.6: mDazl stimulates translation of the EMCV-Luc-MS2 reporter.  
A: The EMCV-Luc-MS2 reporter initiates translation at the initiation codon and utilises all 
initiation factors except eIF4E.  4G=eIF4G.  4A=eIF4A.  4B=eIF4B.  1=eIF1.  1A= eIF1A.  
2=eIF2.  3=eIF3.  5=eIF5.  5B=eIF5B.  Met=initiator tRNA methionine.  40S= 40S ribosomal 
subunit.  60S= 60S ribosomal subunit.  AUG= indicates initiation codon and start of ORF. 
B: MS2-mDazl can stimulate m7GpppG -capped Luc-MS2 reporter (M7G-Luc-MS2) or ApppG 
capped EMCV-Luc-MS2 reporter (PV-Luc-MS2).  Reporters were co-injected with β-Gal mRNA 
into stage VI oocytes expressing MS2-U1A or MS2-mDazl.  Luciferase activity was normalised 
to β-galactosidase activity and plotted.  * = A significant stimulation by MS2-mDazl is seen (P < 
0.0005) compared to MS2-U1A, despite the lower stimulation compared to that achieved on the 
M7G-Luc-MS2 reporter. 
C:  Translational stimulation was plotted with MS2-U1A values set to one.  The average of four 
experiments is shown.   
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This result again reinforces the hypothesis that Dazl does not stimulate translation 
initiation at the stage of cap binding.  This reporter still initiates translation by recruiting 
the small ribosomal subunit in a similar way to ‘classic’ translation initiation, but in 
contrast to PV there is no scanning of the ribosomal subunit through the 5’UTR 
involved.   
 
This intermediate result raises some interesting questions.  Is there less stimulation 
because Dazl stimulates scanning and the mechanism of 43S recruitment by the EMCV 
IRES means that there is no scanning to stimulate.  Or does the fact that Dazl can still 
stimulate this reporter indicate that scanning is unimportant to Dazl’s stimulatory action 
and that Dazl stimulates 43S joining, which still occurs as ‘normal’ on the EMCV IRES.   
One sensible experiment that was not conducted was to inject the EMCV and PV 
reporters on the same day in order to compare the stimulation directly.  I do not think 
that any differences would be seen as each time they were injected they were compared 
to the same M7G control.  However it would be sensible to confirm that the differences 
seen in stimulation are real.   
 
The implications of this result and that of the other reporters tested will be discussed in 











3.9 Dazl can not stimulate translation via the classical swine 
fever virus IRES 
 
The ability of Dazl to stimulate the PV reporter and to a lesser extent the EMCV reporter 
suggests that Dazl utilises factors other than eIF4E and eIF4G that are not involved in 
cap binding.  To investigate this further a classical swine fever virus IRES was 
engineered into the tethered reporter mRNA (CSFV-luc-MS2).  
 
Whilst this IRES initiates translation at a region of complex structure remote from the 5'-
cap, in contrast to the PV and EMCV IRESs, it does not utilise any of the eIF4F 
initiation factors (Pestova et. al., 1998). Instead it recruits the ternary complex consisting 
of the 40S ribosomal subunit, eIF2 and a Met-tRNA to the mRNA via an interaction 
with eIF3 and the IRES.  Similar to EMCV it recruits the small ribosomal subunit 
directly to the initiation AUG codon, in the absence of a prerequisite for scanning.  eIF1 
and 1A are thought to be dispensable for the CSFV IRES action (Pestova et. al., 2001).  
Once the small ribosomal subunit has joined the IRES AUG recognition and 60S joining 














































Figure 3.7: mDazl cannot stimulate translation of the CSFV-Luc-MS2 reporter 
A:  The CSFV-Luc-MS2 reporter initiates translation at the initiation codon and only requires 
eIF3, the 40S ribosomal subunit, eIF2 and a Met-tRNA eIF4E.  2=eIF2.  5B=eIF5B.  Met=initiator 
tRNA methionine.  40S= 40S ribosomal subunit.  60S= 60S ribosomal subunit.  AUG= indicates 
initiation codon and start of ORF. 
B:  MS2-mDazl can stimulate m7GpppG -capped Luc-MS2 reporter (M7G-Luc-MS2) but cannot 
stimulate ApppG capped CSFV-Luc-MS2 reporter (CSFV-Luc-MS2).  Reporters were co-injected 
with β-Gal mRNA into stage VI oocytes expressing MS2-U1A or MS2-mDazl.  Luciferase activity 
was normalised to β-galactosidase activity and plotted. 
C:  Translational stimulation was plotted with MS2-U1A values set to one.  The average of four 
experiments is shown. 
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The translation achieved from the CSFV IRES was efficient when compared to the other 
IRES containing reporters and in fact produced more luciferase with MS2-U1A than the 
M7G reporter despite being ApppG capped (figure 3.7B).  The translation of this mRNA 
is not significantly increased when m7GpppG capped showing that this efficient 
translation is indeed due to IRES activity (tested by W. Richardson, unpublished).  
 
As can be seen, despite the efficient translation initiated from the CSFV IRES, neither 
CSFV-Luc-MS2 nor CSFV-luc-∆MS2 was regulated by tethered Dazl (figure 3.7C).     
 
The result suggests that Dazl does not stimulate large ribosomal subunit (60S) joining as 
the CSFV IRES is thought to recruit this in the same manner as all the previous 
reporters, but suggests instead 43S joining or scanning.  This result also implies that 
stimulation by Dazl is be mediated by an initiation factor that is required by the PV and 
EMCV but not the CSFV IRES.   
 
3.10 Testing the binding affinity of MS2 for the reporters 
 
The previous experiments show that Dazl is able to stimulate the M7G-Luc-MS2, ApG-
Luc-MS2 and the PV-Luc-MS2 reporters fully and is able to partially stimulate the 
EMCV-Luc-MS2 reporter.  In contrast Dazl is unable to stimulate the CSFV-Luc-MS2 
reporter.  It is attractive to conclude that this is because of the differing mechanisms of 
translation initiation of these reporters, only some of which can support Dazl function.  
However there are other purely technical explanations that must be taken into account 
before it is possible to reach this conclusion.  One alternative explanation is that the 
insertion of the IRESs into the luciferase reporter constructs disrupted the binding of the 
fusion proteins to the MS2 sites and this was the reason for the apparent differences in 
stimulation.  Whilst the binding sites are located far from the IRES, mRNA secondary 
structure is complex and is not determined purely by local folding (Shapiro et. al., 
2007), thus long range effects on structure have been reported (Shapiro et. al., 2007). 
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To eliminate the possibility that unintended alterations in RNA structure may be 
responsible for these effects by disrupting the ability of the MS2-fusion to bind the 
reporter RNAs a series of electro-mobility shift assays (EMSAs) were conducted.  
Eliminating this possibility will further validate the conclusions drawn from the variable 
tethered function assay.  
 
In these assays short MS2 containing RNA were in vitro transcribed in the presence of 
32P-UTP from the pMSCU-CAT plasmid (Stripecke and Hentze, 1992), which contains 
two MS2 binding sites.  This RNA was incubated with purified recombinant MS2 
protein (the kind gift of Dr B. Gorgoni), and the complexes resolved by native gel 
electrophoresis (figure 3.8A).  Labelled RNA (lane 1) can be seen to shift to a higher 
molecular weight complex with the addition of MS2 protein (lane 2).  This band shift 
can be reduced by adding non-radio-labelled (cold) competitor MSCU-CAT RNA to the 
complex (lane 3).  Increasing amounts of cold full-length Luc-MS2 RNA can also 
eliminate the band shift (lanes 6, 7, 8) indicating that the MS2 protein is binding to the 
Luc-MS2 RNA leaving it unavailable to form complexes with the labelled MSCU-CAT 
RNA.  When increasing amounts of Luc-∆MS2 RNA, which is the same luciferase 
reporter lacking the MS2 binding sites, is added, there is no competition (lanes 9-11) 
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Figure 3.8: The various full-length luciferase reporters all bind MS2 with similar affinities.  
Short radiolabelled probes alone (lane 1, A+B) were visualized by non-denaturing gel 
electrophoresis.  Addition of MS2 protein forms a complex with the RNA and causes a mobility 
shift (lane 2, A+B) as indicated by the arrow labelled ‘complex’.  The ability of cold full-length 
mRNAs to compete this shift was tested by the addition of:- 
A: Increasing amounts of either unlabelled MSCU-CAT RNA (lane 3) or full-length luciferase 
reporter mRNAs with MS2 (Luc-MS2; lanes 6-8) or without MS2 sites (Luc- MS2; lanes 9-11).   
Competitors were added at the following amounts; 250ng, 1000ng, 4000ng.  
B: Increasing amounts of unlabelled full-length Luc-MS2 (lanes 3-5), PV-Luc-MS2 (lanes 6-8), 
EMCV-Luc-MS2 (lanes 9-11) and CSFV-Luc-MS2 (lanes 12-14) were added as competitors.  
Competitors were added at the following amounts; 250ng, 1000ng, 4000ng.  Loss of the 
complex shows that the full-length mRNA contains correctly folded MS2 sites which can be 
bound by MS2. 
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The relative abilities of the different full-length mRNAs, Luc-MS2, PV-Luc-MS2, 
EMCV-Luc-MS2 and CSFV-Luc-MS2 (figure 3.8B) to compete the MS2/MS2 complex 
were then investigated.  The band shift (lane 2) was successfully competed with 
increasing amounts of full-length Luc-MS2 (lanes 3-5), PV-Luc-MS2 (lanes 6-8), 
EMCV-Luc-MS2 (lanes 9-11) and CSFV-Luc-MS2 (lanes 12-14).  Luc-MS2, PV-Luc-
MS2 and EMCV-Luc-MS2 all competed effectively at the highest concentration.  The 
CSFV-luc-MS2 competition appeared to be more effective however, with less RNA 
being required to compete away the shift.  However this increased competition by 
CSFV-Luc-MS2 was not reproducible between repeats of this experiment, consistent 
with the absence of a linear increase in competition with the different amounts of cold 
CSFV mRNA (figure 3.8b, lanes 12-14).  In contrast to the MS2 containing reporters, 
Luc-∆MS2 (lane 15) did not compete the band shift even at the highest concentration. 
 
These experiments indicate that the differences seen in levels of luciferase expression of 
the different mRNAs by DAZL are due to mechanistic differences in their translation 
and not due to differences in RNA binding affinity.   
 
3.11 Dazl does not increase luciferase by stabilising the 
reporter RNAs 
 
In the initial observations linking Dazl to translational activation (Collier, 2005) it was 
observed that Dazl did not stabilise the reporter RNAs, as shown by northern blot, and 
that Dazl therefore directly stimulated the translation of the luciferase RNA rather than 
allow higher luciferase levels by virtue of stabilisation of the reporter.  Previously in this 
chapter, an increase in luciferase production in a tethered function assay has been 
interpreted to suggest that a stimulation of the translational activity of the reporter 
mRNA.  Another interpretation of these results could be that the tethered Dazl is 
stabilising the reporter mRNA in the oocyte, increasing its lifespan and therefore 
allowing it to produce more luciferase before degradation, giving the impression of a 
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direct effect on translation.  To rule out this possibility, in the case of the variable 
tethered function assay, a series of stability assays were undertaken.   
 
As such the effect of Dazl on RNA stability on the Luc-MS2 reporter had already been 
investigated, however possible effects on mRNA stability for PV-Luc-MS2, EMCV-
Luc-MS2 and CSFV-Luc-MS2 reporters has not been investigated and could alter the 
interpretation of the results from the variable reporter tethered function assays. 
 
Several techniques are widely used for assessing the stability of injected mRNAs in 
oocytes; these involve recovering injected mRNAs and then measuring the amounts of 
different mRNAs using techniques such as analysis of labelled mRNA by gel 
electrophoresis, northern blotting and quantitative reverse transcription polymerase 
chain reaction (QRT-PCR).  Due to the requirement to reduce radioactive material usage 
where possible and the sensitivity of QRT-PCR, it was decided to use this technique to 
measure stability of the above reporters in the tethered function assay.   
 
QRT-PCR has recently been used within the lab for the measurement of mRNA stability 
in oocytes in the presence of several different proteins (Larralde et. al., 2006; Wilkie et. 
al., 2005). This assay functions by using specific PCR primers to measure the amount of 
a certain transcript in a cDNA sample.  The cDNA is made from RNA extracted from 
micro-injected oocytes both directly after injection (T=0) and at the end of the assay 
(T=16 hours).  The assay works by using fluorescent technologies to measure the 
amount of PCR product.  As the amount of PCR product is dependent on the amount of 
cDNA in the original reaction the total fluorescence is dependant on the number of 
molecules of the specific cDNA template that is being amplified.  By including 
standards containing known numbers of molecules of the particular template that it 
being amplified it is possible to generate a standard curve for each template.  This 
standard curve can then be used to calculate the number of molecules of a particular 
cDNA and thus original RNA in each sample.   
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There are multiple different QRT-PCR fluorescent chemistries available but as one, 
SYBR green, had previously been used successfully in the lab (Larralde et. al., 2006; 
Wilkie et. al., 2005) I decided to use it for my experiments.  SYBR green is a fluorescent 
dye that binds to the minor groove of double-stranded DNA.  The binding increases the 
dye’s fluorescent emission by over 100-fold.  As the PCR reaction progresses more 
double stranded product accumulates and thus the fluorescent output increases. 
 
Tethered function assays were conducted as before, with the Luc-MS2, PV-Luc-MS2, 
EMCV-Luc-MS2 and CSFV-Luc-MS2 luciferase reporters being used.  However rather 
than collecting all the injected oocytes for luciferase and β-gal assays, half were utilised 
in RNA stability assays.  These oocytes were snap-frozen in liquid nitrogen to preserve 
the mRNAs contained within. 
 
The aim of these experiments was to measure the amount of reporter RNA in the oocytes 
immediately after injection at time equal zero (T=0) and then after the overnight 
incubation in the presence of the fusion proteins (T=16).  The amount of the reporter 
RNA is entirely limited by the initial injection as no more can be produced.  Thus this 
enables a measurement of the decrease in mRNA levels over the time course of the assay 
and whether the different fusion proteins have an effect on the kinetics of mRNA 
turnover.  Due to the stability of mRNAs in oocytes it is unlikely that a stabilising effect 
of Dazl on the rate of reporter RNA decay significantly contributes to the increase in 
luciferase seen upon Dazl tethering, however this must be formally ruled out.  Moreover, 
a destabilising effect of Dazl on an mRNA such as EMCV or CSFV could mask a 
simultaneous increase in their translation.  Effects on transcription, splicing or mRNA 
export are not possible due to the design of the experiments where the reporter mRNAs 






RNA samples were extracted from those oocytes set aside using Tri-reagent.  The RNA 
was then reverse transcribed using specific primers to the open reading frames of the 
luciferase and β-galactosidase reporters.  The numbers of molecules of the reporter 
RNAs were then calculated using a quantitative PCR (QPCR) approach.  The results of 
these assays represent the numbers of molecules of both the luciferase and β-gal 
reporters in each sample (figure 3.9A) and the percentage of injected luciferase reporter 
at T=0 and T=16 (figure 3.9B).  As the β-gal reporters are not subject to any stabilisation 
or decay effects inherent to fusion protein binding, they can be used to normalise RNA 
recovery between sets of oocytes.  Therefore the number of molecules of luciferase 
RNA were normalised to the number of molecules of β-gal to take into account any 













































































Figure 3.9: Levels of luciferase reporter in oocytes 
Quantitative reverse transcription PCR was employed to measure the effect of Dazl binding on 
the stability of the reporters used in the variable tethered function assay over time.   
A: The tethering of Dazl to the different luciferase mRNAs does not have an mRNA stabilisation 
effect.  Oocytes expressing either MS2-UIA or MS2 mDazl were injected with one of luc-MS2, 
PV-luc-MS2, EMCV-luc-MS2 or CSFV-luc-MS2 and β-galactosidase.  Total RNA was extracted 
either immediately or 16 hours post injection.  Quantitative reverse transcription PCR was 
performed with primers directed against the reporter mRNAs.  The numbers of molecules of 
luciferase reporter were normalised to the β-galactosidase and plotted.  The data represents the 
averages of three repetitions with standard errors. 
B: The values represented in figure 3.9A were transformed to show % of luciferase reporter 
injected at T=0 and T=16. 
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Quantitative reverse transcription-PCR showed that the levels of reporter mRNA vary at 
T=0 (figure 3.9A).  As the experimental design of the tethered function assay is such that 
each oocyte should be injected with the same amount of RNA, the differences seen in 
numbers of molecules injected between the different sets is disturbing.  As the assay 
involves very low concentrations of RNA being injected (7.5ng/μl) the most likely 
source of this variation is the quantification of the RNA preparations prior to injection.  
Importantly, however, the levels of individual reporter RNAs did not change 
significantly over the course of the experiment (figure 3.9B).   
 
There are however changes in the abundance of mRNA in the presence of MS2-U1A 
compared to MS2-mDazl.  This difference was not reported in the initial characterisation 
of Dazl mediated stimulation, and may be due to the high sensitivity of QRT-PCR 
versus Northern blotting, injection error or capping efficiency.  Stage VI oocytes cannot 
decap mRNAs to promote turnover (Gillian-Daniel et. al., 1998), thus changes in mRNA 
stability are not anticipated in this system but could reflect differences in capping 
efficiencies of the reporter mRNA preparations utilised in these experiments. The 
changes seen in the assay conducted have been quantified in table 3.1.  
 
   
Luc-MS2 MS2-U1A 
MS2-mDazl 
- 29%   (+/- 17%) 
+ 10%  (+/- 5%) 
PV-luc-MS2 MS2-U1A 
MS2-mDazl 
- 37%   (+/- 13%) 
- 6%     (+/- 8%) 
EMCV-luc-MS2 MS2-U1A 
MS2-mDazl 
+ 24%  (+/- 21%) 
- 14%   (+/- 5%) 
CSFV-luc-MS2 MS2-U1A 
MS2-mDazl 
- 42%   (+/- 12%) 
- 26%   (+/- 17%) 
Table 3.1: % change of luciferase reporter from T=0 to T=16 
 
 
Taking these possible effects on mRNA stability/mRNA abundance into account, the 











Luc-MS2 + 39% 8 4.8 
PV-luc-MS2 + 31% 11 7.6 
EMCV-luc-MS2 -  38% 2.5 3.5 
CSFV-luc-MS2 + 16% 1.2 1 
Table 3.2: Overall effect of Dazl on luciferase levels and effect of stabilisation on 
translational stimulation 
 
The data in figure 3.9A and B and tables 3.1 and 3.2 establish that changes in mRNA 
stability cannot account for the differences in luciferase expression in oocytes expressing 
MS2-Dazl compared to the control protein MS2-U1A.  Thus, the adjusted stimulation 
values in luciferase expression in table 3.2 are solely due to translational effects.  This 
adjustment in the absolute levels of translational stimulation does not, however, affect 
the interpretation of the variable tethered function assay results.  MS2-mDazl stimulates 
the translation of capped and PV IRES-containing mRNAs and cannot stimulate the 
translation of CSFV IRES-containing mRNAs.  The stimulation of the EMCV IRES 
reporter remains intermediate, but is not as reduced compared to Luc-MS2 as prior to 




As detailed at the start of this chapter the aim of this work was to enable a better 
understanding of when and how Dazl stimulates translation.  Previously, a model for 
Dazl’s actions in translation was proposed (Collier et. al., 2005) in which Dazl directly 
recruits PABP to mRNAs with short poly(A) tails in a manner analogous to 
polyadenylation.  These PABP molecules, recruited to the 3’UTR of the mRNA, then 
interact with factors bound to the 5’UTR thus circularising the mRNA and enhancing 
translation.  The key factors that PABP is thought to interact with are eIF4G, eIF4B and, 
via an interaction with Paip1, eIF4A.  PABP is also known to interact with eukaryotic 
release factor three, which may promote ribosomal recycling from the 3’ end of mRNAs.  
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It was also established using sucrose gradient analysis that Dazl stimulated translation at 
the stage of initiation. 
  
One aim of this study was to investigate further the stage in initiation at which Dazl 
stimulated.  To do this a variation on the tethered function assay was employed.  Here 
luciferase reporters with different cap structures and in some cases containing IRESs 
were used.  Whilst it is possible that the that the effects of Dazl on these IRES reporter 
mRNAs are due to residual cap-dependent translation, as bicistronic reporters were not 
utilised, the differences in the level of translation for the ApppG capped reporter (figure 
3.4C, 3.5B, 3.6B and 3.7B) make this unlikely.  Moreover, each of these IRESs are 
heavily secondary structured, a feature that is likely to impede scanning and thus cap-
dependent translation.  In addition each of the IRES containing reporters is stimulated to 
a different degree by Dazl, which is inconsistent with initiation through the same cap-
dependent mechanism.   
 
Thus, by looking at which reporters Dazl could and could not stimulate I gained insight 
into the mechanism of translational stimulation.  If Dazl had been unable to stimulate the 
ApG or PV reporter then it would have implicated cap-binding as the step that Dazl 
stimulated as the key difference in the mechanism of translation initiation in these 
reporters is the lack of cap-binding.  As Dazl stimulates the PV reporter then this 
suggests 40S joining, scanning, or 60S joining as the possible stages in initiation that 
Dazl acts on.  As Dazl could not stimulate the translation of the CSFV reporter (figure 
3.7), 60S joining appears unlikely as the CSFV IRES is thought to recruit the 60S 
subunit in the same manner to the other reporters.  If Dazl did act by increasing 60S 
subunit joining then it would have been expected that it would have stimulated all the 
reporters utilised.  This suggests a role in either 40S joining or scanning.  As Dazl 
cannot fully stimulate the EMCV reporter it could be argued that perhaps Dazl affects, at 
least in part, scanning as it does not play a role in the translation of this reporter.  
Conversely, in light of the comparatively small differences in stimulation between luc-
MS2 and EMCV-luc-MS2 (the adjusted values in table 3.2) it can be argued that Dazl 
can stimulate a reporter that does not utilise scanning as a predominant mechanism.  
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This is consistent with Dazl mediating the majority of its effects at the level of 43S 
joining.  The caveat that must be considered with this conclusion is that table 3.2 
combines data from all the variable tethered function assays with data from the stability 
experiments.  As these stability experiments only represent a minor fraction of the data, 
it can be argued that the stability analysis should have been conducted with every 
tethered function assay for this conclusion to be firmly drawn.  However, the stimulation 
in the stability experiments was representative of the experiments as a whole and I 
therefore consider the conclusions to be valid. 
 
The question of why the EMCV IRES can only be stimulated to a more limited degree 
remains a complicated one.  Perhaps the ‘land and dock’ mechanism of this IRES limits 
the rate at which 43S complexes can be loaded onto the RNA in a manner that the ‘land 
and scan’ mechanism of the PV IRES does not.  With a ‘land and scan’ mechanism the 
recruited 43S complex would depart the IRES, scanning to the initiator codon where 
events would proceed as in ‘normal’ translation.  In the ‘land and dock’ mechanism 
there will be additional steps occurring at the landing site, such as AUG recognition, eIF 
release and 60S joining before the 80S ribosome clears this site.  It is envisaged that 
these extra events would limit the rate at which the next 43S complex could be recruited 
onto the mRNA and thus limit the stimulatory effect of Dazl or a poly(A) tail on this 
process.  Alternatively, the ‘intermediate’ stimulation with the EMCV reporter may 
indicate subtle differences in the factor requirements for PV and EMCV driven 
translation (see below).  Ultimately, sucrose gradient analysis of initiation intermediates 
and toe-printing will be required to fully reconcile whether 43S joining, scanning or both 
are affected by Dazl (see chapter 6).    
 
The analysis in figures 3.4-3.7 also gives some indication of the initiation factors 
required for Dazl-mediated stimulation.  Both the EMCV IRES and the CSFV IRES 
operate via the ‘land and dock’ mechanism but Dazl can only stimulate the EMCV 
IRES, so what are the key differences between the IRESs that could cause this effect?  
The EMCV IRES has been shown to require eIF2, eIF3, eIF4A and at least a portion of 
eIF4G protein whereas the CSFV IRES requires only eIF2 and eIF3.  The role of eIF4B 
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with regards to these IRESs is unknown, but it was not required in the reconstitution 
experiments that established the factor requirements for these IRESs (Pestova et. al., 
1998) but its role in IRES-mediated translation in oocytes is unclear (see below).  It is 
attractive to conclude that the reason why Dazl cannot stimulate the CSFV IRES is 
because it is mediated via one of the factors that the CSFV IRES does not utilise.  
Interestingly as stated earlier, PABP is thought to stimulate translation through 
interactions with eIF4G, eIF4B and, via an interaction with Paip1, eIF4A.  The fact that 
these factors are the differentially required by EMCV and CSFV support the 
involvement of PABP in the model of Dazl action, which will be addressed in more 
detail in the next chapter. 
 
Importantly the pattern of stimulation seen by Dazl differs to that of a translational 
stimulator previously investigated using the variable tethered function assay, the stem-
loop binding protein (SLBP).  SLBP could only stimulate the translation of the M7G 
reporter and failed to significantly stimulate the ApG or PV reporter (Gorgoni et. al., 
2005), this lead to the conclusion that SLBP stimulates an early cap-dependent stage of 
translation initiation; this has been subsequently verified (Cakmakci et. al., 2008).  This 
confirms that the variable tethered function assay is a useful technique and that the 
results obtained for Dazl are specific and not recapitulated by other regulators.  
 
Overall the work presented in this chapter enables the model previously proposed 
(Collier et. al., 2005) to be developed in a number of ways.  First, it expands on the 
observation that Dazl acts at the stage of initiation to delineate the steps affected.  My 
results suggest that Dazl stimulates initiation at the 43S joining or scanning stages (as 
discussed above).  Second, the variable tethered function assay provides valuable insight 
into the initiation factor requirements of this mechanism and again expands the previous 
knowledge about this process.  Interestingly this varies from other studied activators 
(Cakmakci et. al., 2008; Gorgoni et. al., 2005; Michlewski et. al., 2008), suggesting a 
new model for translational regulation.   
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Despite giving much useful information the limitations of the tethered function assay 
used in this chapter must be considered.  Although to date all proteins shown to regulate 
translation using this method have been later confirmed using other techniques 
(Cakmakci et. al., 2008) (Michlewski et. al., 2008).  This widely adopted technique has 
recently been reviewed in detail (Keryer-Bibens et. al., 2007).  Because the assay uses a 
fusion protein there is always the possibility that the structure and therefore the function 
of the protein of interest is compromised in some manner (though this is common to 
many molecular biology assays), thus a negative outcome is hard to interpret.  Another 
potential drawback is that sometimes the immobilisation of the tethered protein to the 
3’UTR of the reporter could potentially inhibit the action of a protein that has to be able 
to move along RNA to function, such as a helicases.  Third, expression of fusion 
proteins at high levels may result in disruption of the stoichometry of binding to protein 
partners, thus altering their function.  
 
When considering the variable reporter tethered function assay the fact that the 
mechanisms of translation and the factor requirements of the various different reporters 
discussed above were all inferred from previously published work must be taken into 
account.  The level of knowledge regarding the translational initiation three IRESs used 
here differs between IRESs.  The initiation factor requirements for CSFV and EMCV 
were characterised by biochemical reconstitution assays in vitro, so a clear knowledge of 
factor requirement is known.  However this type of experiment has not been conducted 
for PV, as discussed earlier.  One problem with the in vitro reconstitution assays used to 
establish the factor requirements is that they do not answer the question of what is 
happening in the oocytes.  For example it has been shown that eIF1, eIF1A and eIF4B 
are not required for EMCV and CSFV IRES activity.  However, the effect of these 
proteins when on translation complexes when present (as they would be in the oocytes) 
is unclear.  Moreover, the effect of intact eIF4G must be considered as no viral proteases 
are present in the oocytes.    
 
Factors may also play a different role in initiation for different 5’UTRs.  For example in 
the CSFV IRES eIF3 is known to contact directly with the IRES (Sizova et. al., 1998) 
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and provide a direct link between the RNA and the small ribosomal subunit.  In capped 
PV and EMCV driven mRNAs eIF3 is recruited to the mRNA via its interaction with 
eIF4G.  Due to the different roles of initiation factors in the different IRESs it is 
uncertain how this may affect the ability of Dazl to stimulate in oocytes, for instance 
eIF3 subunits bound to the CSFV IRES may be unavailable for interaction with proteins 
such as Dazl or PABP (not suggesting DAZL directly touches eIF3) with which they 
could normally interact.  Questions are also unanswered with the respect to the way that 
eIF4G interacts with IRES structures.  In the PV and EMCV IRES there is a requirement 
for eIF4G but it is known that it is not making contact with the mRNA via eIF4E and the 
cap-structure.  This leads to the question of exactly how is eIF4G interacting with the 
IRES and how does this effect the binding of other factors such as PABP.  It is known 
that the PV and EMCV IRESs are stimulated by the presence of a poly(A) tail 
(Bergamini et. al., 2000) but that the CSFV IRES is not (W. Richardson, unpublished). 
 
Another factor that must be taken into consideration in the analysis of these experiments 
is the role of different IRES trans-activating factors (ITAFs) on the different IRESs.  
ITAFs are other non-initiation factor proteins that have been identified as important for 
IRES function.  Both the PV and EMCV IRES require the La autoantigen and the 
polypyrimidine tract binding protein (PTB) and PV also requires the RNA-binding 
protein UNR and the poly(rC)-binding proteins PCBP1 and PCBP2.  It is possible that 
the stimulatory potential of each IRES could be limited by the ITAF complement in the 
oocyte and that is the reason why reduced stimulation is seen in some cases.   
 
This discrepancy between factors necessary for IRES translation and those actually 
present leads to the conclusion that their true mechanism of translation in oocytes could 
potentially be different from that assumed.  To be entirely certain of the conclusions that 
have been drawn from these experiments these mechanisms must be confirmed by a 
second method.  The best way to establish the mechanism in oocytes would to move to 
an oocyte extract system where factors could be manipulated by depletion and 
reconstitution or specific inhibitory proteins or drugs.  The biggest obstacle to this 
approach is that it requires the production of highly pure full-length recombinant Dazl 
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protein, to allow the regulation to be reconstituted in vitro.  This has proven technically 
difficult, despite many different techniques being employed.    
 
Another test that could be employed to check that ITAF concentration was not limiting 
would be to reduce the levels of reporter RNA and see if the translational stimulation 
increases.  The effect of reducing the concentration of reporter RNA concentration has 
been tested for the PV IRES reporter but not for EMCV and CSFV.  The concentration 
of the reporter was reduced by four and this did not affect the stimulation seen.  
However this experiment was not sufficiently repeated so has not been shown in this 
thesis.  This experiment would be especially important for the CSFV and EMCV 
reporters as in figure 3.9 it is shown that there was the highest amount of reporter 
present for these RNAs, thus increasing the chance of an ITAF being the limiting factor.  
Though it should be noted that the experiments that make up the data for the IRES 
stimulation experiments (figures 3.5, 3.6 and 3.6) were conducted separately to figure 
3.9 so it is not known whether the higher levels of CSFV and EMCV RNA was 
consistent throughout the experimental series.  
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The previous chapter investigated the stage in translation at which Dazl stimulates 
translation, but also mentioned Dazl’s relationship with PABP.  In this chapter the nature 
and significance of that relationship will be explored further. 
 
Dazl’s interaction with PABP was first suggested in a previous study in this laboratory 
(Collier et. al., 2005).  It was demonstrated that a C-terminal PABP1 portion binds Dazl 
and that this interaction was RNA independent.  This was confirmed by the co-
immunoprecipitation of endogenous Xdazl with Xenopus laevis PABP1 and ePABP 
from testis and stage VI oocytes.  Subsequently Xdazl and ePABP were found to be 
located in the same complexes in another laboratory (Padmanabhan and Richter, 2006).  
Other Dazl family members that stimulate translation, mouse Dazl, human DAZL, 
human DAZ and human BOULE were also able to interact with Xenopus PABP1, 
suggesting that this interaction may have an important role in this function.  
 
Previous yeast 2-hybrid analysis has shown that amino acids 99-166 of mDazl are 
responsible for its interaction with PABP1 (Collier et. al., 2005).  This region was also 
shown to be necessary for translational stimulation (Collier et. al., 2005) indicating that 
it and perhaps the interaction with PABP is required for Dazl’s translational activity.  
Whilst is has been shown that reducing the 3’ boundary of this region by 15 amino acids 
disrupts its interactions with PABP, the 5’ boundary and thus minimal region for PABP-
binding has yet to be established.   
 
In this chapter the role of residues within the 99-166 region will be explored further 
using a combination of bioinformatics and yeast two hybrid analyses.  Defining a short 
region or an amino acid motif that binds PABP and could be used to design a 
bioinformatic search for other proteins that may recruit PABP to activate the translation 
of mRNAs to which they are bound.  A targeted mutagenesis of key residues identified 
by bioinformatics in Dazl will also be conducted and tested by yeast-2-hybrid assay to 
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assess whether the interaction with PABP is disrupted.  The generation of  a specific 
mutant of Dazl that could not bind to PABP will not only be invaluable in functional 
assays to further investigate the role of PABP in Dazl mediated translational stimulation 
but in the longer term to generate transgenic mice to assess the physiological relevance 
of the observed reaction between Dazl and PABP.   
 
Mouse Dazl was chosen as the target of this analysis, as it had previously been used in 
the mapping of the 99-166 region and to facilitate the generation of transgenic mice to 
examine the physiological role of DAZL/PABP interactions in male and female fertility. 
 
4.2 To what extent is PABP required for Dazl-mediated 
stimulation? 
  
Previous work (Collier et. al., 2005; Padmanabhan and Richter, 2006) has described a 
correlation between Dazl function and its interaction with PABP and it was proposed 
that Dazl’s translational activity was dependent on this interaction with PABP. Indirect 
evidence to support this model came from the observation that the presence of a poly(A) 
tail on a reporter mRNA, and thus PABP recruited by an alternate means, decreased the 
relative stimulation by Dazl (Collier et. al., 2005).  
 
In the previous chapter the mechanism of Dazl-mediated stimulation was investigated 
using the variable tethered function assay.  However, given the multiple effects of PABP 
on initiation and the lack of characterisation of its ability to stimulate the different IRESs 
utilised in this study, this work did not shed light on the role of PABP.  If PABP is 
sufficient to explain the role of Dazl’s translational stimulation then it would be 
expected that PABP would show the same pattern of stimulation as Dazl in the variable 
reporter tethered function assay.  To test this hypothesis tethered function assays were 
performed with mRNAs encoding MS2-U1A and MS2-PABP and the reporter mRNAs 
Luc-MS2, PV-Luc-MS2, EMCV-Luc-MS2 or CSFV-Luc-MS2 described in chapter 3.  
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Some experiments were conducted by Dr. Barbara Gorgoni, who was examining the role 





























Figure 4.1: PABP pattern of stimulation in the variable reporter tethered function assay.  
A: MS2-PABP can stimulate m7GpppG capped Luc-MS2 (Luc-MS2) or ApppG capped PV-Luc-
MS2 (PV-Luc-MS2), but cannot stimulate ApppG capped CSFV-Luc-MS2 (CSFV-Luc-MS2).  
Reporters were co-injected with β-Gal mRNA into stage VI oocytes expressing MS2-U1A or 
MS2-PABP.  Luciferase activity was normalised to β-galactosidase activity and the relative 
luciferase units were plotted with MS2-U1A values set to one.  These experiments were 
conducted by Dr. B. Gorgoni and used with permission. 
B: MS2-PABP can stimulate m7GpppG capped Luc-MS2 (Luc-MS2) or ApppG capped EMCV-
Luc-MS2 (EMCV-Luc-MS2).  Reporters were co-injected with β-Gal mRNA into stage VI oocytes 
expressing MS2-U1A or MS2-PABP.  Luciferase activity was normalised to β-galactosidase 
activity and the relative luciferase units were plotted with MS2-U1A values set to one.  The 
average of five experiments is shown. 
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Similar to Dazl (see chapter 3), PABP1 stimulates the Luc-MS2 reporter and the PV-
Luc-MS2 reporter, approximately 7-fold.  This level of stimulation of Luc-MS2 is 
consistent with published data that shows an average stimulation of 7-fold by PABP1 
(Gray et. al., 2000).  Interestingly, PABP1 only stimulates the EMCV-Luc-MS2 reporter 
approximately 3 fold and failed to stimulate the CSFV-Luc-MS2 reporter.  This is 
consistent with the partial stimulation of EMCV and failure to stimulate CSFV observed 
for Dazl (figures 3.6 and 3.7).   
 
This result supports the hypothesis that Dazl translational stimulation is dependant on 
PABP, as PABP stimulates the same reporters as Dazl, showing that they share common 
mechanistic features.  If PABP stimulated a different set of reporters to Dazl, this would 
have indicated that it used a different mechanism of translational stimulation to Dazl 
thus suggesting that it was unlikely to be Dazl’s effector molecule.  This is true for other 
regulators such as SLBP which utilise a different mechanism (Cakmakci et. al., 2008; 
Gorgoni et. al., 2005). However the result shown here is supportive of a role for PABP 
in Dazl’s mechanism of translational stimulation.  This observation will be addressed 
further in the chapter discussion.  
 
4.3 The yeast two hybrid assay as an experimental system  
 
The interaction between Dazl and PABP has been investigated previously using yeast-
two hybrid assays amongst other techniques.  Later in this chapter this investigation will 
be expanded on, further utilising this technique. 
 
The yeast-two hybrid assay (see figure 4.2A) utilises the fact that the DNA-binding 
domains and activating domains of transcription factors can be separated.  These 
domains are expressed as fusion proteins, with the proteins of interest and the interaction 
of the test proteins bringing the domains into proximity activating the transcription of 
reporter genes.  These reporter genes are inactive in the absence of an activating protein 
domain.    
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Figure 4.2: The yeast-two hybrid assay 
A: General scheme of the yeast-two hybrid assay.  A fusion of a DNA binding domain and the 
first protein of interest binds to a specific promoter upstream of reporter genes.  If a second 
protein fused to a transcription activating domain interacts with the first this brings the activating 
domain into proximity of the promoter and reporter gene expression is activated. 
B: The L40 yeast strain contains LexA DNA binding sites upstream of the LacZ and His3 
reporters.  The strain is deficient for Trp, Leu and His thus allowing for selection of transformed 
yeast and screening of Y2H interactions respectively.  
C: The Mav99 yeast strain contains GAL4 DNA binding sites within the promoters of LacZ, His3 
and Ura3 reporters.  The strain is deficient for Trp, Leu and His thus allowing for selection of 
transformed yeast and screening of Y2H interactions respectively.  
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Two different yeast two-hybrid systems are utilised in this chapter.  The first of these 
utilises fusions of the ‘bait’ protein with the LexA DNA binding domain.  This fusion is 
capable of binding the LexA-binding sites that have been engineered into the promoter 
of several reporter genes present within the L40 (figure 4.2B) yeast strain.  These 
reporters encode β-galactosidase and His3.  The expression of β-galactosidase is 
detected by the presence of blue as opposed to white colonies and activation of the His3 
gene allows growth on histidine deficient media.  The stringency of the histidine 
selection can be increased by the addition of 3-amino-triazole (3-AT), which is toxic to 
yeast without an activated His3 gene; therefore protein interactions confer a 3-AT 
resistant phenotype.  
 
The second system utilises fusions with the GAL4 DNA-binding domain.  The Mav 
strains contain selectable markers that enable both positive and negative selection with a 
variable number of GAL4 binding sites within the promoter region.  In these studies 
Mav99 (figure 4.2C) was used which contains 10 GAL4 binding sites (Vidal et. al., 
1996). Like L40 this strain contains the His3 and β-galactosidase reporters, but also has 
the URA3 gene.  URA3 is a selectable marker that confers lethality when the yeast is 
grown on plates containing 5-fluororotic acid (FOA); therefore an interaction between 
the proteins of interest confers a FOA-sensitive phenotype. 
 
 
The different mechanisms for selecting positive and negative protein-protein interactions 











 -ve +ve 
Lac Z White Blue 
His  No growth on –His media 
No growth on 3-AT 
Growth on –His media 
Growth on 3-AT 
 
Mav99 
 -ve +ve 
Lac Z White Blue 
His No growth on –His media 
No growth on 3-AT  
Growth on –His media 
Growth on 3-AT 
Ura 3 Growth on FOA Death on FOA 
Table 4.1: Summary of the different selection methods available to the L40 and Mav99 
yeast strains 
The L40 and Mav99 yeast strains have different methods to determine if two proteins tested 
interact.  The negative (-ve) and positive (+ve) outcomes are shown for the different assays 
available.  LacZ = β-galactosidase assay.  His = Selection on His deficient media.  Ura 3 = 
Selection on media containing 5-fluororotic acid.  
 
It is worth noting that the activating domain plasmids can be used in both systems, the 
main differences being in the DNA-binding domain plasmids and in the complement of 
reporter genes.  
 
The preferred system was L40 yeast with the LexA system as one of the major 
advantages of that system was that the LacZ reporter gene is present on a high copy-
number plasmid, and therefore weak signals are more efficiently amplified than in the 
GAL4 system.  However sometimes the Mav99/Gal4 system was used in order to be 
comparable to previous work.  In this chapter the activation of the β-Galactosidase 
reporter that is present in both strains was monitored. 
 
4.4 DAZL/PABP family interactions 
 
The data presented in figure 4.1 provides additional evidence for the model in that 
DAZL utilises PABP1 and/or ePABP, at least in part, to stimulate translation in Xenopus 
oocytes.  However there are multiple members of the PABP family (see introduction) in 
vertebrates, and an additional PABP family member, PABP4, has been recently been 
found in Xenopus oocytes (Gorgoni, manuscript in preparation).  Mammals have a more 
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complex family of proteins with five structurally similar cytoplasmic PABPs; PABP1, 
ePABP, tPABP, PABP4 and PABP5.  Several of these PABPs have been shown to be 
expressed in male or female gonads at least at the RNA level (Feral et. al., 2001).  This 
raises the possibility that several different PABP proteins may be utilised by Dazl family 
members within the mammalian gonad or that specific interactions occur between 
individual PABP and Dazl family members.  As the full complement of Dazl proteins 
are only found in man and old world monkeys (see introduction), the ability of different 
family members to interact was pursued using human proteins due to their demonstrated 
ability to stimulate translation and interact with at least one PABP family member and 
the availability of expression analysis within the gonads. 
 
In order to see the extent of potential Dazl-PABP interactions a directed yeast two-
hybrid approach was undertaken.  To this end human PABP1 and tPABP were PCR 
amplified and cloned into a DNA-binding domain vector BTM.  PCR amplification of 
PABP4 resulted in a frameshift event and was therefore not examined.  Lack of 
annotation of the human ePABP gene prevented the design of primers to amplify the C-
terminal region of this predicted protein.  BTM-PABP5 was a gift from Ross Anderson 
(MRC HGU).  These PABP-fusions were co-transformed into L40 alongside activating 
domain fusions with different Dazl family members or another RNA-binding protein, 
IRP, which acted as a negative control.  MS2 serves as a negative control for interactions 










Figure 4.3: Family interactions between Dazl and PABP. 
Directed yeast two hybrids were undertaken to determine the interactions between human Dazl 
family members and human PABP family members.  Yeast were transformed with the proteins 
shown and positive or negative interactions were determined using qualitative β-Gal filter 
assays.  Yeast strain L40 was co-transformed with plasmids encoding the proteins indicated.  
PABP1, tPABP, PABP5 and MS2 were present in the BTM DNA binding vector.  hDAZL, hDAZ, 
hBOULE and IRP were in present in the pGAD activating domain vector. 
 
Interestingly, interactions were not observed between all family members.  For instance 
whilst each of the DAZL family members interacted with tPABP (forming blue 
colonies), none interacted with PABP5 (white colonies).  Interactions with PABP1 
varied dependent on Dazl family member with DAZL and BOULE interacting whilst 
DAZ did not.  The ability of DAZ to interact with tPABP shows that it is active in this 
assay, although differences in expression level may contribute to its apparent inability to 
interact with DAZ, as the relative levels of expression have not been determined.  
Interpretation of results based purely on yeast-two hybrid must be cautious and 
confirmation by a second in vitro method such as GST-pull-down would be required, 
and ultimately a demonstration of endogenous interactions in cells.  Nevertheless a 
failure to interact with PABP5 is consistent with the absence of a C-terminal domain in 
this protein, which was the region of Xenopus PABP1 that was demonstrated to interact 
with DAZL (Collier et. al., 2005).   
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The finding that only two family members interact with PABP1 is intriguing, and given 
the similarity between PABP1 and tPABP suggests a high degree of specificity.  This 
raises the possibility that certain PABPs mediate specific roles within germ cells as 
dictated by which Dazl family proteins they can interact with (see chapter discussion).  
 
4.5 The PABP binding 99-166 region is conserved across Dazl 
family members 
 
A major goal of this chapter is to characterise the residues within mouse Dazl required 
for binding PABP, and to examine the functional relevance of this interaction.  To this 
end, a comparison between the region of mouse Dazl known to bind PABP and other 
Dazl proteins was performed.  This comparison was restricted to Dazl family members 
that have been shown to stimulate translation and to bind PABP (Collier et. al., 2005).   
 
The protein sequence of the 99-166 region of mouse Dazl and the corresponding regions 
of human DAZL, human DAZ, human BOULE and Xenopus dazl were retrieved from 
the Genbank gene database at the National Centre for Biotechnology Information 
(NCBI) website and were aligned using the ClustalW software (Higgins et. al., 1996).   
 
This comparison (figure 4.4) shows that there is a large block of homology at the N-
terminal end of the amino acid 99-166 region.  This corresponds to part of the RRM 
domain, a conserved domain present in many RNA-binding proteins.  Interestingly, a 
number of RRM domains have been shown to mediate protein-protein interactions in 
addition to RNA binding (Maris et. al., 2005).  Thus it is possible that amino acid 
residues in this area could contribute to PABP binding.  The structure of RRM domains 
bound to RNA has been solved for a number of proteins (Maris et. al., 2005), and this 
has shown that one face binds RNA whilst the other face is involved in protein-protein 
interactions.  To exclude conserved residues most likely to mediate RNA-binding rather 
than protein-protein interactions the RRM region of the Dazl proteins were aligned to 
UIA, another RNA binding protein for which the structure bound to RNA is solved 
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(Oubridge et. al., 1994). This analysis excluded residues 101, 107, 108, 110, 111, 112, 
113, 114 and 115 (shown in pink in figure 4.4).  This analysis was performed in silico by 
Dr P. Gautier, a bioinformatician.  
 
A 
         99        109       119       129       139       149       159    166 
         -         -         -         -         -         -         -      -        
mm_dazl  SQINFHGKKLKLGPAIRKQNLCTYHVQPRPLIFNPPPPPQFQSVWSSPNAETYMQPPTMMNPITQYVQ  
hs_DAZL  SQINFHGKKLKLGPAIRKQNLCAYHVQPRPLVFNHPPPPQFQNVWTNPNTETYMQPTTTMNPITQYVQ  
hs_DAZ   SQIHFHGKKLKLGPAIRKQKLCARHVQPRPLVVNPPPPPQFQNVWRNPNTETYLQPQITPNPVTQHVQ  
xl_dazl  SQISFHGKKLKLGPAIRK--ICTY-VQPRPVVLSHPTP--FHHAWNNQNADSYIQHSPIVSPITQYVQ  
hs_BOL   EKLNYKDKKLNIGPAIRKQQVGIPRSSIMPAAGTMYLTTSTGYPYTYHNGVAYFHTPEVTSVPPPWPS  
 
Figure 4.4: Conservation of the 99-166 region of mDazl 
ClustalW alignment of the amino acid sequences of the 99-166 region of mouse Dazl and 
equivalent regions of human DAZL, human DAZ, Xenopus dazl and human BOULE.  A number 
of conserved residues can be identified in the region as indicated by different coloured shading.  
Blue shading = identical residue, Dark grey shading = conserved substitutions, Light grey 
shading = semi-conserved substitutions, Pink shading = conserved residues recognised as part 
of the RRM 
mm_dazl = Mouse Dazl.  hs_DAZL = Human Dazl.  hs_DAZ = Human DAZ.  Xl_dazl = Xenopus 
laevis dazl.  hs_BOL = human BOULE 
 
Apart from the RRM, relatively few fully conserved residues are present in this region 
that might potentially be key PABP-binding amino acids and these remaining residues 
are marked in blue in figure 4.4.   
 
However, it has not been established whether other Dazl family members utilise this 
’99-166’ region for binding PABP and this must be established before the analysis of 
key residues can proceed further.  
 
Human BOULE is the most divergent of these proteins and inclusion of it in the 
alignments excludes many amino acids, which are conserved or similar (e.g. amino acids 
120, 124, 125, 127, 134, 136 between the other proteins).  Thus it was decided to 
determine whether the analogous region of human BOULE (106-173), is responsible for 
its interaction with PABP.  Given the suitability of the yeast-two hybrid assay for 
identifying the short PABP-binding region in mouse Dazl, the same approach was 
utilised for the 106-173 region of human BOULE. 
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4.6 The 106-173 region of BOULE interacts with PABP 
 
To test if the region of human BOULE corresponding to 99-166 of mouse Dazl is 
responsible for interactions with PABP, plasmids containing fusions of the GAL4 
activation domain with amino acids 106-173 of human BOULE were cloned.   
 
Yeast-two-hybrid analysis with this plasmid was undertaken to test its ability to interact 
with the LexA fusion of human PABP1Ct (see figure 4.5).  Activating domain fusions of 
human PAIP and IRP were included as positive and negative controls respectively for 
interactions with the PABP1 C-terminus.  A fusion of the LexA DNA-binding domain 
and the bacteriophage MS2 protein was used as a negative control for interaction with 
the BOULE protein fragment.   
 
PABP vs BOULE 106-173
PABP vs IRP
PABP vs PAIP
MS2 vs BOULE 106-173
 
 
Figure 4.5: Directed yeast two hybrid of the interaction of the human Boule 106-173 
region with human PABPC1  
PABP1 can interact with the 106-173 fragment of BOULE as demonstrated by directed yeast-2 
hybrid assay.  Yeast strain L40 was co-transformed with the proteins shown and positive or 
negative interactions were determined using qualitative β-Gal filter assays.  Negative control 
interactions between PABP1 and IRP and MS2 and BOULE 106-173 were included to ensure 
that the fusion proteins were not self activating.  A positive control interaction between PABP1 
and PAIP was included to ensure that the PABP1 fusion protein was able to interact with a 
known partner.  
 
This analysis revealed a clear interaction between the 106-173 region of human BOULE 
with PABP1.  Importantly, this shows that the PABP binding region originally identified 
in mouse Dazl is conserved between different Dazl family members and across species.  
In light of this result it was decided to not test the corresponding region of human DAZL 
or DAZ or Xenopus Dazl (see chapter discussion). 
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4.7 Fine mapping of the 99-66 region  
 
The region of interest as it stands is 68 amino acids long, which is still a relatively large 
region in terms of protein-binding sites and the conserved amino acids are dispersed 
throughout this region.  In order to further define the minimal region that is capable of 
binding PABP1 a yeast-two-hybrid approach was employed, using progressively smaller 
fragments of mouse Dazl.  As shortening the 3’ end of the 99-166 region by 15 residues 
abrogates its ability to interact with PABP (Collier et. al., 2005), it was decided to focus 
on N-terminal deletions. 
 
In order to be consistent with the preceding work (Collier et. al., 2005) where the 99-166 
fragment was cloned into the GAL4 DNA-binding domain vector (pGBKT7) the 
relevant fragments of the mouse Dazl protein were cloned into pGBKT7 and tested 
against the C-terminal region of Xenopus PABP1.  Initially two shorter fragments of 
Dazl were cloned, the first containing 37 amino acids consisting of the 129-166 region 
and the second containing the 27 amino acids representing the 139-166 region.  













Figure 4.6: Directed yeast two hybrid of the interaction of Dazl fragments with Xenopus 
PABP1 Ct.  
Directed yeast two hybrids were undertaken to determine the interactions between mDazl 
fragments and PABP.  The mDazl 99-166, 129-166 and 139-166 fragments can all interact with 
PABP.  Negative control interactions with a known non-interactor IRP were included to show if 
the mDazl fragments self activated.  Yeast strain Mav99 was co-transformed with the proteins 
shown and positive or negative interactions were determined using qualitative β-Gal filter 
assays.  Negative control interactions between PABP1 and IRP with MS2 were included to 
ensure that the fusion proteins were not self activating.   
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Directed yeast-two-hybrid analysis in Mav99 confirmed that the 99-166 region of mouse 
Dazl is sufficient to support an interaction with PABP1 (compare 99-166 versus PABP 
to the negative control IRP).  When the region of Dazl was reduced to amino acids 129-
166 the yeast were still blue indicating the interaction was maintained although they 
appear lighter in colour than amino acids 99-166.  As the relative levels of the fusion 
proteins were not determined by Western blotting, it cannot be concluded whether this 
apparent reduction on β-Galactosidase levels is due to a reduction in binding affinity.  
 
When the region was reduced further to amino acids 139-166, the yeast were dark blue 
upon assay, indicating a substantial interaction.  However, the corresponding IRP 
control for the 139-166 fragment is light blue suggesting a degree of self-activation.  
However, as the signal seen with PABP1 is considerably stronger than the IRP signal, 
this result was considered to be significant.  This suggests that the minimal region for 
PABP-binding can be further narrowed to amino acids 139-166. 
 
4.8 Identification and mutagenesis of key residues in Dazl  
 
With the knowledge that the critical region for interacting with Dazl has been narrowed 
down to amino acids 139-166 the alignments of the 99-166 region were re-examined, 
with the aid of Dr P. Gautier.  
 
The structure of this region, which does not share significant homology with proteins 
outside the DAZL family, has not been solved by crystallography or protein nuclear 
magnetic resonance spectroscopy (protein NMR).  The absence of structural information 
for this family thus precludes the identification of residues that are likely to be in the 
protein surface and available for protein-protein interactions.  Structural predictions 
were made by Dr Gautier using protein explorer (www. protein explorer.org, Copyright 
© 2003 by Eric Martz), but revealed very limited information suggesting that the non-
RRM region is a “long non globular region”, of low complexity.  However, a few areas 
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of beta strand were predicted in human Dazl and BOULE (shown as red boxes on figure 
4.7).  Only these proteins were put into the prediction software as a representative test to 
see if it could generate any useful information.    
 
Due to the absence of a clear structural prediction for the region, candidate residues for 
site directed mutagenesis were selected on a number of criteria: First they had to be 
located within the 139-166 region.  Second the residues had to show a high degree of 
conservation or similarity across the proteins examined experimentally (Collier et. al., 
2005) indicating potential functional importance and thirdly residues were also 
prioritised based on their ability to direct protein/protein interactions.  The analysis of 
the PABP binding critical region was also expanded to include other Dazl family 
members that had not been experimentally shown to stimulate translation.  This analysis 
revealed that the residues identified as conserved in figure 4.4 are also conserved in a 
number of other species, thus suggesting a potentially important role. 
 
         139       149       159   166 
         -         -         -      -        
 
xl_dazl  FHHAWNNQNADSYIQHSPIVSPITQYVQ  
xt_dazl  FHPTWNSQNADSYIQHSPIISPVTQYVQ  
mm_dazl  FQSVWSSPNAETYMQPPTMMNPITQYVQ  
rn_dazl  FQSVWSSPNAETYMQPPTMMNPITQYVQ  
bt_dazl  FQSVWSNPNAETYMQPPTMINPITQYVQ  
cc_dazl  FQSVWSNPNTETYMQPPTMMNPITQY--  
hs_DAZL  FQNVWTNPNTETYMQPTTTMNPITQYVQ  
hs_DAZ   FQNVWRNPNTETYLQPQITPNPVTQHVQ  
gg_dazl  FHSVWSNQNTETYVQPQAVVSPLTQYVQ  
am_dazl  FHSMWSSQNAETYMQHPHMISPVPQYVP  
hs_BOL   TGYPYTYHNGVAYFHTPEVTSVPPPWPS  
mm_BOL   TGYPYTYHNGVAYF
             1   2   3 
HTPEVTSVPPSWPS  
 
Figure 4.7: Selection of candidate residues 
Expansion of the alignment of the 139-166 region to include other Dazl family members.  Three 
residues are identified as possible candidates for mutagenesis as indicated in Yellow. 
Xl_dazl = Xenopus laevis dazl.  Xt_dazl = Xenopus tropicalus dazl.  mm_dazl = Mouse Dazl.  
rn_dazl = Rat Dazl.  cc_dazl = Dog Dazl.  hs_DAZL = Human DAZL.  hs_DAZ = Human DAZ.  
gg_dazl = Chicken Dazl.  am_dazl = Amphioxus Dazl.  hs_BOL = Human BOULE.  mm_BOL = 
Mouse Boule.  Yellow = Suggested as mutational candidates within the 139-166 region.  Dark 
grey= conserved substitutions.  Light grey= semi-conserved substitutions.  Red residues denote 
area of complexity identified (see main text).  NB.  In this alignment areas of conserved and 
semi-conserved substitutions are shown regardless of if they are fully conserved throughout all 
protein aligned.  
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The new alignment as shown in figure 4.7 was used to identify three residues that were 
considered as the best candidates to take forward into the planned mutagenesis scheme.  
These residues were considered to be the most likely to be crucial for Dazl-PABP 
protein-portion interactions based on their conservation and amino acid type.  The three 














1 W143  TGG Tryptophan GTG Valine 
2 N147 AAT Asparagine GCT Alanine 
3 Y151 TAC Tyrosine GCT Valine 
Table 4.2: Mutagenesis scheme in mouse Dazl 
 
The residues were mutated to alanines and valines on the basis that these uncharged 
residues do not typically support protein-protein interactions.  The choice of alanine or 
valine was dictated by the minimal number of base changes in the codon.  Where all the 
bases had to be changed, for example Y151, valine was chosen as the default.   
 
 
The mutations were inserted cumulatively, from the C-terminal end of the protein, in 
case one mutation alone was not capable of abrogating the Dazl/PABP interaction.  The 
first construct (M3) contained mutation #3 alone, the second (M2,3) mutations #2 and #3 
and the third (M1,2,3) mutations #1, #2 and #3, as detailed in figure 4.8.  If the triple 
mutant abrogated binding it was then planed to test mutations 1 and 2 together and 1 and 













Figure 4.8: Dazl mutagenesis scheme.    
Schematic of Dazl mutagenesis scheme showing location of residues to be mutated as indicated 
by *.  RRM = RNA recognition motif.  DAZ = location of the DAZ domain.   
 
The method used to generate the mutants was a PCR based site directed mutagenesis 
approach called overlap extension PCR.  This allows the insertion of point mutations 
into DNA sequences without the need to generate single stranded DNA as in other 
techniques (Ling and Robinson, 1997).   The method is described in detail in chapter 2.  
 
The three Dazl mutants were generated as described in chapter 2, cloned into the GAL4 
activation domain plasmid pGADT7 and tested on their ability to interact with the C-
terminal region of Xenopus ePABP in a directed yeast -2-hybrid assay.  ePABP was 
chosen for this analysis rather than PABP1 because ePABP is the most abundant protein 
in stage VI Xenopus oocytes, and had been shown during the completion of this thesis to 
be capable of stimulating translation and was therefore regarded as the predominant 
PABP available to Dazl in these oocytes with which to interact and stimulate translation. 
 
PAIP IRP mDazl mDazl









Figure 4.9: Effect of Dazl mutations on interactions with PABP.  
Directed yeast two hybrid experiments were conducted in yeast strain Mav99 to measure if the 
mDazl mutants could still interact with PABP.  Yeast strain Mav99 was co-transformed with the 
proteins shown and positive or negative interactions were determined using qualitative β-Gal 
filter assays.  BTM.ePBAP (Xl) was tested against pGAD.Paip, pGAD.IRP, pGAD.mDazl, pGAD, 
pGAD.mDazl.M3, pGAD.mDazl.M2,3 and pGAD.mDazl.M1,2,3.  IRP is included as a negative 
control and Paip as a positive control.   
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Paip was included as a positive control for an ePABP-interacting protein, while IRP 
served as the negative control.  The three Dazl mutants were compared to wild type Dazl 
for their ability to interact with ePABP.  All the Dazls, including the three mutants, gave 
a strong blue signal in the filter binding assay (figure 4.9) indicating a robust interaction 
with PABP.  This result suggests that the mutation of the ‘critical’ residues identified by 
the earlier bioinformatics did not have any significant effect on the interaction between 
Dazl and PABP, although quantative β-galactosidase assays were not performed.   
 
4.9 The mutations have little effect on translation 
 
The mutations were also tested by tether function assay to determine if they affected 
translation stimulation by Dazl.  As the mutations did not disrupt interactions with 
PABP, they would be predicted to stimulate if PABP is indeed important for Dazl 
function.  If the mutations failed to stimulate, this would raise questions with respect to 
the model for the mechanism of translation by Dazl. 
 
 
To this end full-length Dazl constructs containing the mutations were cloned into the 
MS2 fusion expression vector, MSPN, and compared to wild-type Dazl in standard 



















Figure 4.10: Effect of Dazl mutants on translation  
The ability of the mutant Dazls to stimulate translation was measured using tethered function 
assays.  All three mutants still stimulated translation.  m7GpppG -capped Luc-MS2 reporter 
(M7G-Luc-MS2) was co-injected with β-Gal mRNA into stage VI oocytes expressing MS2-U1A, 
MS2-mDazl, MS2-mDazl.M3 MS2-mDazl.M2,3 or MS2-mDazl.M1,2,3.  Translational stimulation 
was plotted with MS2-U1A values set to one.  The experiment was repeated four times and 
average values were plotted.   
 
When compared to wild type mouse Dazl (figure 4.10) the single, double and triple 
mutants displayed slightly reduced levels of translational stimulation as shown by the 
mean values represented by the solid bars.  However, the standard error bars overlap 
with the wild-type protein showing that the mutants do not give significantly lower 
levels of stimulation.    
 
The fact that these mutants, which still interact with PABP, stimulate translation is 
consistent with the current model of Dazl action; however it does not provide additional 








4.10 Reassessment of the region required  
 
As the mutations identified above did not abrogate interactions with PABP or 
translational stimulation it was decided to re-examine the minimal region required for 
PABP interaction.  In section 4.3 the 99-166 region of interest was narrowed down to 
amino acids 139-166.  Further deletion the N-terminal end of the protein fragment was 
tested by cloning a fragment consisting of amino-acids 149-166 being cloned into 
pGBKT7.  This new fragment was tested for is ability to interact with PABP1 with IRP 













Figure 4.11: The area of interested can be narrowed to amino acids 149-166 
Directed yeast two hybrids were undertaken to determine if the minimal region for interaction 
between mDazl and PABP could be narrowed further.  The mDazl 139-166 and 149-166 
fragments can both interact with PABP.  Negative control interactions with a known non-
interactor IRP were included to show if the mDazl fragments self activated.  Yeast strain Mav99 
was co-transformed with the proteins shown and positive or negative interactions were 
determined using qualitative β-Gal filter assays.  Negative control interactions between PABP1 
and IRP with MS2 were included to ensure that the fusion proteins were not self activating. 
 
Both the 139-166 and the 149-166 fragment displayed a degree of self-activation with 
IRP-1.  The 139-166 region gave a good strong interaction with PABP, as previously 
described (figure 4.6), and importantly the 149-166 fragment also showed a robust 
interaction with PABP over background.  Taken together with the data in figure 4.6, this 
narrows the PABP-binding site from the original 67 amino acids (Collier et. al., 2005) to 
just 18 amino acids.  It was decided not to further narrow this region due to the 
propensity of these small fragments (139-166 and 149-166) to self activate in the yeast-
two hybrid assay, and because it is unclear whether the natural protein folding and 
secondary structure of these small fragments is maintained.  Moreover, this small region 
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of 18 amino acids is easily manageable for future analysis by point directed or saturation 
mutagenesis.  
 
4.11 Design for future mutagenic approaches 
 
With the knowledge that the minimal region for binding PABP is just a small peptide of 
18 amino acids, it was decided to re-examine the alignments with a view to identifying 
more candidate residues. 
 
A   
            149       159    166           
            -         -      -                                       
mm_dazl     ETYMQPPTMMNPITQYVQ                 
hs_DAZL     ETYMQPTTTMNPITQYVQ                 
hs_DAZ      ETYLQPQITPNPVTQHVQ                 
xl_dazl     DSYIQHSPIVSPITQYVQ                 
hs_BOL      VAYFHTPEVTSVPPPWPS                 
              3 
 
B 
            149       159    166 
            -         -      - 
mm_dazl     ETYMQPPTMMNPITQYVQ 
hs_DAZL     ETYMQPTTTMNPITQYVQ 
hs_DAZ      ETYLQPQITPNPVTQHVQ 
xl_dazl     DSYIQHSPIVSPITQYVQ 
hs_BOL      VAYFHTPEVTSVPPPWPS     
     
C 
  
AVFPMILW RED Small (small+ hydrophobic (incl.aromatic -Y)) 
DE BLUE Acidic 
RK MAGENTA Basic - H 
STYHCNGQ GREEN Hydroxyl + sulfhydryl + amine + G 
    
Figure 4.12: Features of the minimal region 
A: Yellow = Original Suggested mutational candidates.  Dark grey= conserved substitutions.  
Light grey= semi-conserved substitutions.  mm_dazl = Mouse Dazl.  hs_DAZL = Human Dazl.  
hs_DAZ = Human DAZ.  Xl_dazl = Xenopus laevis dazl.  hs_BOL = human BOULE 
B: Residues can be classified according to chemical characteristics 
C: Residue characteristics as described by ClustalW program. 
 
Figure 4.12 shows the newly identified minimal region a) including the originally 
identified candidate mutation #3 (marked in yellow) and b) the amino acids as sorted by 
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type (based on the ClustalW program).  There are areas of conserved substitutions 
immediately flanking the Y151 residue but as seen in figure 5.6B two of the three are 
not conserved by amino acid type in BOULE.    
 
This leaves three possible candidates residues that are fairly well conserved and also 
within the same amino acid type.  These are residues Q153, N159 and Q166 in mouse 
Dazl.  However these residues were not originally chosen from the bioinformatics 
survey of the 99-166 region because they were not considered sufficiently conserved to 
meet the selection criteria.  Therefore these residues merely represent the best remaining 
candidates, but as these residues were not compelling enough to be selected in the 
original analysis, the value of mutating them is unclear.   
 
With no clear candidates remaining it was decided that the generation of a PABP-
binding deficient Dazl would be best served by a random mutagenesis scheme.  
Unfortunately due to time constraints this could not be undertaken during the course of 




This chapter focuses on the role and importance of the interaction of Dazl with PABP 
and how that this protein-protein relationship affected translation.  
 
In chapter 3 the mechanism of Dazl-mediated stimulation was investigated using the 
variable tethered function assay.  Here the role of PABP in stimulating these IRESs was 
investigated and importantly gave the same pattern of stimulation as Dazl (figure 4.1).  
This is consistent with PABP being the effector molecule for Dazl and provides further 
support for the proposed model.  These observations are also consistent with an analysis 
of poly(A) tail function of different IRESs showing that an EMCV IRES was only 
augmented approximately three fold and PV by ten fold (Bergamini et. al., 2000). As a 
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poly(A) tail is thought to primarily act in translation via PABP, this provides 
independent confirmation of my observations in figure 4.1.  
 
The analysis of IRES stimulation in this chapter is consistent with and supports a role for 
PABP in translational stimulation.  However both Dazl and PABP are members of 
multi-protein families, thus it is unclear what the full extent of interactions between the 
family members may be.  Xenopus oocytes contain at least one other PABP that may 
also be utilised by Dazl, ePABP.  In fact an interaction between species DAZL and both 
Xenopus PABP1 and ePABP was demonstrated previously (Collier et. al., 2005).   
 
However mammals are known to contain a larger complement of both Dazl and PABP 
proteins and only partial expression analysis at the protein level is available for either 
family.  Within human gonads, DAZL is known to be expressed in spermatogonia, 
primary and secondary spermatocytes, spermatids and postmeiotic cells, DAZ in 
spermatogonia and spermatocytes and Boule in spermatocytes (see section 1.6.3 for 
details).  Only the expression of PABP1 and tPABP has been examined in the gonads in 
human testis using in situ hybridisation these show restricted expression to the 
spermatocytes and spermatids for PABP1 and spermatids for tPABP (Feral et. al., 2001). 
Mouse northern blots show expression of both PABP1 and tPABP mRNAs in 
spermatocytes and spermatids (Kleene et. al., 1994).  Northern blot and RT-PCR 
analysis suggests that PABPC4 and ePABP may also be present in the testis (Wilkie et. 
al., 2005; Yang et. al., 1995).   
 
This raises the question of which PABPs are utilised by Dazl family members in the 
germ cells where the Dazl phenotype is evident.  However, as all of these PABPs have 
not been observed at the protein level and it is unclear which cell-type they are 
expressed in within this tissue making their ability to interact with Dazl family proteins 
on a protein level impossible to predict until this knowledge is known.   
 
However, PABP5 at least does not provide a good candidate for DAZL family function 
in these early germ cells as, at least by two-hybrid analysis, it does not interact.  Whilst 
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this result requires confirmation by a second technique, this is consistent with the 
mapping of the interaction to the C-terminal region of PABP1, which is missing in 
PABP5.   
 
It remains possible however that the early DAZL phenotype is not due to a lack of 
activation of target mRNAs through PABPs but may be due to a loss of translational 
repression or mislocalisation of target mRNAs as DAZL protein appear to be present in 
multiple complexes (see main discussion in chapter 6).  This also raises the possibility 
that certain PABPs mediate specific roles within germ cells and should be the subject of 
further investigation (see chapter 6). 
 
One of the main aims of this chapter was to further characterise the PABP-binding site 
within family members leading to the generation of a point mutation that is deficient in 
PABP binding that would have enable the categorical address of whether Dazl 
stimulation is entirely dependent on its interaction with PABP or whether other factors 
are involved.  This mutant could also have been used to generate transgenic mice to 
determine the physiological role of the PABP-Dazl interaction in germ cells (see chapter 
6).  Dazl presents a better mutational candidate for such physiological analysis, as 
although both are members of multi-proteins families, loss of Dazl function has been 
shown to result in an easily identifiable loss of fertility.  However, the mutation would 
need only to affect PABP-binding and not interaction with other protein partners or its 
ability to bind RNA. 
 
Prior to this work, it was assumed that PABP-interactions were mediated by equivalent 
regions of the different Dazl family members.  Here the prediction was tested using the 
most diverse equivalent of the mouse 99-166 region, human BOULE 106-173.  This 
confirmed the importance of this region in mediating PABP interactions and allowed 
comparison between different family members shown to stimulate translation in our 
assays to identify important residues.  Whilst this region was not shown to be sufficient 
for each family member the equivalent regions for human DAZL, human DAZ and 
Xenopus Dazl do not diverge far from the mouse Dazl 99-166, and therefore the 
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interaction with 106-173 of human BOULE was seen as adequate support for the 
alignments.  These alignments identified six residues of particular interest for 
mutagenesis and further deletion reduced the region to 27 amino acids, resulting in three 
amino acids being prioritised for mutation.  The selected mutations had little effect on 
either PABP binding or translational activity (figure 4.10 and 4.11).  Whilst this is 
consistent with a role for PABP, it was not the desired outcome as this result neither 
definitively confirms or excludes or defines the extent of PABP’s role in Dazl mediated 
stimulation of translation.  However, in the absence of additional information such as 
structural prediction or similarity to other PABP binding proteins, these residues remain 
the most obvious candidates for mutagenesis. 
 
This work presented here reduced the minimal binding site to 18 amino acids (fig 4.12), 
a short region that could be used for random mutagenesis.  Given that there are 
apparently no high quality candidates for further site directed mutagenesis this approach 
would appear to be the most appropriate.  This could be achieved by creating a library of 
mutations spanning this region by a low fidelity PCR in a yeast two hybrid vector.  PCR 
conditions can be established to result in an average of only one mutation per clone in 
the region of interest.  There is precedent for single mutations abrogating the interaction 
of PABP with other factors.  For instance the point mutation M161A in mouse PABP1 
results in a loss of interaction with eIF4G (Kahvejian et. al., 2005) and single (M16) and 
double point mutations (M15) in the herpes simplex virus ICP27 protein appears to 
abrogate its interaction with PABP (O. Larralde, R. Smith, B. Clements and N. Gray, 
unpublished).   
 
Mutants that disrupt interaction could be screened by yeast-two hybrid analysis using the 
Mav99 strain and selecting on plates containing FOA.  Using Ura3 gene as a reporter 
allows positive selection for mutants that do not interact, as interaction will result in 
lethality (Table 4.1).  By varying the amount of FOA the selection can be less stringent 
to allow for the selection of mutations that reduce but do not fully abrogate the 
interaction.  Clones that fail to or have significantly reduced interaction with PABP 
would be sequenced and defects in interaction confirmed by another means such as 
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GST-pull down experiments or immunoprecipitation assays of endogenous PABP in 
oocytes expressing wild type or mutant Dazl.  This would address the ability of the 
mutant to disrupt binding in the context of the full length Dazl, as other regions of the 
protein may contribute to binding in vivo.  For instance it has been reported that deletion 
of the DAZ motif from mouse Dazl reduces the interaction with PABP in oocytes 
(Collier et. al., 2005), even though this domain is out-with the PABP binding site 
defined by Y2H (this will be discussed in more detail in the next chapter). 
 
Finally, full-length mutant Dazls that fail to interact with PABP would be tested for their 
ability to stimulate translation in tethered function assays.  If a single point mutation is 
not sufficient to abrogate the Dazl-PABP interaction then the mutagenesis scheme could 
be altered to allow multiple mutations or alternatively two or more weak mutations 
could be combined by site directed mutagenesis.  Once a mutant had been identified it 
would be important to check that interactions with other protein partners was not also 
disrupted, as otherwise it would be impossible to attribute any affects of the mutations to 
PABP alone.  
 
The results presented in this chapter imply that the binding site for PABP does not 
constitute an easily identifiable motif.  This may not be surprising given that the PABPC 
binding motif PAM2, which has been identified in a number of different proteins, only 
has three fully conserved residues out of eighteen and has a highly variable sequence 
(Albrecht and Lengauer, 2004) despite being capable of binding PABP.  It appears that 
structural features may be more important than sequence in dictating interactions with 
translation factors such as PABP.  This trend is also demonstrated in proteins that 
interact with eIF4E, with Maskin, 4E-BPs and eIF4G all having a eIF4E binding region 
14 amino acids long but only having two common  residues as shown in figure 4.14 






        Maskin EFKLATEADFLIAA 
 Human 4E-BP 2 GTRIIYDRKFLLDR 
 Human 4E-BP 3 GTRIIYDRKFLLEC 
 Human 4E-BP 1 GTRIIYDRKFLMEC 
Human eIF-4G 1 EEKKRYDREFLLGF 
Human eIF-4G 2 EGKKQYDREFLLDF 
Human eIF-4G 3 DLKVKADREFLLDF 
  Yeast eIF-4G HVKYTYGPTFLLQF 
 Yeast 4E-BP 1 KVKPNNKIIFLPDD 
    Fly eIF-4G ANEKAELEAFLEEE 
 
 
Figure 4.14: Comparison of eIF4E binding regions.   
eIF4E binding regions of Xenopus Maskin, Human 4E-BPs 1, 2 and 3, Human eIF4G 1, 2 and 3, 
Saccharomyces cerevisiae eIF4G and 4E-BP1 and Drosophila eIF4G.  Adapted from (Stebbins-
Boaz et. al., 1999). Yellow indicates conserved residues. 
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Chapter 5: What is the function of DAZAP1 





In the last chapter the importance of the interaction between Dazl and PABP was 
investigated.  Whilst the current evidence supports a predominant role for PABP in 
Dazl-mediated simulation, it does not exclude a role for other factors.  Several other 
DAZ or Dazl interacting proteins have also been described (see section 1.7.3). 
 
One of these partner proteins is DAZ associated protein 1 (DAZAP1).  This protein was 
identified in a yeast two hybrid screen looking for novel protein partners of the human 
DAZ protein and was shown via GST-pull down assays to bind to both DAZ and DAZL 
through the DAZ repeats (Tsui et. al., 2000a). An interaction between DAZL and 
DAZAP1 was also demonstrated in human tissues by co-immunoprecipitation of DAZL 
and DAZAP1 from ovarian and testis extracts.  DAZL and DAZAP were also shown to 
colocalise by immunohistochemical staining of human ovary sections (Pan et. al., 2005). 
Thus several lines of evidence support an interaction between Dazl family members and 
DAZAP1.  
 
DAZAP1 is evolutionary conserved across  vertebrates with the gene being identified in 
the human, mouse, rat, Xenopus and Zebrafish genomes (Uniprot Knowledgebase), but 
appears to be absent from Drosophila and C. elegans.  In contrast to DAZL family 
members, DAZAP1 appears to be widely expressed.  In mouse both DAZAP1 RNA and 
protein is present in multiple tissues, although they are most abundant in the testis (Dai 
et. al., 2001). Dazap1 was also shown to be expressed throughout oogenesis in Xenopus 
laevis (Zhao et. al., 2001), consistent with a role in germ cells. However, its wide 
expression pattern suggests that DAZAP1 has other functions in addition to any role in 
Dazl-mediated regulation.   
 
DAZAP1 contains two RNA-binding domains and a proline-rich C-terminal portion.  
Several studies have investigated DAZAP1’s ability to bind RNA: Human DAZAP1 was 
shown to bind preferentially to poly(U) and poly(G) and to a lesser degree poly(A) in 
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(Tsui et. al., 2000a).  Xenopus DAZAP1 was shown to bind an U-rich element in the 
3’UTR of Vg1 RNA (Zhao et. al., 2001) and SELEX analysis identified that mouse 
DAZAP1 bound RNAs containing a AAAUAG and GU1-3AG sequence. All these RNA 
binding experiments were performed in vitro.  
 
The function of the DAZAP1 protein has not been investigated in detail.  DAZAP1 was 
first identified in Xenopus where it was called proline rich protein (Prrp), due to the 
composition of the C-terminal region and based on its interaction with the RNA 
localization element in Vg1 mRNA.  (Zhao et. al., 2001) was suggested to potentially 
play a role in mRNA transport.  DAZAP1 was found to be present in mRNP particles in 
mouse testis extract consistent with a potential role in the localization of Dazl-bound 
mRNAs; however no active role in mRNA localization has been demonstrated leaving 
the function of this protein unclear.   
  
The observation that DAZAP1 interacts with the DAZ motif is of interest, not only 
because this motif is only present in this family suggesting a specific functional role, but 
also as this motif has been suggested to be required for the association of Dazl with 
polysomes (Tsui et. al., 2000b). This is perhaps consistent with the deletion of the DAZ 
motif reducing the extent of stimulation by DAZL in tethered function assays and in 
vitro (Collier et. al., 2005). As Dazl was tethered in one of these studies, this suggests 
that this reduction was not due to the proposed ability of this motif to bind RNA but due 
to disruption of the structure of Dazl or due to this motif serving as binding site for a 
protein that contributes to Dazl-stimulatory activity.  Yeast two-hybrid analysis 
suggested that PABP does not bind the DAZ motif although PABP-binding although 
appeared somewhat reduced in oocytes expressing a DAZ deleted version of DAZL 
(Collier et. al., 2005). Thus it is possible that the DAZ motif forms part of a structure 
that can influence the efficiency of PABP-binding.  Alternatively, this motif may 
influence Dazl function through its interaction with DAZAP1.  In this chapter the 
possible role of DAZAP1 in Dazl mediated translational activation will be explored.  
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5.2 Generation of Anti-DAZAP1 antibody 
 
The interaction between DAZ/DAZL and DAZAP1 was established with human and 
mouse proteins but has not been shown to extend to non-mammalian species such as 
Xenopus.  Thus to understand the potential translational role of DAZAP1 in Xenopus 
oocytes, it was deemed necessary to determine whether these proteins interact in these 
cells.  An antibody was previously generated against Xenopus DAZAP1 (Zhao et. al., 
2001), by another lab however it is no longer available. Thus it was decided to raise a 
new anti-Dazap1 antibody.  To this end, two rabbits were immunised with two peptides 
specific to Xenopus laevis DAZAP1 over a three month period at Covalab (France). 
 
The first peptide corresponded to amino acids 218- 231 (GWTGQPPQTWQGYS) and 
the second peptide corresponded to amino acids 338-352 (SGQQDFPFSQFGNAC).  
The locations of these peptides with respect to the RRM motifs of DAZAP1 protein are 
represented in the diagram in figure 5.1A and their specific locations are shown in 5.1B.  
These peptides were chosen based on their estimated immunogenic activity.  Other 
potential regions of good immunogenic potential were identified in N-terminal half of 
the protein near the RRMs but were discounted as BLAST analysis of the protein 
databanks suggested an increased risk of cross-reactivity with other proteins (data not 



















peptide1         ------------------------------------------------------------ 
peptide2         ------------------------------------------------------------ 
DAZP1_XENLA      MNNQGGDEIGKLFVGGLDWSTTQETLRSYFSQYGEVVDCVIMKDKTTNQSRGFGFVKFKD 60 
DAZP1_HUMAN      -MNNSGADEIGKLFVGGLDWSTTQETLRSYFSQYGEVVDCVIMKDKTTNQSRGFGFVKFK 59 
DAZP1_MOUSE      -MNSAGADEIGKLFVGGLDWSTTQETLRSYFSQYGEVVDCVIMKDKTTNQSRGFGFVKFK 59 
 
                                                                              
peptide1         ------------------------------------------------------------ 
peptide2         ------------------------------------------------------------ 
DAZP1_XENLA      PNCVGTVLASRPHTLDGRNIDPKPCTPRGMQPERSRPREGWQQKEPRTENSRSNKIFVGG 120 
DAZP1_HUMAN      DPNCVGTVLASRPHTLDGRNIDPKPCTPRGMQPERTRPKEGWQKGPRSDNSKSNKIFVGG 119 
DAZP1_MOUSE      DPNCVGTVLASRPHTLDGRNIDPKPCTPRGMQPERTRPKEGWQKGPRSDSSKSNKIFVGG 119 
                                                                              
 
peptide1         ------------------------------------------------------------ 
peptide2         ------------------------------------------------------------ 
DAZP1_XENLA      IPHNCGETELKEYFNRFGVVTEVVMIYDAEKQRPRGFGFITFEDEQSVDQAVNMHFHDIM 180 
DAZP1_HUMAN      IPHNCGETELREYFKKFGVVTEVVMIYDAEKQRPRGFGFITFEDEQSVDQAVNMHFHDIM 179 
DAZP1_MOUSE      IPHNCGETELREYFKKFGVVTEVVMIYDAEKQRPRGFGFITFEDEQSVDQAVNMHFHDIM 179 
                                                                              
 
peptide1         -------------------------------------GWTGQPPQTWQGYS--------- 14 
peptide2         ------------------------------------------------------------  
DAZP1_XENLA      GKKVEVKRAEPRDSKSQTPGPPGSNQWGSRAMQSTANGWTGQPPQTWQGYSPQGMWMPTG 240 
DAZP1_HUMAN      GKKVEVKRAEPRDSKSQAPGQPGASQWGSRVVPNAANGWAGQPPPTWQQGYGPQGMWVPA 239 
DAZP1_MOUSE      GKKVEVKRAEPRDSKNQAPGQPGASQWGSRVAPSAANGWAGQPPPTWQQGYGPQGMWVPA 239 
 
 
peptide1         ------------------------------------------------------------ 
peptide2         ------------------------------------------------------------ 
DAZP1_XENLA      QTIGGYGQPAGRGGPPPPPSFAPFLVSTTPGPFPPPQGFPPGYATPPPFGYGYGPPPPPP 300 
DAZP1_HUMAN      GQAIGGYGPPPAGRGAPPPPPPFTSYIVSTPPGGFPPPQGFPQGYGAPPQFSFGYGPPPP 299 
DAZP1_MOUSE      GQAIGGYGPPPAGRGAPPPPPPFTSYIVSTPPGGFPPPQGFPQGYGAPPQFSFGYGPPPP 299 
                                                                              
 
peptide1         ------------------------------------------------------------ 
peptide2         -------------------------------------SGQQDFPFSQFGNAC-------- 15 
DAZP1_XENLA      DQFVSSGVPPPPGTPGAAPLAFPPPPGQSAQDLSKPPSGQQDFPFSQFGNACFVKLSEWI 360 
DAZP1_HUMAN      DQFAPPGVPPPPATPGAAPLAFPPPPSQAAPDMSKPPTAQPDFPYGQYAGYGQDLSGF-- 359 
DAZP1_MOUSE      DQFAPPGVPPPPATPGAAPLAFPPPPSQAAPDMSKPPTAQPDFPYGQYG-YGQDLSGF-- 358 
 
peptide1         ------------------------------------------------------------ 
peptide2         ------------------------------------------------------------ 
DAZP1_XENLA      ------------------------------------------------------------ 
DAZP1_HUMAN      GQGFSDPSQQPPSYGGPSVPGSGGPPAGGSGFGRGQNHNVQGFHPYRR 407 
DAZP1_MOUSE      GQGFSDPSQQPPSYGGPSVPGSGGPPAGGSGFGRGQNHNVQGFHPYRR 406 
 
 
Figure 5.1: Generation of an anti-DAZAP1 antibody 
A: Schematic diagram of location of peptides injected to make anti-DAZAP1 antibody.  The 
position of the RRMs is marked and the positions of the peptides used to generate the antibody 
are shown. 
B: ClustalW alignment of protein sequences of Xenopus DAZAP1, Human DAZAP1 and Mouse 




The protocol for the generation of the antibody was designed and supplied by Covalab 
and is shown in table 5.2.  The antigen injections consisted of in vitro synthesised 
peptide tethered to Keyhole limpet hemocyanin (KLH) as a carrier.  
 
Day Protocol 
0 Pre-immune bleed (4 - 5 ml) 
0 Injection (1 ml  / rabbit) 0.5 ml antigen + 0.5 ml complete Freund's adjuvant 
21 Injection (1 ml  / rabbit) 0.5 ml antigen + 0.5 ml incomplete Freund's adjuvant 
42 Injection (1 ml  / rabbit) 0.5 ml antigen + 0.5 ml incomplete Freund's adjuvant 
53 Test bleed (4 - 5 ml) 
54 Dispatch of sera (D0 & first test bleed) 
63 Injection (1 ml  / rabbit) 0.5 ml antigen + 0.5 ml incomplete Freund's adjuvant 
74 Test bleed (12 - 15 ml) 
75 Dispatch of sera 
81 FINAL BLEED 
  Immunopurification & Titration 
89 Dispatch of final bleed,  affinity purified antibodies 
Table 5.1: Initial immunisation protocol for generation of anti-DAZAP1 antibody  
 
The rabbits were bled at day 53 (D53) and at day 74 (D74) post immunisation and the 
























Table 5.2: Immunogenic activity of D53 and D74 bleeds against peptides 1 and 2. 
The immunogenic activity of D53 and D74 bleeds against peptides 1 and 2 was tested by ELISA.  
Immunogenicity was defined as follows: Titre < 500: no immunoreactivity.  500 ≤ Titre < 2000: 
low immunoreactivity.  2000 ≤ Titre < 8000: good immunoreactivity.  Titre ≥ 8000: very good 
immunoreactivity 
 
As can be seen from table 5.1 the antibody titre for both peptides in both rabbits was low 
at both D53 and day D74 with the highest titre being for peptide 1 in rabbit 2.  However, 
a titre of 2000 is the lowest value included in the ‘good’ immunoreactivity bracket.  The 
D53 and D74 bleeds were tested for their ability to detect DAZAP1 in stage VI oocyte 
extracts by Western blotting however results were inconclusive (data not shown).  This 
coupled with the relatively low immunoreactivity of the bleeds led to the antibody 



















0 Pre-immune bleed (4 - 5 ml) 
0 Injection (1 ml  / rabbit) 0,5 ml antigen + 0,5 ml complete Freund's adjuvant 
21 Injection (1 ml  / rabbit) 0,5 ml antigen + 0,5 ml incomplete Freund's adjuvant 
42 Injection (1 ml  / rabbit) 0,5 ml antigen + 0,5 ml incomplete Freund's adjuvant 
53 Test bleed (4 - 5 ml) 
54 Dispatch of sera (D0 & first test bleed) 
63 Injection (1 ml  / rabbit) 0,5 ml antigen + 0,5 ml incomplete Freund's adjuvant 
74 Test bleed (12 - 15 ml) 
75 Dispatch of sera 
109 FINAL BLEED 
  Immunopurification & Titration 
117 Dispatch of  affinity purified antibodies 
Table 5.3: Revised immunisation protocol for generation of anti-DAZAP1 antibody 
 
At day 109 (D109) the rabbits were sacrificed and the final bleeds were collected and the 
sera from them were extracted.  A portion of these sera from rabbits 1 and 2 were pooled 
and affinity purified using an immunogen-affinity resin with the two original peptides 
immobilised on a sepharose column.  This is designed to only select antibodies from the 
sera that can bind the peptides and therefore eliminate other antibodies from the sera, 
thus reducing background and increasing the effective antibody concentration.   
 
 
The pooled sera’s antibody titre was determined by ELISA at Covalab.  The results of 
this assay are shown in table 5.4.  As can be seen the immunogenicity is still in the range 





Peptide  Titre 
Peptide 1 1000 
Peptide 2 1000 
Table 5.4: Immunogenic activity of pool of D109 sera against peptides 1 and 2. 
The immunogenic activity of the pooled sera against peptides 1 and 2 was tested by ELISA.  
Immunogenicity was defined as follows: Titre < 500: non immunoreactivity.  500 ≤ Titre < 2000: 
low immunoreactivity.  2000 ≤ Titre < 8000: good immunoreactivity.  Titre ≥ 8000: very good 
immunoreactivity 
 
The unpooled sera was not tested at this time as Covalab decided that as the titre did not 
change from D53 to D74 that it would not be worth testing the unpooled sera.  In 
retrospect it would be desirable to have this information but it was not supplied by the 
company. 
 
Both the D109 sera and the affinity purified antibodies were tested for their ability to 
detect DAZAP1 (figure 5.3).  Their ability to detect endogenous (lane 1) and 







































Figure 5.2: Testing of the anti-DAZAP1 antibody.  
Western blots were used to test the specificity of the anti-DAZAP1 D109 sera and purified 
antibody.  One oocyte’s worth of total protein extract from either uninjected oocytes or oocytes 
overexpressing a DAZAP1 plasmid was separated by SDS-PAGE on a 10% gel in each lane.  
The oocytes used were: Lane 1= endogenous oocyte extract.  Lane 2= MSPN.DAZAP1 injected 
oocyte extract.  Lane 3= Pet.DAZAP1 injected oocyte extract.  Lane 4= MSPNΔMS2.  DAZAP1 
injected oocyte extract.  (3) and (4) should result in over expression of DAZAP1 that migrates at 
the same size as the endogenous protein.   
A: Western blotting with D109 serum from rabbit 1 (1/1000 dilution) detects a band the predicted 
size of DAZAP1 as indicated by an arrow.  
B: Western blotting with D109 serum from rabbit 2 (1/1000 dilution) detects a band the predicted 
size of DAZAP1 as indicated by an arrow.  
C: Western blotting with affinity purified antibody (1/1000 dilution: 0.156μg of antibody) detects a 
band the predicted size of DAZAP1 as indicated by an arrow. 
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As can be seen from figure 5.2 both the sera antibodies and the affinity purified 
antibodies can detect a protein band that runs just above the 40KDa marker.  The 
predicted size for DAZAP1 is 39229Da (Swiss-Prot database, www.expasy.org/sprot/).  
DAZAP1 appears to migrate slightly higher than the predicted molecular weight.  This 
may be due to the amino acid composition of the protein or post-translational 
modification.  The band is enhanced in lanes 3 and 4 that contain non-MS2-fused over-
expressed DAZAP1.  A band corresponding to this size is also observed in lane 1 for all 
three antibodies indicating consistent with the presence of endogenous DAZAP1 as 
previously reported (Zhao et. al., 2001), although a fainter band of this size can also be 
detected in pre-immune (See figure 5.3). No clear band the size of MS2-DAZAP1 is 
observed.  Data in figure 5.7B suggest that this is most likely due to experimental error, 
although steric occlusion of the antibody recognition site cannot be formally excluded, 
although the peptides to which the antibodies were raised are located in the C-terminal 
of the protein, distant from the N-terminal MS2 fusion making this very unlikely.  
 
A doublet is seen in the blots with the rabbit 1 and the affinity purified antibody.  The 
doublet is consistent with previously published results (Zhao et. al., 2001) where a 
similar doublet was observed throughout oogenesis. Possible explanations include the 
possibility that the protein undergoes a post-translational modification, or that there are 
alternative splice forms of the gene.  Finally, the Xenopus laevis is a tetraploid organism 
and the annotation of its genome is incomplete, so there could be multiple forms of the 
same gene.  As rabbit 2 had very low immunogenicity for peptide two (see table 5.1) it is 
conceivable that the reason why it can only detect one of the doublet bands is that 
recognising the upper band is dependent on antibodies to peptide two and rabbit 2 did 
not produce these antibodies.  However, the upper band in this doublet does not always 
appear to increase in intensity upon expression of exogenous DAZAP1, thus this may 
not correspond to DAZAP1 (see also figure 5.3 below). 
 
As the D109 serum seemed to recognise a wider variety of proteins, it was decided to 
characterise the affinity purified antibody further.  First the affinity purified antibody 
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Figure 5.3: Comparison of the anti-DAZAP1 antibody to pre-immune sera 
One oocyte’s worth of total protein extract from oocytes expressing either Pet.DAZAP1 (Lane 1) 
or MSPNΔMS2 (Lane 2) was separated by SDS-PAGE on a 10% gel.   
A: Western blotting with pre-immune sera (1/1000 dilution) does not detect a strong band. 
B: Western blotting with affinity purified antibody (1/1000 dilution: 0.156μg of antibody) detects a 
band the predicted size of DAZAP1 as indicated by an arrow. 
 
When the affinity purified antibody is compared to pre-immune sera (figure 5.3) a faint 
signal in the pre-immune blot corresponding to the size that DAZAP1 (approx 40KDa) 
is observed.  This indicates that there are some antibodies in the sera that react with 
proteins of the same size as DAZAP1 (or even that recognize DAZAP1) prior to peptide 
inoculation.  However, there is a marked and clear difference between the pre-immune 
sera and the immuno-purified antibody with respect to the lower band within the doublet 
that is greatly enhanced in the presence of exogenous DAZAP1- suggesting that the 
immuno-purified sera recognizes DAZAP1 expressed in oocytes. 
 
Although the experiments presented above did give some indication of the ability of the 
D109 sera and the affinity purified antibody to recognise DAZAP1 they did have some 
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flaws that should be addressed in the future.  First, a pre-immune control blot should 
have been presented for each of the sera and second the protein concentration of the sera 
should have been measured so that a comparison of the amount of immunoglobulins 
used in each blot could have been made.  Without doing these controls it is difficult to 
truly assess the relative abilities of the sera and purified antibody to recognise DAZAP1.  
In addition the ability of the affinity purified antibody to recognise DAZAP1 appears to 
differ between figure 5.2 (panel C) and figure 5.3 with a clearer signal being seen in 
figure 5.3.  The levels of background also differ between the two figures.  However, 
there were also consistencies between the two test experiments with a band of the 
correct size for DAZAP1 always being observed as significantly stronger than the 
background.  Because of this it was decided to continue with the affinity purified 
antibody and use it in some of the future experiments in this chapter despite the 
problems.  It was felt that the signal was strong enough and specific enough to justify its 
use.   
 
5.3 The anti-DAZAP1 antibody generated can be used for 
immunoprecipitations 
 
The affinity purified antibody was tested for its ability to immunoprecipitate (IP) 
radiolabelled Xenopus DAZAP1 synthesised in vitro using the coupled transcription and 
translation (TNT) system (Figure 5.4, panel A).  An empty vector and a vector encoding 
the human PABP5 were included alongside DAZAP1 as specificity controls.  The 
radiolabelled proteins translated from each of these are shown in lanes 1-3.  The 
DAZAP1 TNT reaction produced a doublet of bands around 45KDa in length (lane 3).  
Immunoprecipitations from all three TNT reactions were conducted with antibodies 
against DAZAP1 and PABP5 as a control.  The anti-PABP5 antibody was a gift from R. 
Anderson.  The IP with the anti-DAZAP1 antibody recognised the protein from the 
DAZAP1 TNT with high efficiency (lane 9) and the IP with the anti-PABP5 antibody 
recognised the protein produced by the PABP5 TNT (lane 5).  Neither IP recognised 
anything significant from the empty TNT reaction (lanes 4 and 7), though there is a faint 
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band in lane 4 that could be protein spilt over from lane 5.  There appeared to be a minor 
cross-reactivity between the PABP5 and DAZAP1 antibodies (lanes 6 and 8).  Based on 
the peptides used to raise these antibodies and the divergent nature of these proteins, this 
was surprising.  However, due to the nuclease treatment of TNT extracts, the only 
radiolabelled proteins present will be derived from the plasmids used to program the 
lysates.  Thus, it is possible that this represents precipitation of the proteins in the buffers 
used or proteins bound to the beads in a non-specific manner suggesting that the 
washing protocol was not sufficient.  However, as the signal is weak compared to the 
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Figure 5.4:  The anti-DAZAP1 antibody can immunoprecipitate radiolabelled DAZAP1 
A: The ability of the anti-DAZAP1 antibody to IP protein from TNT reactions was tested.  An IP 
with anti-PABP5 antibody was included as a positive control.  Lanes 1-3: input (5μl of TNT 
reaction).  Lanes 4-6: IP with anti-PABP5 antibody (TNT input into IP = 20μl).  Lanes 7-9: IP with 
anti-DAZAP1 antibody (TNT input into IP = 20μl).   
B: The ability of the anti-DAZAP1 antibody to IP protein from metabolically labelled oocytes was 
tested.  Oocytes are either not injected (NI) or over expressing Xenopus DAZAP1 (OE).  Lanes 
1-2: input (1 oocyte’s worth of extract).  Lanes 3-4 IP with anti-DAZAP1 antibody (input into IP = 
5 oocyte’s worth of extract).  Lanes 5-6 IP with anti-PABP5 antibody (input into IP = 5 oocyte’s 
worth of extract).   
 
The ability of the anti-DAZAP1 antibody to immunoprecipitate endogenous or 
overexpressed Xenopus DAZAP1 in oocytes was also determined.  To this end, stage VI 
Xenopus oocytes were collected and half injected with an mRNA encoding DAZAP1 
(OE) and the other half remained uninjected (NI).  The oocytes were incubated for six 
hours with 35S-methionine to radiolabel newly synthesised proteins.  After the 
incubation period extracts were made from the OE and NI oocytes.  The DAZAP1 
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antibody was used to immunoprecipitate proteins from these extracts.  Samples of the 
protein extract (Input) and the proteins recognised by the IP were resolved by SDS-
PAGE (figure 5.4, panel B) and identified by autoradiography.  The anti-DAZAP1 
antibody efficiently recognised a protein from the overexpressed extract (lane 4) and a 
very faint signal was seen in the NI extract (lane 3) representing the endogenous protein.  
The anti-PABP5 antibody was included as a negative control (lane 6) and produced 
some of the same bands, but importantly not at the same size as the strong band in lane 
4, suggesting that this band represented immunoprecipitated DAZAP1.    
 
5.4 DAZAP1 and Dazl interact in Xenopus oocytes 
 
The availability of this antibody permitted the testing of an interaction between Dazl and 
DAZAP1 in Xenopus oocytes similar to that described for human protein in vitro (Tsui 
et. al., 2000a) and in human ovarian tissue (Pan et. al., 2005).   
 
Stage VI oocytes were collected and half left not injected (NI) and the other half was 
injected so that they over-expressed DAZAP1 (OE).  Following incubation, protein 
extracts were made form both sets of oocytes.  IPs were conducted using the affinity 
purified anti-DAZAP1 antibody and pre-immune (day 0) sera as a negative control.  A 
sample of each protein extract and the IPs were separated by SDS-PAGE (figure 5.5) 
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Figure 5.5: Co-immunoprecipitation of Dazl with DAZAP1 in Xenopus oocytes. 
Protein was immunoprecipitated from either uninjected (NI) oocytes or from oocytes over 
expressing DAZAP1 (OE) with affinity purified anti-DAZAP1 antibody (lanes 3-4) or with pre-
immune sera (lanes 5-6) at 1/1000 dilution.  Lanes 1-2 show input protein (1 oocyte’s worth of 
extract).  Dazl was detected by Western blot after IP with anti-Dazl antibody at 1/1000 dilution.  
The experiment has not been repeated.  
 
Dazl protein could be clearly seen in the input lanes for both not-injected and DAZAP1 
overexpressing samples, though the presence of more Dazl protein in the OE lane 
indicates that the protein concentrations of the two extracts differed slightly.  
Importantly, the IP with the affinity purified anti-DAZAP1 antibodies appeared to co-
precipitate Dazl as indicated by the presence of a Dazl band in lanes 3 and 4.  More Dazl 
was recovered from the cells expressing exogenous DAZAP1, suggesting that DAZAP1 
concentrations may be limiting compared to Xdazl, however this may also be a direct 
result of the difference in protein concentration between the lysates.  The IP with the 
pre-immune sera (lanes 5 and 6) did not isolate proteins of the same size as the Dazl, 
suggesting that the pull down is specific to the anti-DAZAP1 antibody.  
 
Overall this result could be taken to suggest that Xenopus DAZAP1 and Dazl interact in 
oocytes.  However this result is still in the preliminary stages with only one repetition 
performed and needs to be confirmed before any firm conclusions can be drawn.  As 
discussed in section 5.2 the antibody was suboptimal and repeating this experiment with 
either a much better antibody or another method would be desirable, though this was not 
possible given the time frame of this project.  Other methods that could be used to 
confirm the interaction include using tagged proteins so more effective antibodies to the 
tags can be used for co-IP or GST pull downs.  Despite the preliminary nature of the 
result observed here it does give an indication that an interaction is possible, which 
enables the consideration of the potential implications of this observation. 
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5.6 Does DAZAP1 associate with translational machinery? 
 
Having established that DAZAP1 and Dazl may interact in oocytes this raises the 
possibility that DAZAP1 may participate in DAZL-mediated translational regulation.  In 
mouse testis DAZAP1 was shown to associate with the mRNP fraction and not localise 
to actively translating polyribosomes, under the conditions and developmental stage 
used.  Moreover, a recent in vitro study (Morton et. al., 2006) using human DAZAP1, 
suggested that DAZAP1 was an inducer of RNA instability and blocked the ability of 
Dazl family proteins to stimulate translation. These results are consistent with DAZAP1 
as a negative rather than a positive regulator of mRNA translation.  
 
To determine whether DAZAP1 is associated with mRNP complexes or ribosomes in 
Xenopus oocytes, sucrose gradient analysis was undertaken.  Stage VI Xenopus oocytes 
were treated with cycloheximide, a drug that prevents peptidyl transfer and prevents 
ribosome run-off during extract preparation.  Translation complexes were resolved on 
10-50% sucrose gradients, and A254 absorbance was used to track the position of 
polysomes, ribosomes and mRNPs.  In stage VI oocytes 80S ribosomes, some of which 
may be associated with mRNA rather than empty couples, are predominantly observed 
with few clear polysomes observed in A254 profiles.  This preponderance of 
monosomes is due to the large number of ribosomes that have been synthesised in 
preparation for fertilisation.  Though extraction of mRNA from the fractions heavier 
than the 80S shows that ribosomal RNAs are present (Personal communication, B. 
Gorgoni) at least in the three fractions preceding the 80S peak, though it is unknown if 
these are di-somes, light polysomes or merely heavier monosome complexes.    
 
Following fractionation, proteins were precipitated from the 10 fractions using 
trichloroacetic acid (TCA) and resolved by SDS-PAGE.  The fractions were then 
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Figure 5.6: Sucrose gradient analysis of DAZAP1 in Xenopus oocytes.  
The association of DAZAP1 with translational machinery was assessed by sucrose gradient 
analysis.  Each figure shows the A254 absorbance trace (upper panel) and the precipitated 
DAZAP1 from fractions detected by Western blot using anti-DAZAP1 antibody (1/1000 dilution).  
Only fractions 4-10 are shown as these fractions contain detectable DAZAP1.  Locations of 
endogenous (En) and over expressed (OE) DAZAP1 are indicated.  
A: The localisation of endogenous DAZAP1 was assessed in extracts from stage VI and mature 
Xenopus oocytes treated with cycloheximide (CHX) (Panel A) or EDTA (Panel B).  The positions 
of 80S ribosomes or 60S and 40S ribosomal subunits and mRNPs are indicated.   
C: As in A, but with oocytes over expressing His-tagged DAZAP1 
D: As in B, but with oocytes over expressing His-tagged DAZAP1 
 
In stage VI oocytes extracts treated with cycloheximide DAZAP1 is mainly localised to 
fractions 6, 7 and 8 (figure 5.6A), being most abundant in fraction 7.  These fractions 
correspond to an area of the gradient that consists of free 80S ribosomes and mRNAs 
bound by one or a limited number of ribosomes (light polysomes).  DAZAP1 is not 
located in heavy polyribosomes and only a minority is present in the mRNP fraction 
associated with non-translated mRNAs.  Treatment of extracts with EDTA releases 
mRNAs from ribosomes and the polysomes and 80S peak are lost, resolving into the 40 
and 60S subunits.  In the presence of EDTA the majority of DAZAP1 co-sediments with 
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ribosomal subunits.  This may reflect an incomplete release of the RNA by EDTA but 
the loss of the 80S peak suggests that the EDTA treatment was effective.  Alternatively 
this may reflect a direct interaction of DAZAP1 with ribosomal subunits or its presence 
in heavy mRNPs (see discussion).  Taken together this suggests that DAZAP in stage VI 
oocytes is found in an area associated with 80S ribosomal subunits and light polysomes 
rather than light mRNP fraction as previously reported for mouse testis.  The presence of 
DAZAP1 in 80S complexes could be consistent with a role in active translation on short 
or infrequently initiating mRNAs undergoing efficient elongation.  Alternatively, it is 
also consistent with very heavy mRNPs associated with repression or repressed mRNAs 
associated with a single 80S ribosome, as has been described for a limited number of 
uORF containing mRNAs (Wang and Sachs, 1997). 
 
During oocyte maturation, there is reprogramming of cellular translation, with the 
activation of mRNAs required for meiotic maturation and a silencing of many 
housekeeping genes (Mendez and Richter, 2001). Given the knockout phenotype of Dazl 
in the majority of model organisms and the report that repression by Pumilio of Dazl 
bound mRNAs in stage VI oocytes is relieved during maturation (Padmanabhan and 
Richter, 2006), the association of DAZAP1 with the translational machinery was also 
examined following maturation.  In mature oocyte extracts treated with cycloheximide 
DAZAP1 is mainly localised in fractions, 5, 6, and also fraction 7 (figure 5.6 A and C).  
This represents a shift towards heavier complexes heavier than the 80S that likely 
corresponds to light polysomes.  As maturation leads to the activation of translation for 
many mRNAs this result is consistent with DAZAP1 associating with actively 
translating ribosomes.  As with the stage VI oocyte extract EDTA treatment results in 
most of the DAZAP1 associating with both the 40S and 60S peaks. 
 
The experiment was also conducted using extracts from oocytes over expressing a His-
tagged DAZAP1.  This results in a slightly larger protein representing the slightly larger 
fusion protein being present on the Western blot in addition to the endogenous 
DAZAP1.  The distribution of the endogenous DAZAP1 was very similar, but not 
identical, to the uninjected oocytes with DAZAP1 being present around the 80S peak in 
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stage VI and mature oocytes.  An additional upper band representing his tagged DAZAP 
seems to localise across the gradient with a small amount in each fraction with the 
majority being in the mRNP fractions (note that this band is not the same as the faint 
upper band seen while testing the antibody, which is never seen in this experimental 
system).  
 
This apparent difference between endogenous and tagged DAZAP1 could be because the 
target RNAs are already bound by endogenous DAZAP1 resulting in the majority of 
overexpressed DAZAP1 not being associated with mRNA and being located in the 
lighter fractions.  Alternatively the N-terminal His tag could interfere with the N-
terminal RRMs in DAZAP1 or other structural feature, thus inhibiting RNA binding or 
protein-protein interactions by the over expressed DAZAP1 resulting in its 
mislocalisation.  There is also the possibility that DAZAP1 has a protein partner 
required for its normal function RNA that is only present in limited amounts in the 
oocyte and the additional DAZAP1 cannot participate in complexes with this protein so 
remains at the top of the gradients.    
 
5.7 What is the effect of DAZAP1 in translation assays? 
 
Previous publications have suggested that DAZAP1 is a negative rather than a positive 
regulator of translation.  However, in Xenopus oocytes DAZAP1 appears to be localised 
with ribosomes.  This result leads to the question of whether DAZAP is a regulator of 
translation and whether it has a positive or negative effect.    
 
To test this directly tethered function assays were performed as the physiological 
mRNAs to which DAZAP1 is bound remain to be unambiguously identified (see 
discussion).  mRNAs encoding MS2-U1A and MS2-DAZAP1 were injected followed by 
the β-galactosidase control and M7G Luc-MS2 reporter mRNA.  The oocytes were 
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Figure 5.7: DAZAP1 stimulates translation in oocytes (part 1) 
A: Xenopus DAZAP1 can stimulate translation.  m7GpppG capped Luc-MS2 reporter was co-
injected with β-Gal mRNA into stage VI oocytes expressing MS2-U1A or MS2-DAZAP1 
(Xenopus).  Luciferase activity was normalised to β-galactosidase activity and the relative 
luciferase units were plotted with MS2-U1A values set to one.  The average of three experiments 
is shown. 
B: Human DAZAP1 can also stimulate translation.  m7GpppG capped Luc-MS2 reporter was co-
injected with β-Gal mRNA into stage VI oocytes expressing MS2-U1A, MS2-mDazl or MS2-
DAZAP1 (human).  Luciferase activity was normalised to β-galactosidase activity and the relative 
luciferase units were plotted with MS2-U1A values set to one.  The average of five experiments 
is shown. 
C: The MS2-DAZAP1 (human) fusion protein is expressed in oocytes.  Oocytes were injected 
with fusion-protein mRNAs and incubated in buffer containing 35S-methionine for 6 hours and 
protein lysates made.  An oocyte’s worth of lysate was separated by SDS-PAGE and analysed 
by autoradiography.  A star indicates the fusion protein band. 
D: DAZAP1 does not have a stability effect on reporter mRNAs.  Oocytes expressing either 
MS2-UIA or MS2-DAZAP1 (human) were injected with luc-MS2, and β-galactosidase.  Total 
RNA was extracted either immediately or 16 hours post injection.  Quantitative reverse 
transcription PCR was performed with primers directed against the reporter mRNAs.  The 
numbers of molecules of luciferase reporter were normalised to the β-galactosidase and plotted.  



























Figure 5.7: DAZAP1 stimulates translation in oocytes (part 2) 
E: The values represented in figure 5.7D were transformed to show % of luciferase reporter 
injected at T=0 and T=16. 
F: MS2-DAZAP1 cannot stimulate a reporter with no MS2 binding sites.  M7G capped Luc-MS2 
reporter or Luc-ΔMS2 was co-injected with β-Gal mRNA into stage VI oocytes expressing MS2-
U1A or MS2-DAZAP1 (human).  Luciferase activity was normalised to β-galactosidase activity 
and the relative luciferase units were plotted with MS2-U1A values set to one.  The average of 
three experiments is shown. 
 
When tethered, Xenopus MS2-DAZAP1 stimulated production of luciferase 6-fold 
(figure 5.7A) when compared to MS2, suggesting a positive role in gene expression, 
consistent with the polysome analysis (figure 5.6).To see if this result was conserved 
across species, human DAZAP1, which was previously suggested to repress translation, 
was also tested by tether function.  Interestingly, human DAZAP1 also stimulated 
translation (figure 5.7B), with a 7-fold increase, which was nearly as efficient as the 
positive control, mDazl, which stimulated 8-fold.  To ensure that DAZAP1 fusion 
protein was expressed, stage VI oocytes were injected with RNAs encoding the human 
MS2-DAZAPl or left uninjected and new protein production was monitored by 
metabolically labelling the oocytes with 35S-methionine.  Protein extracts from oocytes 
were made and analysed using SDS-PAGE.  A protein band corresponding to human 
MS2-DAZAP1 protein can be observed (figure 5.7C).  
 
As mentioned earlier, it has been suggested that human DAZAP could be an inducer of 
RNA instability.  Because of this and as with any reporter assay it is possible that 
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increased expression is due to the stabilisation of the reporter mRNA rather than a 
translational effect, reporter stability was measured by employing the QRT-PCR method 
detailed in chapter 3.  The tethered function assays shown in figure 5.7B were repeated 
with additional oocytes.  RNA was extracted from these additional oocytes and the 
numbers of molecules of both the luciferase and β-gal reporters in each sample (figure 
5.7D) and the percentage of injected luciferase reporter at T=0 and T=16 (figure 5.6D) 
were measured as detailed in chapter 3.  The QRT-PCR assays showed that while the 
tethering of MS2-U1A appeared to have a small stabilising effect on luciferase reporters 
levels, the tethering of DAZAP1 did not stabilise the reporters with a 33% reduction in 
luciferase RNA at T=16 compared to T=0.  However the error of the measurement (+/- 
30%) is such that any drop in luciferase mRNA levels can not be said to be significant.  
However there is a clear lack of stabilisation, which implies that DAZAP1 does not 
increase luciferase levels in the tethered function assays by virtue of stabilisation and 
does indeed do so via a translational effect.   
 
To test whether the increase in luciferase production seen was a specific effect of 
DAZAP1 binding the reporter or a more general trans effect a specificity control was 
conducted.  The stimulatory effect of DAZAP1 required MS2 binding, as no effect on 
luciferase production was observed in the absence of MS2 binding sites in the PV-Luc-
∆MS2 reporter.  
 
5.8 What are the interactions between DAZAP, Dazl and PABP? 
 
So far in this chapter DAZAP1 has been shown to be localised with ribosomes and to 
stimulate translation in tethered function assays.  These results are contrary to current 
theories that have suggested that DAZAP is a localisation factor or that it blocks 
interactions between Dazl family members and PABP preventing translational 
stimulation (Morton et. al., 2006). The observation that human DAZAP1 shares the 
ability to stimulate translation shows that these differences can not be explained purely 
as a species specific effect.  In order to resolve this problem a number of possible 
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models of DAZAP action were proposed that could be explored to explain the 
translational activity seen especially with relation to Dazl and PABP.  
 















Figure 5.8: Possible models of DAZAP1 action 
Dazl, DAZAP1 and PABP are as indicated.  3’UTR= 3’ untranslated region 
1: DAZAP1 stimulates translation via an interaction with Dazl where DAZAP1’s function is to aid 
the recruitment of Dazl to mRNAs.  
2: Dazl stimulates translation via both PABP and DAZAP1, perhaps independently rather than 
concurrently.  
3: DAZAP1 stimulates translation independent of Dazl or PABP. 
 
The first model is that DAZAP1 and both Dazl bind RNA as a complex and then Dazl 
recruits PABP that is then responsible for interacting with 5’ factors and stimulating 
translation (figure 5.8A).  The function of DAZAP1 in this complex would be to aid the 
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recruitment of DAZL to specific mRNAs and is consistent with the action of other 
3’UTR regulatory complexes such as Nanos recruiting Pumilio (Wickens et. al., 2002).  
This model would explain the tethered function data with DAZAP1 as tethered 
DAZAP1 could recruit Dazl, which in turn could recruit PABP, thus resulting in the 
stimulation of translation (figure 5.8B).  Inconsistent with this model is the in vitro data 
using overexpressed proteins in somatic cell-lines where DAZ could not be detected in a 
triple complex with DAZAP1 and PABP.  The second model is that DAZL utilises both 
DAZAP1 and PABP to directly stimulate translation (figure 5.8B).  This model would 
explain why Dazl with the DAZAP1 binding DAZ domain removed has reduced 
translational activity even though it can still bind PABP (Collier et. al., 2005).  Again 
this model would require that Dazl, PABP and DAZAP form a triple complex.  The third 
model proposes that the translational activity of DAZAP1 is unrelated to its ability to 
interact with Dazl and that is an independent translational regulator (figure 5.8C).   
  
5.9 What is the number dependency of tethered DAZAP 
stimulation? 
 
It was decided to further investigate the action of DAZAP1 with a variety of tethered 
function assays.  Previously, it was shown that Dazl can stimulate the translation of 
mRNAs with multiple MS2-binding sites to a greater degree than an mRNA with one 
(Collier et. al., 2005).  However there was a limit to the number of binding sites that 
increased stimulation as increasing the number of sites from three to nine made little 
difference.  This may relate to DAZL target mRNAs having multiple binding sites 
within their target mRNAs.  This assay has also been conducted for the histone stem 
loop binding protein (SLBP).  This protein binds to a single stem loop on its target 
mRNA and stimulates its translation.  When testing the number dependency of this 
protein, maximal stimulation is seen with one tethered protein, reflecting its 
physiological role (Gorgoni et. al., 2005). 
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To test whether DAZAP1 showed a similar dependency to Dazl, tethered function assays 
were performed with luciferase reporters containing one, three or nine MS2 binding sites 
in the 3’UTR (see figure 5.9A).  The ‘standard’ number of MS2 sites used previously in 


















Figure 5.9: Multiple molecules of DAZAP1 stimulate translation 
A: Schematic of luciferase reporter mRNAs, which vary as shown in the number of MS2 sites 
within the 3’UTR 
B: MS2-DAZAP1 stimulates a reporter with one MS2 site at low levels and reporters with three 
or nine MS2 sites at high levels.  Oocytes expressing MS2-U1A or MS2-DAZAP1 were co-
injected with β-Gal mRNA and Luc-MS21, Luc-MS23 or Luc-MS29.  Luciferase activity was 
normalised to β-galactosidase activity and the relative luciferase units were plotted with MS2-
U1A values set to one.  The average of three experiments is shown. 
 
Figure 5.9B shows that although one-MS2 binding site is sufficient for DAZAP1 to 
stimulate translation, the level of stimulation is much reduced compared to three MS2-
sites, with only 2-fold stimulation rather than 7-fold.  Increasing the number of sites 
from three to nine had little effect indicating that beyond three binding sites the 
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translational stimulation is saturated.  This pattern is similar to that of Dazl with these 
reporters (Collier et. al., 2005).   
 
If the pattern of stimulation of these reporters had differed from Dazl, for instance giving 
a pattern similar to SLBP, this would have suggested that DAZAP1’s action may not be 
related to that of Dazl (model #3).  As the pattern is similar to that of Dazl this result 
could suggest that DAZAP1 stimulation of translation related to Dazl function, as 
suggested in model #1 and 2.  
 
One quantative difference between DAZAP1 and Dazl is that Dazl could stimulate the 
reporter with a single MS2 site 4-fold where DAZAP1 could only stimulate 2-fold.  One 
possible suggestion to account for this discrepancy is that Dazl has been shown able to 
dimerise (Ruggiu and Cooke, 2000) that could result in one tethered Dazl recruiting 
another thus having a greater effect on translation.   
 
This experiment has also been conducted using PABP1 (N. Gray, unpublished) and the 
result is similar to Dazl and DAZAP and implies that multiple molecules of PABP 
bound to an mRNA can further enhance translation, consistent with the current models 
for poly(A) function.  The similarity seen with all three proteins is consistent with them 











5.10 What is the role of poly(A) in DAZAP stimulation? 
 
All the reporters used in the tethered function assays in this thesis so far have been 
unadenylated so the effect of tethered proteins could be seen without the complicating 
effects of PABP molecules bound to the poly(A) tail.  When Dazl was originally 
investigated it was discovered that Dazl showed a reduced fold stimulation on an 
adenylated reporter compared to one with a poly(A) tail, although this mRNA was the 
most efficiently translated.  As it has been proposed that Dazl’s translational activity 
depended on recruiting PABP, this result supported that hypothesis as if there are 
multiple molecules of PABP bound to the poly(A) tail then the effect of bring additional 
molecules of PABP to the mRNA would be less marked.   
 
To determine whether DAZAP1-mediated stimulation was also sensitive to poly(A), 
DAZAP1 tethered function assays were conducted as previously but using the 
unadenylated Luc-MS2 reporter and the Luc-MS2polyA, with its (at least 45 base) poly(A) 



























Figure 5.10: DAZAP1 shows reduced stimulation of translation in the presence of a 
poly(A) tail 
A: DAZAP1 translational stimulation is sensitive to the presence of a poly(A) tail.  Luc-MS2 
reporter with no poly(A) tail (Luc-MS2) and polyadenylated Luc-MS2 reporter (Luc-MS2 PolyA) 
was co-injected with β-Gal mRNA into stage VI oocytes expressing MS2-U1A or MS2-mDazl.  
Luciferase activity was normalised to β-galactosidase activity and plotted.  One representative 
experiment is shown.  
B: Relative luciferase units were plotted with MS2-U1A values set to one.  The average of three 
experiments is shown. 
 
The reporter with the poly(A) tail is translated at a much higher rate than the 
unadenylated reporter (figure 5.10A), but is further stimulated by DAZAP1.  This is 
important as it shows that DAZAP1’s stimulator activity is not restricted to 
unadenylated mRNAs but also applies to mRNAs with a physiological length of 
poly(A).   
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As can be seen in figure 5.10B the fold-stimulation of DAZAP1 is reduced by 64% in 
the presence of the poly(A) tail.  This result suggests that at least some of the effect of 
tethering DAZAP1 is mediated by PABP, as adding a poly(A) tail diminishes the effect 
of DAZAP.  The poly(A) tail added to the luciferase reporter would have had the effect 
of recruiting molecules of PABP to the reporter.  If DAZAP1 stimulation had been 
insensitive to the presence of these molecules of PABP this would have indicated that it 
operated via a PABP insensitive mechanism.  The fact that stimulation by DAZAP1 is 
reduced in the presence of PABP suggests that DAZAP1 may function by recruiting 
PABP in some manner. 
 
This suggests model #1 as the most plausible as in this model the effect of DAZAP on 
translation is mediated by Dazl recruiting PABP.  
 
5.11 What happens to DAZAP1’s effect on translation during 
meiotic maturation? 
 
In Xenopus the Stage VI to mature oocyte transition is equivalent to the G2 to meiosis 1 
transition, with the end of the growth stage and the first meiotic division occurring upon 
maturation.  Previously Dazl has been suggested to be functional during meiosis in 
Drosophila (Eberhart et. al., 1996) and C. elegans (Karashima et. al., 2000) and possibly 
mouse (Saunders et. al., 2003) (see chapter 1 for more detail).  In Xenopus Dazl has 
been shown to be phosphorylated during maturation and to become dephosphorylated 
shortly after fertilisation (Mita and Yamashita, 2000). To investigate the physiological 
relevance of this observation, the activity of tethered dazl was compared in stage VI and 
mature oocytes.  This showed that Dazl stimulated translation to a significantly greater 
extent in mature oocytes than in stage VI (B. Gorgoni, unpublished).  This experiment 
was also conducted for PABP1 and ePABP that also showed a significant increase in 
translational stimulation (Wilkie et. al., 2005), although no change in the 
phosphorylation of these proteins is observed (Cosson et. al., 2002).  
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To determine whether the activity of DAZAP1 was altered during maturation, tethered 
function assays were performed as previously, but in this case half the oocytes injected 
were treated with progesterone after injection.  The progesterone treatment causes the 
oocytes to mature.  Progesterone treated oocytes were collected after an overnight 
incubation and not at GVBD50 when half the oocytes had matured, to mirror the 
conditions used for DAZL and PABP1/ePABP.  Maturation can be easily scored by the 



















Figure 5.11: The effect of oocyte maturation on DAZAP1 translational stimulation 
DAZAP1 translational stimulation is not affected by oocyte maturation.  
Oocytes expressing MS2-U1A or MS2-DAZAP1 were co-injected with Luc-MS2 alongside β-Gal 
mRNA.  Half the oocytes were treated with progesterone to induce maturation.  Luciferase 
activity was normalised to β-galactosidase activity and the relative luciferase units were plotted 
with MS2-U1A values set to one.  The average of three experiments is shown. 
 
Mean DAZAP1 stimulation of translation increased slightly upon maturation (figure 
5.11).  However this increase was not significant as can be seen by the overlapping 
errors of the MS2-DAZAP1 relative luciferase units 6.5 +/- 0.5 for immature oocytes 
and 7.9 +/- 3.1 for mature oocytes. 
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Thus the action of DAZAP1 during maturation appears to differ from both DAZL and 
PABPs which show a 1.7-2.3 fold increase in their activity.  The observation that 
DAZAP1 does not increase translational stimulation in mature oocytes is surprising as 
the previous experiment suggested that PABP may play a role in DAZAP activity, 
however this result appears inconsistent with this conclusion.  This issue will be returned 
to in the chapter discussion.   
  
5.12 DAZAP1 phosphorylation mutants do not change 
stimulatory activity in tethered function assays 
 
A published study investigated the phosphorylation state of DAZAP1 and the effect of 
phosphorylation upon DAZAP1’s interactions with DAZ (Morton et. al., 2006).  It was 
shown that a human DAZAP1 with an N-terminal truncation removing the RRMs could 
interact with DAZ in vitro.  Two phosphorylation sites were identified at Thr269 and 
Thr315 and two DAZAP1 mutants were introduced into the truncated protein, mutating 
these residues to alanine or asparagine.  The alanine mutant, DAZAP1-AA, mimicked 
the effect of hypophosphorylation and the asparagine mutant, DAZAP1-DD, mimicked 
the effect of hyperphosphorylation of these residues.  It was demonstrated that the AA 
mutant could still interact with DAZ but that the DD mutant could not, suggesting that 
the phosphorylation of DAZAP1 causes its dissociation from DAZ.  These experiments 
were repeated with full-length DAZAP1 mutants and the results were similar, though the 
DD mutant did not totally abrogate binding to DAZ, but instead was substantially 
reduced.   
 
In collaboration with the authors of this study the two full-length DAZAP1 
phosphomimetic mutants were investigated in tethered function assays.  It was hoped 
that the results of this experiment could reveal the significance of the Dazl/DAZAP1 
interaction in the tethered function assay.  
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Tethered function assays were performed using wild-type DAZAP1, DAZAP1-DD and 
DAZAP1-AA.  Because it is known that oocyte maturation is accompanied by numerous 
phosphorylation events (Ferrell, 1999) and it has been suggested that DAZAP1 
dissociates from DAZ upon phosphorylation the activity of these mutants were also 































Figure 5.12:  Testing the ability of phosphorylation mutants of DAZAP1 to stimulate 
translation. 
The phosphorylation mutants of DAZAP1 do not significantly alter the pattern of translational 
stimulation.  Oocytes expressing MS2-U1A or MS2-DAZAP1, MS2-DAZAP-AA or MS2-DAZAP-
DD were co-injected with Luc-MS2 alongside β-Gal mRNA.  Half the oocytes were treated with 
progesterone to induce maturation (B) and half were not (A).  Luciferase activity was normalised 
to β-galactosidase activity and the relative luciferase units were plotted with MS2-U1A values set 
to one.  The average of three experiments is shown. 
 
 193
When compared to the translational activity of wild-type DAZAP1 the AA and DD 
mutants did not differ substantially in translational activity (figure 5.12A) nor did  
oocyte maturation substantially alter stimulation by tethered DAZAP1 and mutants 
thereof (figure 5.12B). 
 
This could be interpreted to suggest that DAZAP1 does not need to interact with Dazl to 
stimulate translation as it assumed that the DD mutant would not be able to interact with 
Dazl in the oocyte, consistent with either model 2 or 3.  However, the interaction of 
these mutant proteins with endogenous Xenopus DAZL where not investigated.  
Alternatively as the interaction of the full-length DD mutant was not completely 
abolished binding in vitro, the residual binding may be sufficient to recruit Dazl given 
the expression levels of the MS2-DAZAP proteins.  The implications of this experiment 




In this chapter the role of DAZAP1 in translation and specifically its role in translation 
with regards to Dazl and PABP have been investigated.  Previous work had proposed 
different potential functions for DAZAP; the first of these was that of a RNA 
localisation protein (Zhao et. al., 2001) and the second was that of an inducer of RNA 
instability or a repressor of DAZ (Morton et. al., 2006).  In figure 5.5 it was established 
that endogenous DAZAP1 and Dazl could possibly interact in Xenopus oocytes.  This 
observation raised the question of whether DAZAP1 had any bearing on the model of 
Dazl stimulation of translation, the main focus of this thesis.   
 
When the localisation of DAZAP1 on a sucrose gradient was explored it was found to 
co-sediment with ribosomes and light polysomes in stage VI oocytes and show an 
increased interaction with light polysomes in mature oocytes perhaps suggesting an 
interaction with the translation machinery.  This indicates that DAZAP may have a 
potential role in translation, but may merely mean that it is associated with actively 
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translating mRNAs rather than directly promoting their translation.  Such a 
sedimentation pattern could also be consistent with a role in stability.  However, proteins 
that are associated with actively translating ribosomes tend to localise with polysomes 
fractions and then release to the mRNP fraction upon EDTA treatment so this pattern of 
co-localisation is not typical.  One encouraging result is that in the same experimental 
system, over-expressed Xenopus PABP1, a known translational regulator localises to the 
same fractions as DAZAP1 (B.Gorgoni, personal communication).  This recent result 
gives more precedence to the theory that DAZAP1 is involved with actively translating 
ribosomes. 
 
This could be a result of a lack of intact polysomes in the sucrose gradients from these 
experiments.  It has been shown by extracting ribosomal RNA from gradient fractions 
that there are ribosomes in the three fractions (usually numbers 4, 5, and 6) just 
proceeding the 80S peak (B.Gorgoni, personal communication).  However it is not clear 
if these represent true polysomes, or just heavier monosomes.  The distribution of 
DAZAP1 after EDTA release could indicate that DAZAP1 interacts directly with 
ribosomal subunits and that hypothesis is worth investigating in the future.  Another 
explanation for DAZAP1 localising in the same sedimentation fraction as the ribosomes 
could be that they are part of a ‘heavy mRNP’, a complex of proteins on an RNA that 
contains enough large proteins that it co-sediments with translational machinery, despite 
not actually being associated with them.  Heavy mRNPs have been proposed to account 
for the reason that mRNAs bound by microRNAs were observed to co- sediment with a 
polysomes fraction (Thermann and Hentze, 2007).  Given the number of proteins that 
interact with Dazl, i.e. DAZAP, PABP, DZIP, Dynein and Pumilio, it is possible that 
DAZAP can be found in a large enough protein complex to localise where it does on a 
gradient without being bound to RNA.  This could be further investigated by releasing 
the ribosomes with puromycin rather than EDTA.  This drug also causes the release of 
the ribosome from mRNA but does not disrupt other protein/protein and RNA/protein 
interactions in the manner of EDTA, and is therefore more specific (Xaplanteri et. al., 
2003). It would also be of interest to look at the gradient profile of tethered MS2-
DAZAP1 on a MS2 containing RNA.   
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The result seen in the sucrose gradient here is directly opposed to the result for a similar 
experiment conducted previously (Dai et. al., 2001).  In this experiment post-
mitochondrial mouse testis extract was analysed on a 15-45% sucrose gradient and 
blotted for DAZAP1.  DAZAP1 was found to be localised exclusively in the mRNP 
fraction suggesting that it was not directly involved in translation.  The disparity seen 
between this experiment and the results presented in this chapter could be caused by a 
number of factors.  First, the differences seen here could be due to the species used, 
DAZAP1 could behave differently in mice to Xenopus.  The effect could also be due to 
the tissue used, Xenopus oocytes represent a pure germ cell sample whereas the previous 
experiment was conducted in a whole testis extract.  This is important as DAZAP is also 
present in somatic cells where Dazl is absent and may have a different role with different 
protein partners in these cells.  There could be a developmental stage specific DAZAP1 
interaction with mRNAs, especially at meiosis.  The oocytes used in the experiments 
were either stage VI, which are all pre-meiotic or mature oocytes that are entering the 
first meiotic division.  In an adult mouse testis not all cells would be germ cells and only 
a subsection would be at a particular stage of meiosis.  It could be that by using a mixed 
lysate, Dai et al missed the translational activity of DAZAP1.  Support for this idea 
comes from the finding that human DAZAP1 can also stimulate translation in these 
germ cells, suggesting that there is not an inherent difference between the frog and 
mammalian DAZAPs.  These hypotheses could be investigated by looking at single cell 
type systems in mouse, and also by investigating if the result present in this thesis is 
common to all oocyte and early embryo stages, or if DAZAP1 re-localises on a sucrose 
gradient over time, reflecting a changing function.  There could also be differing effects 
in different stages of oocyte or embryo development regarding the interactions of Dazl 
and DAZAP1. 
 
In the gradients presented in figure 5.6 there are variations in the distribution of the 
endogenous DAZAP1 seen between the two gradient experiments presented.  It would 
be expected that the endogenous protein distribution would remain constant, so what are 
the possible explanations?  First, it could be the result of experimental variation between 
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the two different experiments (one with endogenous DAZAP1 alone, one with 
endogenous and overexpressed DAZAP1).  For this reason it is only possible to compare 
gradients run on the same day with the same oocytes (i.e. A and B or C and D).  Second, 
the variation could be the result of over-expressing additional DAZAP1, which may 
have caused the changes in the disruption of the original message.  However, as these 
experiments were not run in parallel, this remains to be determined. 
 
To investigate a potential active role in translation, tethered function assays were 
undertaken.  Although the translational activity of DAZAP1 had never been directly 
assessed in previous work, it was found that it stimulated translation strongly when 
tethered, perhaps surprisingly given the previously proposed functions.  One explanation 
is that DAZAP1 is a bona-fide stimulator of translation, and another plausible 
explanation is that the stimulation seen in tethered function assays could be an artefact 
of Dazl binding activity recruited by DAZAP1.  These results lead to the development of 
three possible models to explain the relationship between DAZAP1 and Dazl-mediated 
translation (fig 5.8).  The first model was that DAZAP1 acts as an RNA anchoring 
protein to a complex containing Dazl which through its interaction with PABP 
stimulates translation.  The second model was that Dazl stimulates translation via both 
PABP and DAZAP1 and DAZAP1 has its own stimulatory activity.  The third model 
was that DAZAP1 stimulates translation independent of Dazl or PABP.  The remainder 
of the chapter tried to reconcile these models with the tools available at the time.  
 
To distinguish between the models available various tethered function assays were 
employed.  The first of these investigated the effect of tethering one or more molecules 
of DAZAP1 to the reporter.  When DAZAP1 was investigated (figure 5.9) it was found 
that multiple molecules could stimulate in a similar pattern to Dazl and PABP.  As this 
evidence is consistent with DAZAP1 acting via Dazl and PABP it supports model #1, 
though it must be noted that is does not rule out models #2 and 3.  In the next 
experiment DAZAP1 showed reduced fold-stimulation of translation in the presence of a 
poly(A) tail (figure 5.10).  This sensitivity to a poly(A) tail provides a strong argument 
for DAZAP ultimately using PABP as an effector for its translational activity as the 
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main difference in adding the tail is that the reporter would already be bound by PABP.  
Thus explaining the reduced stimulation as adding extra PABP molecules via DAZAP1 
when there are already (poly(A) bound) PABP molecules present would have less effect 
then when there are no PABP molecules already present on the mRNA.  This again 
supports model #1 as the most viable.  However, other functions of the poly(A) tail 
independent of PABP have been described (Thoma et. al., 2004) and several other 
proteins have been isolated from poly(A) tails in Xenopus oocytes (Swiderski and 
Richter, 1988).  
 
So far the evidence available has most strongly supported model #1, however when the 
effect of oocyte maturation on DAZAP1 stimulation was investigated (figure 5.11) it 
was observed that translational stimulation did not increase in mature oocytes.  This is 
different to the activity of Dazl and PABP in oocytes, which showed an increase in 
stimulation.  This would imply that DAZAP1 does not depend on Dazl or PABP for its 
translational activity.  However as there are so many changes in mature oocytes upon 
maturation it is difficult to speculate on what may be the cause of any results.  There are 
phosphorylations of Dazl, and possibly DAZAP, which could affect their activity and 
interactions and also the loss of repressors, such as Pumilio, which could also have an 
effect.  In addition, oocyte maturation causes a lot of variation in tethered function 
assays, as can be seen by the error bars in figure 5.11.  Another aspect that could affect 
this result is that the oocytes were collected as mature after an overnight incubation with 
progesterone.  There could be variation between samples and the time each set of 
oocytes takes to reach maturation (3-16 hours).  To make this result more reliable this 
experiment could be repeated taking different time points, including GVBD50 and also 
including Dazl and PABP in parallel in order to discover the true relationship between 
Dazl, DAZAP1 and PABP in mature oocytes.  The difficulties in assessing what is 
causing any changes and the experimental error in this system means that this 
experiment is in my opinion the least convincing of those undertaken when trying to 
decide on a model for DAZAP1 action.    
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The final investigation in this chapter utilised some DAZAP1 phosphomimetic mutants.  
The results of this experiment could be taken as to suggest that DAZAP1 stimulation is 
not dependent on binding DAZ family proteins, such as Dazl.  This would indicate 
model #3, a function for DAZAP1 independent of its Dazl binding activity, as the most 
likely.  However as mentioned earlier there is a lot of potential for DAZ and Dazl to 
interact differently with DAZAP1 so it hard to draw any reliable conclusions form these 
experiments.  While an investigation of the interaction with DAZ is certainly interesting 
it is out with the scope of this thesis, which concentrates on Dazl.  
 
Overall in this chapter there are data that support a role for DAZAP1 in Dazl mediated 
translational stimulation with model #1 being most consistent with the results seen.  
Although this may change with further investigation, what are the implications of this 
current model of Dazl action?  This question will be addressed in chapter 6.  Next the 
possible avenues of investigation to further clarify the activity of DAZAP1 and its 
relation ship with Dazl and translation will be discussed. 
 
As previously stated further work will be required to definitively clarify the relationship 
of DAZAP1 with Dazl.  One of the most informative techniques would be to employ 
further IP experiments to identify what complexes Dazl, DAZAP1 and PABP form in 
oocytes.  These experiments were attempted during the last month of the project, but 
failed to yield any results in the time period available.  Obviously continuing this work 
would be an important element of any future work on this project.  A previous study 
(Morton et. al., 2006) included a study of the complexes made by DAZ, DAZAP1 and 
PABP in vitro.  This study observed that DAZ and PABP or DAZ and DAZAP1 could 
interact but all three could not exist as a triple complex.  Applying this result to the 
proposed models of DAZAP1’s translational activity only model three is consistent.  
However there are reasons why this data may not apply to this investigation.  The first 
reason is that the previous study was conducted in vitro using DAZ.  DAZ although 
related to Dazl has not been subject to much investigation.  It is known to stimulate 
translation and bind Xenopus PABP1 and ePABP (Collier et. al., 2005). However in this 
thesis it was shown that DAZ and human PABP1 may not interact (figure 4.3).  DAZ 
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also differs from Dazl significantly in that it has multiple (9-15 depending on which of 
the four DAZ genes it is expressed from) copies of the DAZ repeat.  Bearing in mind that 
it is via the DAZ repeat that DAZAP1 interacts with DAZ and DAZL (Tsui et. al., 
2000a), the requirement of this repeat for polysome association in mouse and full 
translational stimulation in Xenopus and zebrafish is not necessarily consistent with its 
interacting with a translational repressor. The interactions and function of DAZL and 
DAZ could be very different regarding DAZAP1.  Another possible explanation of why 
triple complexes were not seen in previously published work using overexpressed 
proteins is that the IP conditions were too restrictive to pull out triple complexes, which 
may be transient and only formed on RNA or that these complexes are dependant on a 
germ cell environment as regulation by Dazl has failed to be recapitulated using these in 
somatic systems.  
 
In order to discover the true role for DAZAP1 in Dazl’s ability to stimulate translation it 
would be useful to map the Dazl binding site on DAZAP1.  Initially large truncations or 
internal deletions could be used to discover which part of the DAZAP1 protein is 
required for the binding of Dazl.  The different truncated DAZAP1 proteins could also 
be tested for their ability to stimulate translation in tethered function assays.  This would 
determine whether or not DAZAP1’s observed stimulatory activity is separable from its 
ability to bind Dazl. 
 
If interactions with Dazl and/or PABP are proven or disproven then the other proteins 
that DAZAP1 binds to could be indicative of function.  A screen to discover what the 
protein partners of DAZAP1 would be informative.  So far the only protein partners 
identified for DAZAP1 were profillin, a protein that promotes actin polymerisation, and 
Mena, a microfilament-associated protein (Zhao et. al., 2001).  It was on the basis of 
these interactions that DAZAP1 was suggested to be involved in RNA transport.  This 
ability to bind transport proteins does not preclude a role as a translational activator, 
indeed Dazl also binds a transport protein, dynein, reflecting the potential 
multifunctional roles of these proteins (see chapter 6).  Establishing what the other 
protein partners of DAZAP1 are in oocytes could answer some of the questions 
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presented by the data shown in this chapter, such as why is DAZAP1 seen to associate 
with the ribosomal subunits, does it interact with ribosomal proteins directly?  
Biochemical interaction studies, for example yeast-two hybrid analysis, could be used to 
address this question.  
 
The question of what RNAs DAZAP is acting upon would need to be addressed, 
previous work showed DAZAP1 binding to the 3’UTR of Vg1 RNA (Zhao et. al., 2001). 
Vg1 has not been suggested to be a target of Dazl, and does not have a sequence closely 
resembling the dazl binding site.  This raises the question of whether DAZAP1 has 
separate functions depending on which RNA and proteins it is bound to.  There is also 
the possibility that DAZAP1 may have different functions in different cell types.  In 
Xenopus DAZAP1 has only been shown to be expressed in oocytes whereas in humans 
and mice DAZAP1 has been shown to be more widely expressed  Where DAZAP1 is 
expressed in tissues that do not co-express Dazl family members the function could be 
very different.   
 
Overall whether DAZAP1 is an activator, repressor, inducer of instability or localisation 
protein remains to be seen.  It is also unclear if the main identified protein interaction of 
DAZAP1, Dazl, is significant to its function.  Future investigation into these questions 
could provide insight into this interesting protein.  
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Chapter 6: Final discussion 
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In this thesis I have presented specific discussions in each chapter where individual 
results and the techniques utilised were discussed.  This chapter will consider the results 
of the thesis as a whole and their impact on the current knowledge of Dazl as a 
translational regulator in gametogenesis.  Potential future experimental work to expand 
the studies in this thesis will also be discussed. 
     
6.1 Dazl stimulates translation initiation at 43S joining via an 
interaction with PABP 
 
Before this thesis work was started a model for Dazl action was proposed in which Dazl 
stimulates translation by recruiting PABP to mRNAs with predominantly short poly(A) 
tails (Collier et. al., 2005).  It was also suggested that Dazl acts at the stage of translation 
initiation (Collier et. al., 2005) consistent with the pleiotropic effects of PABP on this 
process. 
 
In chapter 3 of this thesis, use of the variable reporter tethered function assay showed 
that Dazl most likely stimulates translation at the stage of 43S joining and in chapter 4 it 
was shown that PABP gives a pattern of stimulation in the variable reporter tethered 
function assay that is consistent with its role as an affecter molecule for Dazl.  These 
results provide further support for a role of PABP and importantly provide the first 
insight into the point of the initiation pathway that Dazl stimulates. 
 
These analyses were performed using tethered function assays, however since this work 
was completed several target mRNAs of mouse Dazl protein have been verified.  It 
would be of interest therefore to extend this analysis to mRNAs containing the 3’UTR of 
one of these mRNAs to address the physiological relevance of my observations.  The 
verified targets include the mouse Vasa homologue (Mvh) (Reynolds et. al., 2005) 
SYCP3 (Reynolds et. al., 2007) and also Drosophila twine (Maines and Wasserman, 
1999).  The latter is in keeping with the ability to do cross-species rescue of the 
Drosophila Boule phenotype (Slee et. al., 1999).  In the lab, Dazl stimulates translation 
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from the twine 3’UTR 7 fold, the Mvh 3’UTR 5.5-fold and the Scyp3 3’UTR 4 –fold.  
The strong stimulation directed by the twine 3’UTR makes it an attractive candidate for 
such analysis.  However, Mvh and Sycp3 are both physiological targets of mouse Dazl, 
and point mutations in Sycp3 have been identified that prevent Dazl-mediated 
stimulation, providing an excellent specificity control.  However, it must be remembered 
that these 3’UTRs also contain other regulatory signals such as CPEs that could 
potentially influence the results, so mutations of these additional control elements may 
be required to address the influence of the Dazl protein on initiation.   
 
The discovery that Dazl can stimulate translation at 43S joining is of particular interest 
as the mechanism of action of only a handful of cellular mRNA specific activators have 
been examined.  Of these SLBP (Gorgoni et. al., 2005) mediates its effects from the 
3’UTR. In contrast to Dazl SLBP was shown to stimulate translation at the cap binding 
stage of translation initiation (Gorgoni et. al., 2005). 
 
The fact that Dazl activates at a different stage to these proteins is interesting as it 
suggests that it represents a new class of translational stimulatory protein and a novel 
mechanism of stimulating translation.  Since our observations, it has also been suggested 
that BRCA1 may also stimulate translation by direct recruitment of PABP.  Thus the 
model presented here may have relevance to the regulation of other mRNAs outside the 
germ line, and it would be of interest to determine whether other proteins also utilise 
PABP in a similar manner.  The first step to find these other proteins is to establish what 
the binding site that recruits PABP consists of.  The work presented in chapter 4 
represents my efforts to further delineate the PABP binding motif of Dazl.  At the end of 
the chapter some progress had been made, but the question had not been answered fully.  
However, the identification of a PABP binding motif and the critical amino acids for 
PABP binding could be crucial to identifying other translational regulators that act via 
PABP.  It is likely that this motif would be different to the previously identify PAM2 
PABP binding motif as Dazl does not contain a PAM2. 
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However interesting the results presented in this thesis are, the mechanism for Dazl 
stimulation is not yet fully defined.  As mentioned in the discussion of chapter 3, 
although 43S joining remains the most likely stage of initiation that Dazl stimulates at, it 
is possible that there is also an effect on scanning but the assay used in this thesis could 
not distinguish further between the two stages.  Ultimately, sucrose gradient analysis of 
initiation intermediates and toe-printing will be required to fully reconcile whether 43S 
joining, scanning or both are affected by Dazl.  It is possible to use sucrose gradients and 
various different drugs to stall translation at different points and see where on a gradient 
a labelled RNA accumulates in the presence or absence of Dazl.  While this approach 
could be useful it also has a number of drawbacks including the fact that it is difficult to 
asses cap binding effects and gives no insight into possible factor requirements, as the 
variable tethered function did in this study.  Sucrose gradient analysis of initiation 
intermediates is normally performed in vitro, and Dazl-mediated translation appears to 
require a “germ-cell environment” preventing use of commercial extracts such as rabbit 
reticulocyte lysates.  Whilst it is possible to utilise translation extracts derived from 
Xenopus oocytes these do not show robust activity, therefore the possibility of utilising 
Drosophila embryo extracts that are more robust and likely to share many of the key 
features required for Dazl-mediated regulation is currently being explored.  Thus, it may 
be beneficial to utilise the twine 3’UTR for future variable tethered function assays to 
link previous work in Xenopus oocytes with initiation complex analysis in Drosophila 
embryo extracts.      
  
Another pertinent question is which initiation factors does Dazl require for its role as a 
translational stimulator?  A role for PABP has already been established (Collier et. al., 
2005) but the exact protein interactions that are required remain unknown, although a 
number of protein partners for PABP have been established it is also clear that our 
knowledge of PABPs partners in initiation is not complete.  To further resolve the 
mechanism of translational stimulation beyond that presented in this thesis a series of in 
vitro experiments could be undertaken if translational stimulation can be reconstituted.  
This would allow the translation factor complement to be manipulated to ascertain 
which factors are absolutely required.  For instance, to test whether the PABP is required 
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it could be depleted using antibodies of Paip2 (Svitkin and Sonenberg, 2004) and 
recombinant PABP added-back to rescue activity if lost. If PABP was shown to be 
required, the importance of its interaction with eIF4G for instance could be probed using 
viral proteases that cleave eIF4G, for example coxsackievirus B4 protease 2A (Keiper 
and Rhoads, 1997) or proteins that block eIF4G-PABP interactions, for example Paip2 
(Karim et. al., 2006) or rotavirus NSP3 (Groft and Burley, 2002). Ultimately, Dazl-
mediated stimulation could be entirely reconstituted from recombinant factors in a 
manner analogous to how the factor requirements for particular IRESs, EMCV and 
CSFV were determined (Pestova et. al., 1996a; Pestova et. al., 1998). Again this 
approach would require recombinant or purified Dazl, so the development of a strategy 
that could generate this would be the key step in furthering this work. 
 
An alternative approach to examine the factor requirement of Dazl could be a genetic 
approach where the effect of mutations that disrupt the interactions between Dazl and 
various initiation factors is utilised to discover which factors are important.  One of the 
main aims of chapter 4 was to further characterise the PABP-binding site within Dazl 
family members leading to the generation of a point mutation that is deficient in PABP 
binding that would have enabled the categorical address of whether Dazl stimulation is 
entirely dependent on its interaction with PABP or whether other factors are involved.  
This mutant could also have been used to generate transgenic mice to determine the 
physiological role of the PABP-Dazl interaction in germ cells. 
 
6.2 A proposed mechanism for Dazl’s physiological role in 
translation activation 
 
Even if the mechanism behind Dazl stimulation in terms of factor requirements and 
exact event in translation are discovered, there remains the question what is the 
physiological role of Dazl’s translational activation activity.  The identification of target 
mRNAs is an important step towards this end, but does not explain why these mRNAs 
are controlled by an mRNAs specific activator rather than by alternate mechanisms that 
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control many germ cell mRNAs.  In gametogenesis many RNAs are held in the 
cytoplasm with short poly(A) tails (see figure 6.1A), which results in low or no 
translation, until they receive a signal to undergo cytoplasmic polyadenylation.  
Different classes of mRNAs are activated by cytoplasmic polyadenylation at different 
times depending on whether their protein product is required, for instance earlier or later 
in meiosis or following fertilisation (reviewed in (Mendez and Richter, 2001)). 
Regardless of the timing,  newly synthesised poly(A) tails provide binding sites for 
molecules of PABP that then stimulate translation (figure 6.1B).  
 
Whilst it is clear that specific subsets of mRNAs undergo this sort of polyadenylation at 
defined times during gametogenesis, the configuration of elements that determine this 
and the upstream signalling pathways remain an area of intense interest (de Moor et. al., 
2005; Richter, 1999). However, it is also clear that during oocyte maturation in Xenopus 
for instance, events precede the onset of the first subset of mRNAs that undergo 
cytoplasmic polyadenylation, some mRNAs appear to be polyadenylated in response to 
activation rather than being caused by activation, and other mRNAs do not require 
changes in poly(A) tail length for their activation.  Thus these mRNAs require a 
different mechanism of activation.  For some of these loss of a repressor protein may be 
sufficient but for others, especially those with a short poly(A) tail, an activator may be 
required to promote their efficient translation in a competitive environment where many 
mRNAs have undergone polyadenylation.  Dazl may provide one mechanism by which 






























Figure 6.1: Levels of gene expression of mRNAs with and without Dazl binding sites and 
their response to polyadenylation. 
A: mRNA with a short poly(A) tail and no Dazl binding site.  Gene expression is low. 
B: mRNA with a long poly(A) that is binding multiple molecules of PABP.  Gene expression is 
high. 
C: mRNA with a short poly(A) tail and a Dazl binding site, binding PABP via Dazl.  Gene 
expression is high.  Note that potential target mRNAs may contain multiple Dazl binding sites.   
D: mRNA with long poly(A) that is binding multiple molecules of PABP and a Dazl binding site, 
binding PABP via Dazl.  Gene expression is very high. 
E: mRNA with a short poly(A) tail and a Dazl binding site that cannot bind PABP due to the 
presence of a repressor protein.  Gene expression is low. 
 
It is interesting to note therefore that the two best characterised vertebrate Dazl targets, 
Mvh (Reynolds et. al., 2005) and Sycp3 (Reynolds et. al., 2007) both contain both Dazl 
binding sites and CPEs. In the case of Sycp3 these CPEs have been shown to be 
functional and Sycp3 has been shown to be stored with a short poly(A) tail of 20 
nucleotides (Tay and Richter, 2001). Preventing the polyadenylation of Scyp3 (Tay and 
Richter, 2001) or blocking its activation by Dazl (Reynolds et. al., 2007) both result in 
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heavily reduced although not completely abrogated translation of this mRNA, 
suggesting that both contribute to its maximal activation. Whether these events occur 
simultaneously or whether Dazl activation precedes cytoplasmic adenylation of this 
mRNA remains to be determined.  However, The CPE and dazl binding site on this 
mRNA overlap (Reynolds et. al., 2007) suggesting that both proteins are unlikely to be 
simultaneously bound to the mRNA. 
 
It is interesting to speculate what is special about germ cells such that they need specific 
translational activator proteins such as the Dazl family members.  It is known that 
transcription terminates during mid-spermiogenesis (Kierszenbaum and Tres, 1978) 
indicating that the changes to gene expression required for later spermiogenesis must be 
controlled in a post transcriptional manner.  Perhaps the Dazl family of proteins has 
evolved in order to fulfill the need for control of gene expression in cells that cannot 
regulate gene expression via transcription due to events occurring in the nucleus.  
 
6.3 The interactions between different Dazl and PABP members 
may be significant 
 
Examining the interactions between Dazl and PABP family members (chapter 4) 
revealed that different Dazl family members and different PABP family members may 
potentially interact in a non-redundant manner (figure 4.3).  This raises the question of 
which PABPs are utilized by Dazl family members in germ cells where Dazl is 
expressed.  In human germ cells DAZ, DAZL and BOULE are all expressed in various 
different germ cells (see section 1.6.3) as are the mRNAs of PABPC1 and tPABP (Feral 
et. al., 2001). PABP4 (Hannah Burgess unpublished) and ePABP (Wilkie et. al., 2005) 
are also potentially expressed in germ cells whereas PABP5 is restricted to the somatic 
cells of the gonad at least in mouse (Ross Anderson, unpublished). Thus at least two 
PABP proteins with similar structure are potentially present in the cells that Dazl family 
proteins are expressed in.  Whilst the reason underlying the expression of multiple 
PABPs in these cells remains unclear, one intriguing possibility raised by this work is 
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that whilst they share an ability to promote poly(A) mediated translation, they may differ 
in their ability to be recruited to specific mRNAs through proteins such as Dazl.   
 
The exact interactions between Dazl family members in mammalian germ cells are 
currently impossible to determine due to the lack of evidence for which particular 
PABPs are expressed in which particular germ cells.  Traditionally antibodies to 
mammalian PABPs have not discriminated between the different family members and 
until this problem is solved it will be impossible to determine which PABP family 
members have the potential to interact with which Dazl family members in germ cells.  
A project has been initiated (Ross Anderson and Hannah Burgess, unpublished) seeking 
to address this issue but at the time of writing no firm results have been established.   
 
Thus different combinations of Dazl family members and PABPs may regulate different 
target mRNAs or activate at different times.  Elucidating the physiological targets for 
different Dazl family members and investigating the differential roles of PABPs in their 
regulation and how the interactions are regulated will be an important aspect of truly 
understanding how Dazl regulates gene expression.   
 
6.4 The role of DAZAP1 in Dazl mediated translational 
stimulation 
 
In chapter 5 of this thesis it was shown that DAZAP1 can stimulate translation tethered 
function assays consistent with its presence on polysomes.  This contrasts sharply with 
published models of DAZAP1 based on indirect observations of its interaction with 
localisation sequences, its presence in mRNPs and an inability to assemble DAZL-
DAZAP1-PABP complexes in vitro.  Whilst, I have not directly demonstrated the 
presence of DAZL-PABP-DAZAP1 complexes in vivo, a number of mechanistic 
approaches support the hypothesis that DAZAP1 stimulation is most likely dependent on 
PABP.  Most strikingly is the fact that DAZAP1 showed reduced stimulation of 
translation in the presence of a poly(A) tail.  
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It is not yet clear whether this observed activity in stimulating translation is DAZAP1’s 
primary function; many 3’UTR-binding proteins have multiple functions dependent on 
the partners with which they interact.  As mentioned in chapter 5, deletion mapping of 
DAZAP1 could be utilised to determine whether binding to Dazl is required for 
DAZAP1s stimulatory function.  
 
One possible outcome of this analysis is that DAZAP1 may be found to act as a co-
factor for Dazl rather than having its own intrinsic function as a translational activator.  
As DAZAP1 has been shown to bind RNA, it may act as a ‘linker’ molecule, enabling 
Dazl to bind more efficiently to mRNA, or to a different subset of RNAs altering the 
specificity.  Dazl binds to as yet poorly defined consensus sequences and perhaps the 
degenerate nature of these could be due to the separate binding of DAZAP1 to another 
site that helps to anchor Dazl.  Such a model would be reminiscent of regulation of 
mRNAs in Drosophila by Pumilio containing complexes (Wickens et. al., 2002). 
Moreover, some Dazl regulated mRNAs may not be dependent on an mRNA possessing 
a Dazl binding site but instead be regulated by a co-factor such as DAZAP1 binding 
before recruiting Dazl.  
 
If DAZAP1 is found to be able to stimulate translation independent of binding Dazl, this 
does not rule out that it functions primarily as part of this complex in germ cells being 
recruited to mRNAs by Dazl, with the tether protein substituting for Dazl function in our 
assay.  However, if DAZAP1 functions through PABP it is unlikely that it is acting as a 
translational stimulator in these complexes, as DAZL and PABP can interact directly.  
Thus is would seem most likely that this represents a function of DAZAP1 that is 
independent of its function from Dazl.  Thus the observation that DAZAP1 could 
stimulate translation independent of DAZL would be potentially very interesting, 
suggesting that it can function as a novel translational activator in its own right.  
Moreover, as no interaction between DAZAP1 and any component of the translation 
machinery has been reported, understanding the mechanism of DAZAP-mediated 
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stimulation could form the basis of future work.  Thus the determination of whether the 
action seen in this thesis is independent of Dazl is of paramount importance.  
 
Whether DAZAP acts as a linker molecule recruiting DAZL or has translational activity 
in its own right, its function is unlikely to be limited to Dazl-mediated regulation.  
Whilst DAZAP1 is mainly expressed in the testis and ovaries in humans (Tsui et. al., 
2000a) (Pan et. al., 2005), it has also been suggested to be expressed in other tissues at 
lower levels including thymus, heart, liver and muscle as shown by northern blot.  In 
mice the DAZAP1 protein is found mainly in the testis, and also in the ovary, spleen, 
liver, lung and brain (Dai et. al., 2001). Moreover, in Xenopus it has been reported as a 
protein bound to the Vg1 localisation element an mRNA, which has not been reported as 
being subject to Dazl mediated regulation.  The implication of DAZAP1 being expressed 
in tissues that do not also express Dazl family members is that it may have multiple 
partners and functions and there are many possible future studies exploring this 
interesting protein.  
 
6.5 Proteins other than PABP may play a role in Dazl’s 
translational activities 
 
The finding that Dazl family members activate translation does not exclude them having 
other functions related to translation or distinct roles within the cytoplasm or nucleus.  
Indeed, many mRNA binding proteins interact with different partners in different cell 
types or developmental stages to perform different functions.  Thus, it remains possible 
that the early phenotype seen in Dazl family member knockouts is not due to a lack of 
activation of target mRNAs through PABPs but a loss of translational repression or 













Dazl complexes with multiple partners
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Figure 6.2: Potential Dazl functional complexes 
 
In figure 6.2 some of the potential complexes are shown, which will be discussed in 
more detail below.  DAZAP1 was not included as which of these categories it belongs to 
remains to be discovered. 
 
6.5.1 Dazl activation complexes 
 
The most studied type of complex so far is that of a Dazl activation complex, by which 
Dazl activates translation via its interaction with PABP as seen in the work that preceded 
this thesis (Collier et. al., 2005) and further investigated in chapter 4.  As mentioned 
above there are probably many different variations on this complex with different Dazl 
family members binding different PABP family members.  As it is not known if all the 
PABP family members stimulate translation and if they do, what degree of stimulation 
they would give, this is another potential source of variability of Dazl function. 
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6.5.2 Dazl repression complexes 
 
The functional relationship between Pumilio and Dazl is currently unclear.  It is possible 
that Pumilio merely aids the recruitment of Dazl to mRNAs or alters direct target 
specificity due to the presence of Pumilio binding and Dazl binding sites within an 
mRNA.  This would be similar to its role in Drosophila (Parisi and Lin, 2000).  Thus, it 
seems likely that Pumilio may be involved in recruiting repression complex to these 
mRNAs, perhaps silencing them until their translation activation, as proposed for Ringo 
mRNA (see below).  In this context, Pumilio may repress Dazl bound mRNAs by 
interacting with partners that may act independently of Dazl or directly interfere with 
Dazl function or Dazl itself may actively participate in translational repression when 
complexed with Pumilio.  These questions all remain to be addressed.  However, it is 
interesting to note that the proposed Pumilio binding site in Dazl overlaps with the 
PABP binding site, perhaps suggesting a mutually exclusive relationship. 
 
In C. elegans an interaction between CPEB and Dazl was also reported.  CPEB is a 
bifunctional protein involved in mRNA repression as well as cytoplasmic 
polyadenylation.  However, the Dazl target mRNAs analysed to date do not contain the 
multiple CPEs indicative of repression and a complex between these proteins could not 
be detected in mouse.  Moreover the binding sites on the only mRNA analysed 
(Reynolds et. al., 2007) overlap suggesting that these proteins may not bind 
simultaneously.   
 
6.5.3 Dazl localisation complexes 
 
Mouse Dazl was also shown in yeast two-hybrid and GST-pull down experiments to 
interact in with Dynein light chain, a component of the Dynein-Dynactin motor complex  
that has an important role in mRNA localization and was shown to be localised in a 
microtubule dependent manner (Lee et. al., 2006). In addition, DAZAP1, also interacts 
with profilin, a protein involved in localization (Zhao et. al., 2001), and it is possible 
that it may do this whilst also complexed to Dazl. 
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Given the close links between mRNA localization and translation, and the presence of 
germplasm with many localized mRNAs in a variety of model organisms, it is tempting 
to speculate that Dynein may direct the localization of DAZL bound mRNAs, before 
Dazl dictates the levels of translation once localized. 
 
6.5.4 Multiple interaction complexes 
 
Rather than acting with just one protein partner as suggested in the examples above it is 
more likely that Dazl will form complexes of proteins with multiple members at once.  
An mRNA could for example initially be bound by a complex of Dazl, Pumilio, Dynein 
and possibly PABP.  This complex could direct Dazl-bound mRNAs to specific sub-
cellular regions via Dynein and repress their translation during localization or until 
required with Pumilio.  At the appropriate time and place the Pumilio and Dynein could 
exit the complex and thus leave Dazl and PABP to stimulate the translation of the 
mRNA.  The establishment of which complexes of proteins could form, on and off RNA 
is an interesting direction for a future project to take.   
 
One example of a place where this sort of regulation may take place is that of the 
RINGO/Spy mRNA in Xenopus oocytes.  This mRNA has been shown to be bound by 
Dazl, PABP and Pumilio (Padmanabhan and Richter, 2006) although it was not 
established if multi-protein complexes formed on the mRNA at any point.  It was noted 
that Pumilio, was released from the mRNA upon oocyte maturation, thus potentially 








6.6 Many questions about Dazl remain 
 
Through both previous work and the data presented in this thesis progress has been 
made in identifying the mechanism by which Dazl stimulates translation, regarding both 
the role in translation initiation and also the protein partners that are involved in that 
process.  However many fundamental questions remain about the critical role of Dazl 
family members in gametogenesis.  
 
First, important questions remain pertaining to their mechanism, for instance a 
demonstration of the physiological role of PABP is required, as is an understanding of 
how this interaction promotes 43S joining and to what extent this represents a paradigm 
for translational activators.  Secondly, many of the target mRNAs of Dazl remain to be 
identified, in particular the target mRNAs in the spermatogonia, spermatocytes and 
female germ cells where a function for Dazl is known but targets are not.  Thirdly, it is 
also unlikely that Dazl acts in the same manner in all species, as evidenced by the 
differences in knockout phenotypes, so each must be investigated separately.  Indeed the 
differences seen in the effect of a Dazl knockout caused by differences in genetic 
background suggest that it is unlikely that Dazl acts in the same manner even within a 
species and that there could be modifiers of activity beyond those explored in this thesis.  
Fourthly, potential roles of Dazl in other aspects of RNA biology such as translational 
repression, mRNA turnover and mRNA localisation remain to be explored.  Fifthly, the 
regulation of these potentially different complexes will be important and Xenopus Dazl 
has been shown to be a phosphoprotein (Mita and Yamashita, 2000), providing a 
potential avenue for investigation. Lastly, the relationship between Dazl and the other 
Dazl family members and the extent to which their molecular functions and targets are 
related awaits clarification.  
 
A detailed understanding of each of these questions will be required to fully understand 
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